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Summary 
Transforming growth factor-β (TGF-β) is a key cytokine in liver fibrosis. It 
induces the activation of hepatic stellate cells (HSCs) leading to its expression of 
excessive extra-cellular matrix (ECM). TGF-β is expressed in its latent form and it 
needs to be activated to be functional. Previous studies have modeled a network of 
TGF-β activation in liver fibrosis regarding two major players, plasmin and 
Thrombospondin-1 (TSP1). TGF-β regulates cellular responses mainly through the 
Smad signaling pathway. In this network model of TGF-β activation, two species 
were regulated by TGF-β through Smad signaling, but this model treated the Smad 
pathway as a black box.  
We then first aimed to study the Smad signaling pathway using computational 
modeling. In this work, we used tightly coupled model analysis and experiments to 
systematically study the negative regulatory mechanisms in this pathway. 
Superisingly, we found no combinations of known mechanisms could explain the 
dynamics of phosphorylated R-Smad, the output species of this pathway. We then 
sought to find alternative mechanisms. Finally we concluded with a model with 
PPM1A, the phosphatase upregulated by TGF-β. This model was validated by our 
experiments and could explain all observations of phosphorylated R-Smad. 
After we had the updated model of downstream Smad pathway, we could 
possibly integrate it with the previous upstream network of TGF-β activation. This 
was not a simple integration as we noticed that the two species regulated by TGF-β 
signaling in the upstream network should be averaged responses from a population 
  xi 
of cells. An efficient algorithm to simulate the population behavior could be useful 
for our integration of two networks. We then developed two efficient algorithms to 
approximate cell population behavior and applied one of them, Population ODE to 
the integration of two networks. The integrated model maintained the bistable 
behavior and our algorithms could also be applied to other systems in which cell-
population behavior needs to be considered. 
Finally, we moved one step further from the population-level model to study 
the bistable switch of the TGF-β activation network in space. As we know that 
fibrotic regions often distribute unevenly in liver fibrosis. How the fibrotic regions 
and normal regions of liver tissue could affect each other remained a question. It is 
difficult to study the spatial dynamics using biologcial experiments but 
computational modeling could provide some hints. Our modeling assumed diffusion 
of molecules in space. This diffusion effect could cause a traveling wave of species 
steady states in space. Based on our simulations and experimental test, we could 
infer that normal liver tissue has the capability of switching the state of its 
neighbouring fibrotic tissue. Our simulations also predicted that this switching 
could be slowed down because of excessive ECM accumulation. This could be an 
explanation to how liver fibrosis is induced by chronic injury. 
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1 Chapter 1: Introduction 
The discovery of DNA and central dogma of molecular biology back in 1950s 
exploded biological studies. Basic molecular biological tools such as PCR and 
western blotting were developed afterwards promoting the studies of individual 
genes and proteins. Most of biological phenotypes are based on the functions of 
genes and proteins, and these functions are performed mainly by networks of 
protein-protein interactions and gene regulations. All the genes and proteins are 
connected in some way to form a complex system that works like a machine, but a 
much more complicated one than what human beings can build. Lead by the 
human genome project in the early 2000s and functional genomics, a large amount 
of data about genes and proteins were generated. Newly developed techniques such 
as microarray, RNAi, and immunofluorescence imaging allow high-throughput, 
more efficient and more accurate measurement of biological systems. With 
increasing efforts made in biological research and accumulating knowledge and data 
from biological studies, pieces in a large biological system, such as a signaling 
pathway were connected. This led us to look at biological systems from a 
systematic view, putting all genes or proteins that have interactions together. Then, 
systems biology emerges as a new type of approach in biological science. 
Systems biology, a concept have been widely used since 2000s, focuses on the 
study of biological systems as a whole, considering all species involved in a system 
and the interactions between species. This concept is somehow opposite to 
traditional molecular biological studies, in which elements or factors were taken 
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apart and often a single element or factor was emphasized to have the most 
important effect to a certain biological phenomenon. However, after more and more 
of these factors have been discovered, it is now a common sense that a biological 
phenomenon is often affected by multiple factors. High complexity is a nature of 
biological systems. The more components in the systems we discover, the more 
complex we realize they are. Therefore, without knowing how these components 
interact with each other to form and manipulate the system, we cannot fully 
understand the system. If we think the traditional molecular biology type of 
approach to be a top-down approach that breaks up each component in a system to 
study its role, systems biology type of approach is a bottom-up approach that 
integrates the components discovered or identified by the top-down approach. This 
bottom-up approach is necessary because the final goal of all biological research is 
to either change a biological system from outside, or maintain a system in the 
presence of outside changes. When any change or perturbation is applied to a 
biological system, the system itself will behave as a whole and we need to 
understand its behavior from a systematic point of view. 
The systems biology approach often utilizes computational models to integrate 
the biological data. There are various ways of building models for biological 
systems (Different modeling methods will be introduced in Chapter 2: Background 
and Related Work), but there is a general discipline of systems biology modeling.  
Modeling in systems biology generally goes through a cyclic process of theory, 
modeling, model-driven hypothesis, experimental validation, refinement of theory 
and models (Alberghina and Westerhoff, 2005). In most cases, the available 
  3 
biological data is much less than the data required to build an enough complete or 
accurate model. Therefore, models of a biological system is also usually updated 
and refined step by step and from study to study. Computational modeling has 
been applied to a variety of biological systems and predicts systematic behaviors 
that are non-intuitive from just examining a single part of the system. 
Computational modeling has also been used to study the activation of a key 
cytokine, TGF-β in liver fibrosis. It has also been shown that the activation of 
TGF-β exhibits a bistable behavior in liver fibrosis.  This is an initiative work to 
study the systematic behavior of TGF-β in liver fibrosis. However, some aspects of 
this model of TGF-β activation could be improved. In the following section, we 
introduce why and how we planned to contribute to the modeling of TGF-β related 
network in liver fibrosis.  
1.1 Context and Motivations 
Liver fibrosis is a disease affecting hundreds of millions of patients globally. The 
end stage of liver fibrosis, cirrhosis, may further lead to liver failure and liver 
cancer, causing millions of death worldwide every year. Major causes of liver 
fibrosis include chronic viral hepatitis, alcohol abuse (Iredale, 2007). Liver fibrosis 
is a would-healing process which is potentially reversible. It has been found in 
many studies that after removing the source of liver injury, liver fibrosis is 
regressed spontaneously (Hammel et al., 2001, Benyon and Iredale, 2000). However, 
some sources of liver injury are sustained and hard to be removed or stopped, such 
as viral hepatitis. Thus, therapies of liver fibrosis have focused on both removal of 
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liver injury and targeting liver fibrosis regression. In order to target liver fibrosis 
regression, understanding of the mechanisms of liver fibrosis progression and 
regression is important. 
 During liver fibrosis progression, a major change of the liver tissue is the 
accumulation of excessive extracellular matrix (ECM) (Arthur, 1997). Hepatic 
stellate cells (HSCs) are the primary source of the ECM (Bataller and Brenner, 
2005, Friedman, 2003). HSCs are quiescent in normal liver but activated in fibrotic 
liver. In its quiescent state, ECM production and degradation is balanced, while in 
its activated state, excessive ECM proteins are produced. The activation of HSCs is 
primary in liver fibrosis progression and understanding of its activation process is 
crucial in finding targets to block this process and further block fibrosis progression 
(Kinnman et al., 2001, Iredale et al., 1998). 
TGF-β is one of the key cytokine that can induce the activation of HSCs 
(Gressner and Weiskirchen, 2006, Gressner et al., 2002). Several studies have 
targeted TGF-β related signaling and regulations as therapies for liver fibrosis 
(Kondou et al., 2003, Currier et al., 2003, Salgado et al., 2000). TGF-β is expressed 
in its latent form (latent TGF-β), enclosed by the latency-associated protein (LAP) 
(Annes et al., 2003). Many activator and activation process can release active TGF-
β from LAP. These activators and activation process could form a complex network 
that regulates TGF-β. Active TGF-β then binds to receptors on the cell surface and 
induces Smad signaling cascade inside the cell to regulate gene expression (Shi and 
Massague, 2003, Attisano and Wrana, 2002, Massague and Wotton, 2000). Smad 
signaling is tightly controlled by downstream regulations. 
  5 
This thesis was first motivated by lack of understanding of downstream Smad 
signaling regulations. Therefore, we initiated our study from systematic analysis of 
Smad signaling pathway. Different negative regulatory mechanisms in Smad 
pathway have been studied biologically and individually built into computational 
models. However, the roles of these mechanisms in regulating Smad signaling have 
not been compared. We used computational models to analyze each mechanism and 
combination of mechanisms. Model-based predictions and experimental validations 
provided us new insights into Smad pathway negative regulations. This part is a 
cellular level study of TGF-β in liver fibrosis. 
Secondly, previous work has shown that the activation of TGF-β in liver 
fibrosis may exhibit a bistable behavior (Venkatraman et al., 2012), meaning that 
the TGF-β concentration may stay at two different steady states. The two steady 
state of TGF-β could switch back and forth by external perturbations to the system 
of TGF-β regulation. This network of TGF-β upstream activation consists of many 
reactions in the ECM and assumes cells are identical to each other. It is known 
that cell-to-cell variability is common in many types of cell populations. Cell-to-cell 
variability may affect the bistable behavior of the system. We therefore wanted to 
integrate our downstream Smad signaling model with the upstream TGF-β 
activation network and to see if the bistability could be affected by cell-to-cell 
variability. Simulating a population of cells is a computationally expensive task. To 
achieve our goal, we developed efficient algorithms for simulating signaling pathway 
in a population of cells. This part is a cell-population level study of TGF-β in liver 
fibrosis. 
  6 
Last but not least, fibrotic tissue in liver fibrosis does not distribute evenly in 
space. As Venkatraman’s model shows bistability of TGF-β activation, two steady 
states of TGF-β levels may also be present in different region of liver tissue. We 
therefore wanted to study how two steady states of TGF-β regulation network 
would affect each other in space. By assuming simple diffusion/transportation effect 
of molecules in the ECM, we were able to simulate the behavior of bistable system 
in space. This part is a tissue level study of TGF-β in liver fibrosis. 
 
1.2 Our Approaches and Contributions 
As mentioned, we use systems biology methods to study the TGF-β related 
regulations at three different levels: cellular level, cell-population level and tissue 
level. Since different levels of regulation have distinct behaviors, we use different 
approaches for different levels of study. 
For cellular level of TGF-β regulation, we studied the TGF-β signaling pathway 
within the cells. We used ODEs to build computational models to study different 
mechanisms of downstream regulation in TGF-β signaling pathway. The ODE 
models were based on mass action law of chemical reactions and they were able to 
simulate the time variant of reaction species concentrations. This approach allowed 
us to observe and analyze the dynamics of each step in this pathway. Besides using 
ODE as the modeling approach, we utilize parameter estimation to fit our model to 
experimental data and to closely look at the relationship between different 
regulatory mechanisms in TGF-β signaling pathway and the dynamics of the signal 
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transduction. ODE modeling allowed us to analyze detailed dynamics such as 
timing of different events. With this analysis, we found that there needs to be at 
least one “fast-mode” mechanism and one “slow-mode” mechanism to explain the 
dynamics of TGF-β signaling. However, modeling analysis combined with 
experimental measurements suggested that known mechanisms were not sufficient 
to explain the observed dynamics. This could not be discovered without ODE 
modeling. We then utilized the models to help us find possible alternatives. Model 
prediction and experimental validation showed that PPM1A, the phosphatase was 
upregulated in the presence of TGF-β. Our study showed that system level of 
analysis was able to refine some qualitative knowledge in biological discoveries and 
gain insights beyond a collection of biological information. 
For the cell-population level of TGF-β regulation, we wanted to integrate the 
models of upstream network of TGF-β activation and the downstream Smad 
pathway. Since the upstream network is in the ECM, the molecules regulated by 
Smad signaling in this network should be the average response of a population of 
cells. Thus, what we really needed was to integrate the upstream network and a 
population of Smad pathway. There is a naïve way of simulating cell population 
behavior, which is called Monte Carlo simulation. It simply takes random samples 
of the parameters of a system and then simulates all samples to approximate the 
population behavior. However, this method is often time consuming as the 
biological system is often complex and the sample size needs to be large. In the case 
of integrating two networks of TGF-β regulation, this type of sampling-based could 
not synchronize the species existing in both networks. Therefore, we first developed 
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an algorithm, Population ODE, which was more efficient than Monte Carlo 
simulation and not sampling-based. This approach approximated the population 
behavior by a new ODE system derived from single-cell ODE model. Because it is 
still an ODE system, it is easy to integrate a population of Smad pathways with 
the upstream network using this approach. This is a good approach and we wanted 
to extend its application. We found it works well in some well known pathway 
models. However, this algorithm did not approximate bistable system well. We 
then moved on to develop the second algorithm called Sample Reduction method, 
which is based on Monte Carlo simulation, however with significantly reduced the 
sample size. This method is a sampling type of method so that it can be applied to 
all types of systems. Sample reduction was tested in this method in apoptosis 
pathway, a well-known bistable system. The results showed that it significantly 
reduced sample size compared to Monte Carlo simulation. 
For the tissue level of TGF-β regulation, we built a spatial model of TGF-β 
upstream regulations. In this study, we integrated the effect of diffusion of 
molecules and the reactions of molecules to have a reaction-diffusion system, and 
we discretized the space so that we can use ODE system to simulate the effect of 
diffusion. As the TGF-β upstream regulations have a bistable behavior, this 
particular reaction-diffusion system showed a wave of bistable switch in space. This 
kind of behavior has been proven analytically in the field of physics but has not 
been shown in biological systems. Our simulation also showed that the ECM 
accumulation in liver fibrosis would slow down the wave and then prevent the 
fibrotic steady state from switching to normal steady state. This could be an 
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explanation to the phenomenon that chronic injury could cause continuous ECM 
accumulation but liver may regress back to normal if injury is terminated. This is 
one of the pioneer studies of tissue level modeling. Although the lack of 
quantitative information and complexity of the system allows us to only take one 
spatial property, diffusion, into consideration, we have already shown that the 
spatial information is important for biological systems. With new tools and data 
available, further models for biological systems may be able to include more and 
more components and aspects of an organism, and help us understand biological 
systems, the most complex system, better. 
1.3 Overview 
The following contents of this thesis are organized in this way: 
A single chapter (Chapter 2) introducing background information followed by 
three chapters (Chapter 3,4 and 5) of three studies at cellular level, cell-population 
level and tissue level of liver fibrosis. Finally we conclude this thesis in Chapter 6. 
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2  Chapter 2: Background and Related Work 
2.1 Approaches for Modeling Biological Systems 
Modeling is one primary task in systems biology. A variety of modeling 
approaches are applied to model different types of systems, including molecular 
systems (such as protein structure and molecule-molecule binding) (Kelley and 
Sternberg, 2009), cellular systems (such as genetic networks, metabolic systems and 
signaling pathways) (Barabasi and Oltvai, 2004, Weiss et al., 2003), and higher-
level systems (such as brain model, virtual liver and model of immune system) 
(Numminen et al., 2005). As different types of biological systems contain 
completely different information and require completely different ways of analysis, 
modeling approach for molecular, cellular and physiological systems have almost no 
overlaps. Here, we introduce the major approaches for modeling cellular systems as 
our models were built for cellular systems. 
Although there are also subtypes of cellular systems, they share some common. 
Firstly, the structure of a cellular system is often like a network, consisting of 
species and their interactions. These species can be small molecules (i.e. in 
metabolic systems), proteins (i.e. enzymes in metabolic systems and proteins in 
signaling pathways), or genes (i.e. genetic network). The interactions between two 
species can be as simple as a chemical reaction or as complex as a multiple-step 
regulation. Secondly, the network of a cellular system is often dynamic, meaning 
that the states of species may change as a result of their interactions. The dynamics 
  11 
of a cellular system can be as abstract as order of interactions (i.e. genetic network) 
or as detailed as continuous time-evolution of the states of species. The states of 
species can also have different levels of precisions (a boolean value, a discrete state 
number, or a value of its concentration). Thus, the main task of modeling cellular 
systems becomes modeling the structure and dynamics of the system. Because of 
that, many modeling approaches for cellular systems can be applied to all subtypes 
of cellular systems (metabolic systems, signaling pathways, genetic networks, etc.) 
and other approaches can be applied to a subset of all subtypes. These different 
approaches have their own advantages and disadvantages. Here, we introduce some 
representative approaches in modeling cellular systems. In addition, we will explain 
more details about the approach we use in this thesis. 
2.1.1 Boolean Network 
In Boolean network, species were modeled as Boolean values, which has only 
two states: ON and OFF. A Boolean network can be defined as a directional graph 
(Figure 2.1A), in which each node represents a species and each edge represents a 
regulation process (such as activation and inhibition). In addition, a rule for each 
node is defined to determine the result of all regulations applied to that node. As 
species have only two states, a rule can be simply defined by a set of logic gates 
(Figure 2.1B). A Boolean network can be simulated synchronously (all states are 
updated in one time step) and asynchronously (one or some states are updated in 
one time step). The advantage of Boolean network is that it can be used to model 
large-scale networks, as it requires less information of the states of species. The 
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disadvantage of it is that the results it can provide have also less information and 
they are not quantitative.  
 
Figure 2.1 A Boolean network example of cell cycle gene regulation (Shmulevich et al., 2002). (A) 
A diagram of the regulation network showing the species as ellipses and regulations as lines (with 
arrow head: activation; with flat head: inhibition). The black dots explicitly show the rules 
applied to cdk2 and Rb. (B) The logic diagram of the network describing the rules applied to 
cdk2 and Rb. 
 
One of the major applications of Boolean network in biological models is 
modeling genetic network. The biological basis for this application is that genes 
often have switch-like behavior, which means the expression of a gene is often 
turned on and off in its regulations. This switch-like behavior allows us to ignore 
some quantitative details of the state of a gene, and being qualitative makes 
modeling of large-scale network possible. With the efforts of Human Genome 
Project and functional genomics, numerous data for gene regulations are available 
and most of them are qualitative data. Thus, Boolean network takes advantage of 
large qualitative dataset and helps us to analyze large-scale genetic networks. 
2.1.2 Bayesian Network 
Bayesian network is widely used to build statistical models. It is also applied to 
biological systems to represent and inference the causal relationship among species. 
A B
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A Bayesian network can be described as a directed acyclic graph (DAG, a graph 
with no loops). The nodes in the graph represent the species and the edges in the 
graph represent the relationship/dependencies between species. Each species has no 
states but a probability of certain state (high/medium/low, on/off) and this 
probability is dependent on other species. Thus, we have a joint probability 
distribution (JPD) for all species in a Bayesian network. The 
relationship/dependencies between species are encoded by a conditional probability 
table (CPD). Through this CPD, we are able to infer the JPD of all species. 
Simulation of a classical Bayesian network is a one-step event. Therefore this 
method simulates static behaviors of the network. Derivatives of Bayesian network 
such as Dynamic Bayesian Network (DBN) can simulate dynamical changes of 
probabilities and can have loops in the network model. Bayesian network takes 
consideration of the uncertainties of biological observations and can be applied for 
inference of unknown causal relationship between species. 
2.1.3 Petri Nets 
A Petri net is a directed bipartite graph, in which there are two types of nodes, 
representing places and transitions (Figure 2.2). Classical Petri nets represent the 
states of a species as tokens in a place. The number of tokens represents the level of 
species. A transition connects different places and it can consume and produce 
tokens. When a transition fires, a token is consumed in any input places of this 
transition and a token is produced in any output places of this transition. As a 
result of that, the token moves from one place to another and the states of species 
change because of firings of transitions. The classical Petri nets are time-free (firing 
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transitions does not take time), deterministic and discrete (or semi-quantitative). 
But there are some extensions of Petri nets which make Petri nets more powerful of 
modeling biological systems. Stochastic Petri Nets (SPN) fires transitions in a 
stochastic way associating probabilistically distributed firing rates. Continuous 
Petri Nets (CPN) use continuous values (not tokens) for species states and have a 
continuous firing rate for each transition. These extensions allow Petri nets to 
model systems at different abstraction levels and to meet requirements of biological 
experiments with different accuracies and precisions. 
 
Figure 2.2 A diagram of a Petri net. Circles represent places (P1 and P2). Black rectangles 
represent transitions (T1 and T2). Black dots represent tokens. Arrows represent the direction for 
the movement of tokens. 
2.1.4 Ordinary Differential Equations (ODEs) 
Ordinary Differential Equation (ODE) models describe the time-derivative of 
the states of species as a function of time and the states (Equation (2.1)). The 
states in ODEs are continuous values (i.e. concentration of species). 
 
dx
dt = F(t,x)  (2.1) 
The biological/biochemical basis of ODE models is the law of mass action. 
Associating the event of molecule collision and reaction, the law of mass action 
describes the rate of an elementary reaction (a reaction with a single mechanistic 
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step) is proportional to the concentrations of reactants. For example, the rate of 
the reaction A + B k⎯→⎯ C  is k[A][B] , in which [A]  and [B]  represent 
concentrations of species A and B, and k  is a rate constant determined by the 
natural properties of this reaction (i.e. the affinity of A and B, the pH, the 
temperature, etc.). As ODE models have strong theoretical basis, ODE is an ideal 
framework for modeling metabolic systems and signaling pathways, consisting of 
chemical reactions or biochemical reactions (i.e. enzymatic reactions and protein-
protein binding). ODE models are also powerful in analyzing the dynamics of a 
system since the species concentrations are continuous in time. Another advantage 
of ODE models is that some reaction rates measured in previous biochemical 
studies can be directly used in ODE models. Although many rates were measured 
in vitro, they can still be considered as a good approximation of the rates in vivo. 
Sometimes, theoretically ideal methods are not best practically. ODE models have 
a significant drawback that they often require large amounts of quantitative data. 
We all know that biological studies often lack quantitative data. In biological 
studies, it is also difficult to generate large amounts of quantitative data with high 
accuracy. This makes building ODE models difficult, but with more biological 
systems studied in detail and more high throughput and quantitative measurements 
developed, ODE models will become more and more powerful.  
In this thesis, we built our models using ODEs because we need to study 
detailed dynamical behaviors and also some special behavior like bistable behavior. 
ODE models are the best choices for our purpose of study. We also use a special 
mathematical form of the ODE models using Kronecker products. This makes not 
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only the simulation and analysis more efficient, but also the analytical derivations 
possible. This form of ODEs was used in a toolbox KroneckerBio (Toettcher et al., 
2011) and we briefly introduce this formalism in the following section. 
2.1.4.1 Formalism of ODE models in KroneckerBio 
As biological studies usually focus on mechanistic steps of a process, most 
known reactions in a signaling pathway are elementary reactions. There are overall 
four types of elementary reactions shown as below, 
 
 
kprod⎯ →⎯⎯ A (rate = kprod =
d[A]
dt )
A kdeg⎯ →⎯ (rate = kdeg[A]= −
d[A]
dt )



























According to the law of mass action, all the rates of these reactions can be 
mathematically represented with zero-order, linear and quadratic form of equations. 
Therefore, instead of having ODE for each species individually, KroneckerBio 




1x + A2x⊗ x + k  (2.3) 
 In Equation (2.3), x  is a vector of all species concentrations and x⊗ x  is the 
Kronecker product of two x  (shown below in Equation (2.4)). A1  and A2  are 
parametric matrices and k  is a parametric vector. A1 , A2  and k  contains all the 
rate constants. 



































































The benefit of using this mathematical form in Matlab is that stiff ODE solvers 
in Matlab take advantage of the Jacobian matrix to facilitate the simulation. Many 
of the biological systems are stiff and this form of ODEs has an explicit form of the 
Jacobian matrix. In addition, as the connectivity of biological systems is very low, 
the matrices in both Equation (2.3) and its Jacobian matrix are very sparse. 
Matlab has algorithms to deal with operations of sparse matrices efficiently. 
 
2.2 Liver Fibrosis and TGF-β Homeostasis 
2.2.1 Pathology of Liver Fibrosis 
Liver fibrosis is a wound-healing response caused by repeated injury of the 
hepatic parenchyma (Bataller and Brenner, 2005, Hernandez-Gea and Friedman, 
2011). The types of liver injury include ethanol abuse, virus infection, cholestasis, 
metabolic syndrome etc. Liver injury causes damage of liver parenchyma and a 
series of inflammatory responses. Both the damaged parenchymal cells and immune 
cells such as T cell and Kupffer cell can secrete several fibrogenic cytokines, 
including TGF-β1, PDGF (Platelet-Derived Growth Factor), IL-6 (Interleukin-6) 
etc. (Bataller and Brenner, 2005). These cytokines can induce the activation of 
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hepatic stellate cells (HSCs) and other source of myo-fibroblasts. Activated HSCs 
and myo-fibroblasts are the major source of the excessive extra-cellular matrix 
(ECM). They can also secrete some cytokines such as TGF-β1 to activate other 
cells. During liver fibrosis progression, liver parenchyma is often repeatedly injured. 
The process of injury, inflammation and fibrogenic cell activation described above 
keeps happening. As a result of the repeated injury, the injured area of parenchyma 
is replaced by accumulated ECM (Arthur, 1997). In liver fibrosis, not only the 
quantity, but also the quality of ECM is changed (Eng and Friedman, 2000). In 
most cases, acute injury is transient and reversible (Benyon and Iredale, 2000). 
However, when insults are sustained, there will be chronic inflammation as well as 
scar formation. If the insults are not controlled, liver fibrosis will progress to 
cirrhosis, an end stage of liver fibrosis and then leading to high mortality. Cirrhosis 
is not only characterized by large amount of ECM or large area of scar formation, 
but also a structural change of liver parenchyma and vasculature (Desmet and 
Roskams, 2004). At late stage of fibrosis or cirrhosis, bridging fibrotic scar is 
formed and that is called fibrotic septa (Vanheule et al., 2008). The fibrotic septa 
are where most ECM is accumulated and it may connect portal tracts and central 
veins (Sherman et al., 1990). Within the septa, there is usually a wide blood vessel 
called fibrotic shunt (Vollmar et al., 1998). During fibrosis progression, most 
sinusoids (small blood vessels bypass the liver parenchyma) will become thinner 
and the fibrotic shunt is where most blood flow through. This kind of distortion of 
vascular architecture can result in decreased liver function and liver regeneration. It 
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also leads to the development of portal hypertension, one major pathological 
phenotype in liver fibrosis. 
2.2.2 Cellular Responses in Liver Fibrosis 
In liver parenchyma, four major cell types are found: hepatocytes, sinusoidal 
endothelial cells, hepatic stellate cells (HSCs) and Kupffer cells. Hepatocytes 
comprise about 65% of liver mass. They are the cells that perform the metabolic 
function of liver. Sinusoidal endothelial cells form the sinusoid (microvascular 
structure in liver). These cells have small pores called fenestrae (about 200nm in 
diameter in normal liver) to allow efficient molecule exchange between hepatocytes 
and blood. HSCs reside in the space of Disse, the space between the layer of 
hepatocytes and sinusoidal endothelial cells. In normal liver, HSCs maintain the 
basal membrane-like matrix in the space of Disse, which is important for the 
differentiated function of parenchymal cells. Kupffer cells are specialized 
macrophages in the liver. They locate at the wall of sinusoids and do not circulate 
in the blood stream. 
As we mentioned, liver fibrosis is initiated by liver injury. When liver suffers 
from injury, parenchymal cells like hepatocytes are damaged by the insults, such as 
viral infection and toxin. In fibrotic liver, sinusoidal endothelial cells close their 
fenestrae (defenestration) (Friedman, 2003). This can lead to changes of molecule 
exchange between parenchymal cells and blood, and also changes of local blood 
pressure. HSCs are in their quiescent state in normal liver and their secretion of 
ECM is limited. During fibrosis progression, HSCs become myo-fibroblast-like 
(activated state) and express excessive ECM (Friedman, 2000, Gressner and 
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Weiskirchen, 2006). Activated HSCs are also proliferative. Activation of HSCs is 
the major cause of excessive ECM and scar formation in liver fibrosis (other types 
of myo-fibroblasts in liver were also found such as, portal fibroblasts, bone marrow-
derived cells and cells from EMT) (Hernandez-Gea and Friedman, 2011). The 
earliest activation of HSCs is associated with inflammation and paracrine 
stimulation by their neighboring cells, including damaged hepatocytes, injured bile 
duct cells and Kupffer cells (Iredale, 2007). Kupffer cells can stimulate HSC 
activation by secretion of cytokines such as TGF-β1 (Transforming Growth Factor-
β1, an isoform of TGF-β) and PDGF (Platelet-Derived Growth Factor) (Iredale, 
2007). 
2.2.3 TGF-β Activation in Liver Fibrosis 
Many cytokines are involved in liver fibrosis. Liver fibrosis is accompanied by 
repeated or chronic liver injury. The earliest response after injury is inflammation. 
Therefore, in liver fibrosis, inflammatory cytokines such as IL-6 (Interleukin-6), 
IFN-γ (Interferon-γ), TNF-α (Tumor Necrosis Factor-α) are secreted from Kupffer 
cells, hepatocytes as well as some immune cells in the blood (Friedman, 2000). 
These inflammatory cytokines can initiate the activation of myo-fibroblasts (mainly 
HSCs). After the inflammatory phase of fibrosis, there will be a fibrogenic phase 
when the activated myo-fibroblasts/HSCs reconstruct the ECM. Growth factors 
such as TGF-β1 and PDGF play important roles not only in the inflammatory but 
also the fibrogenic phase of liver fibrosis. TGF-β1 is a key cytokine that induces the 
activation of HSCs and other types of myo-fibroblasts in liver (i.e. portal fibroblasts 
and EMT of hepatocytes) (Zeisberg et al., 2007). Initial HSC activation is 
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stimulated by TGF-β1 via paracrine signals from Kupffer cells and injured 
hepatocytes. After HSCs are activated, there is an autocrine signal of TGF-β1 to 
maintain the activation states of HSCs (Gressner and Weiskirchen, 2006, Gressner 
et al., 2002). Activated HSCs are also proliferative. This is mainly due to the 
stimulation of PDGF (Kinnman et al., 2001). Proliferation of HSCs is also initiated 
by paracrine signal of PDGF and maintained by autocrine signal of PDGF 
(Bataller and Brenner, 2005). 
TGF-β1 plays crucial role in liver fibrosis as it initiates and maintains the 
activation of HSCs, the major fibrogenic cells in liver fibrosis. Therefore, many 
studies have focused on TGF-β1 related signaling and tried to discover drug targets 
for liver fibrosis therapies (Salgado et al., 2000, Currier et al., 2003, Kondou et al., 
2003). TGF-β1 binds to specific receptors on the cell surface and activates the 
Smad signaling cascade to regulate gene expression (Wrana and Attisano, 2000). 
Moreover, TGF-β1 is secreted in its latent form and needs to be activated so it can 
stimulate Smad downstream signaling (Annes et al., 2003). Thus, not only the 
downstream Smad signaling, but also the upstream activation of TGF-β1 is 
important for TGF-β1 regulations. Latent TGF-β1 is a protein complex in which 
TGF-β1 dimer binds to a latency-associated peptide (LAP) and LAP further 
associates with the latent-TGF-β1 binding protein (LTBP) (Annes et al., 2003). 
There are several ways that TGF-β1 can be released from LAP and become active, 
including high temperature, low pH, ROS, integrin, proteases (such as plasmin) 
(Lyons et al., 1990, Dallas et al., 2002), and thrombospondin-1 (TSP1) (Murphy-
Ullrich and Poczatek, 2000, Daniel et al., 2004, Schultz-Cherry et al., 1994). Among 
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these activation conditions or activators, plasmin and TSP1 is highly related to 
hepatocytes and HSCs, respectively. In addition, plasmin is regulated by TGF-β1 
signaling and TSP1 is a part of TGF-β1 autocrine of HSCs. 
2.2.4 The Network of TGF-β Activation in the ECM 
Previous work has studied a network of TGF-β activation including two 
activators, plasmin and TSP1; interplay between these two activators; and two 
feedback loops that active TGF-β regulates plasmin and TSP1 (Venkatraman et al., 
2012). Figure 2.3 shows the major players in the network. As we mentioned earlier, 
plasmin and TSP1 could both activate TGF-β from its latent form. These two 
activators of TGF-β have a mutual antagonism that plasmin could cleave TSP1 
slowly (Anonick et al., 1993) and TSP1 could inhibit plasmin by tight binding to 
its activation site (Anonick et al., 1993, Hogg et al., 1992). More interestingly, 
TGF-β could regulate plasmin by inducing the production of plasminogen activator 
inhibitor type 1 (PAI1) (Kutz et al., 2006) and PAI1 inhibits the urokinase 
pathway for plasmin activation (Vassalli et al., 1991, Venkatraman et al., 2010). 
TGF-β could also regulate TSP1 by inducing HSC activation. 
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Figure 2.3 Upstream network of TGF-β activation (Venkatraman et al., 2012). Plasmin (PLS) 
and Thrombospondin-1 (TSP1) can both activate TGF-β. They also have mutual antagonism. 
Plasmin is activated from plasminogen through a positive feedback regulation of urokinase-typed 
plasminogen activator (UPA). TGF-β regulates plasmin activation by inducing the production of 
PAI1 through Smad signaling pathway. It also regulates TSP1 production through Smad 
signaling and hepatic stellate cell (HSC) activation. The Smad signaling pathway was modeled as 
a black box in (Venkatraman et al., 2012). 
 
As shown in Figure 2.3, Smad signaling pathway was modeled as black box in 
(Venkatraman et al., 2012). We then initiate our series of studies from a systematic 
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3  Chapter 3: Systematic Analysis of Negative 
Regulatory Mechanisms in TGF-β Signaling 
Pathway 
3.1 Introduction 
Transforming Growth Factor-β (TGF-β) regulates cell migration and cell fate 
and TGF-β signaling is a target of pharmaceutical research (Yingling et al., 2004) 
for treatment of metastatic cancer and fibrotic diseases. Signal transduction from 
extracellular TGF-β to the cell nucleus through the Smad pathway is well 
documented (Massague, 1998, Shi and Massague, 2003, Attisano and Wrana, 2002, 
Bassing et al., 1994, Schmierer and Hill, 2005, Massague and Wotton, 2000). The 
TGF-β ligand binds sequentially to two heterogeneous receptors (TGF-β receptor 
type II and type I) on the cell membrane to form a ligand-receptor complex 
(Massague, 1998). The type II receptor is a constitutively active kinase, recruited 
by TGF-β to the type I receptor (Bassing et al., 1994). The type I receptor is 
activated by the type II receptor and then phosphorylates the R-Smads (Smad2 
and Smad3) at two C-terminal serine residues. Upon phosphorylation, R-Smads 
form a homomeric complex or a heteromeric complex with Co-Smad (Smad4) (Shi 
and Massague, 2003, Schmierer and Hill, 2005). The key outcome of the Smad 
cascade is accumulation of phosphorylated R-smad (phospho-R-Smad) in the 
nucleus, causing widespread effects on gene regulation (Massague et al., 2000, 
Massague and Wotton, 2000).  
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Recent work by Zi et al. showed that cells respond differently to phospho-R-
smad, depending on the temporal dynamics of Smad signaling (Zi et al., 2011). 
They found that early (45min) phospho-R-Smad levels, and early gene expression, 
had a gradual, graded dependence on the dose of TGF-β. In contrast, later (24hr) 
phospho-R-Smad levels controlled a distinct set of genes with ultrasensitive, 
sigmoidal dependence on the dose of TGF-β. These functional effects demonstrate 
the importance of understanding the dynamics of the Smad system.  
Smad signaling is known to decrease spontaneously after TGF-β stimulation 
(Figure 3.1A), and this self-limiting behavior is a major determinant of Smad 
dynamics. Self-limiting behavior may arise from ligand-induced receptor inhibition 
(Afrakhte et al., 1998, Itoh et al., 1998, Ebisawa et al., 2001, Hayashi et al., 1997, 
Kavsak et al., 2000, Zhang et al., 2012, Eichhorn et al., 2012), phospho-R-Smad 
dephosphorylation (Lin et al., 2006), phospho-R-Smad degradation (Lo and 
Massague, 1999, Lin et al., 2000, Alarcon et al., 2009, Inui et al., 2011, Aggarwal 
and Massague, 2012), or other mechanisms. Extensive experimental evidence 
documents multiple individual mechanisms, but the relative roles and combined 
effects are not well understood. Dynamic measurements (time-series immuno-blots) 
are available from many previous studies, and this wealth of information provides 
an opportunity for systems-level modeling to integrate information about dynamics 
and to integrate mechanisms of negative regulation, toward a better understanding 
of the Smad system behavior. 
Previous computational models of TGF-β/Smad signaling have contributed 
important biological insights, but they have only simulated some selected 
  26 
mechanisms of negative regulation. Villar et al. built a model of TGF-β receptor 
trafficking dynamics, including ligand-induced receptor degradation, which was able 
to simulate some key dynamic effects such as the peak and decay of phospho-R-
Smad levels (Vilar et al., 2006). Models by Klipp and co-workers extended the work 
of Villar et al. to include Smad phosphorylation and nuclear translocation (Klipp 
and Zi, 2007), and to include transient versus sustained Smad signaling (Zi et al., 
2011), but these models simplified the negative regulation processes, giving a strong 
role to receptor degradation. The model by Schmierer et al. provided important 
insights into the short-term dynamics of Smad nucleo-cytoplasmic shuttling 
(Schmierer et al., 2008), but the only mechanism of negative regulation in this 
model was dephosphorylation. Other modeling studies have focused on robustness 
and in silico perturbation analysis (Melke et al., 2006, Chung et al., 2009). 
Mathematical models have yielded important insights, but they have not 
represented TGF-β/Smad negative regulation with enough detail for analyzing the 
contributions of different mechanisms, nor for evaluating alternative hypotheses. 
In this work, we develop a series of computational models representing 
individual and combinations of mechanisms of R-Smad negative regulation. 
Comparisons between models and existing datasets first reveals negative regulations 
on two different time scales. Based on the time scale, we classified negative 
regulatory mechansims into fast- and slow- mode mechanisms. Our modeling also 
shows that at least one fast-mode and one slow-mode mechanisms is required for a 
model to fit phospho-R-Smad dynamics after short- and long-exposure to TGF-β. 
R-Smad Dephosphorylation has been shown to have fast and strong negative 
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regulation effect in the literature and is confirmed in our analysis to be a fast-mode 
mechanism. Although Receptor Degradation and P-R-Smad Degradation are shown 
to be slow-mode mechanisms in our analysis, they are falsified by our modeling and 
experiments. Thus, current understanding of slow-mode negative regulation in 
TGF-β remains unclear, and we seek to find a slow-mode mechanism which could 
explain phospho-R-Smad dynamics. 
One of our key findings is a novel negative feedback effect, in which the 
phosphatase PPM1A is rapidly upregulated after TGF-β stimulation, in 
conjunction with declining levels of phospho-R-Smad. We further explore possible 
mechanisms of PPM1A upregulation via theoretical models of PPM1A 
sequestration. Another contribution of our work is an explanation for a previous 
controversy about R-Smad degradation (Lin et al., 2006, Lo and Massague, 1999, 
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Figure 3.1 The Smad signaling pathway. (A) P-Smad2 dynamics from literature. Curves show the 
quantified western blot measurements of P-Smad2 from Lin et al. (Lin et al., 2006) (blue) and 
Massague et al. (Lo and Massague, 1999) (green) after TGF-β stimulation. (B) Pathway diagram 
of Smad signaling (using template from BioCarta). The dashed arrows indicate those reactions 
which are modeled in black box. The red arrows indicate the negative regulatory mechanisms: (1) 
PPM1A dephosphorylating phospho-R-Smad; (2) Smurf2 induced proteasome degradation of 
phospho-R-Smad; (3) I-Smad induced receptor inhibition; (4) PPM1A upregulation by Smad 
signaling. 
 
3.2 Materials and Methods 
3.2.1 Model Specifications 
3.2.1.1 Model Structure 
The reactions in our TGF-β signaling pathway model can be grouped into three 
sections: trafficking, Smad nucleocytoplasmic shuttling, and negative regulatory 
mechanisms. Our assumptions of the receptor trafficking followed those in (Klipp 
and Zi, 2007). For Smad nucleocytoplasmic shuttling, we followed (Schmierer et al., 
2008). The only difference in Smad nucleocytoplasmic shuttling between (Klipp and 
Zi, 2007) and (Schmierer et al., 2008) is that in (Schmierer et al., 2008), R-Smads 
can form a homogeneric complex. It has been shown that R-Smads can form 
complex with themsevles (Clarke et al., 2009). Although the stoichiometry is not 
clear, we follow the simplest assumption in (Schmierer et al., 2008) that R-Smads 
can form homogeneric and heterogeneric complexes at the same rate. For the 
negative regulatory mechanisms, we tested many possibilities based on literature 
findings and also our hypotheses (such as PPM1A upregulation). Different 
mechansims are listed in Table 3.1. Here we describe each of them in details. All 
species names are listed in Table 8.1. All rate constants are listed in Table 8.2. 
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1) R-Smad Dephosphorylation was modeled as a single reaction in which 
nuclear phospho-R-Smad was dephosphorylated to R-Smad. The rate of 
dephosphorylation was proportional to the concentration of phospho-R-
Smad (Reaction 33, Table 8.3). 
2) Receptor Degradation was modeled according to (Klipp and Zi, 2007) as a 
black box in which the degradation rate of the ligand-receptor complex 
was proportional to the concentration of the Smad complex in the nucleus 
(Reaction 31-32, Table 8.3). 
3) P-R-Smad Degradation was modeled as a single reaction in which nuclear 
phospho-R-Smad was degraded at a rate proportional to its concentration 
(Reaction 34, Table 8.3), assuming that Smurf2 would be unchanged in 
TGF-β signaling. 
4) Endogenous Synthesis and Degradation of R-Smad was modeled by 
incorporating (a) constant production of cytoplasmic R-Smad (Reaction 35, 
Table 8.3) and (b) degradation of total R-Smad, proportional to the total 
R-Smad concentration (Reaction 35-39, Table 8.3), but independent of 
Smurf2-induced degradation. 
5) Receptor Inhibition was modeled such that I-Smad could induce 
degradation, inhibition, and dephosphorylation of the ligand-receptor 
complex. Firstly, I-Smad (Smad7) was produced at a rate proportional to 
the concentration of Smad complex in the nucleus (Reaction 40-41, Table 
8.3) and had a turnover rate proportional to its concentration (Reaction 42, 
Table 8.3). Then I-Smad could either associate with ligand receptor 
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complex (LRC) in the caveolae (LRCCave, Reaction 44, Table 8.3) or could 
associate with LRC in the early endosome (LRCEE, Reaction 45, Table 8.3). 
After association of the LRC with I-Smad, the complex could either be 
dephosphorylated (Reaction 46-47, Table 8.3) or degraded (Reaction 48-49, 
Table 8.3).  
6) PPM1A Upregulation assumed that the Smad complex in the nucleus was 
responsible for inducing PPM1A production. That is, the rate of induced 
production was proportional to the concentraion of Smad complex in the 
nucleus (Reaction 56-57, Table 8.3). To simulate basal (unstimulated) 
levels, PPM1A was also synthesized at a constant rate (Reaction 52, Table 
8.3). All sources of PPM1A, unless bound, were degraded endogenously at 
a rate proportional to PPM1A concentration (Reaction 52, Table 8.3). 
Another assumption concerns the kinetics of PPM1A activity. Prior 
models with constant PPM1A levels used a one-step approximation for the 
kinetics of the dephosphorylation of phospho-R-Smad by PPM1A, but the 
models with explicit regulation of PPM1A employed a two-step model of 
catalysis (Reaction 58-61, Table 8.3) with reversible 
association/dissociation followed by irreversible catalysis. 
7) PPM1A Stabilization assumed that PTEN could associate with phospho-
R-Smad (Reaction 66, Table 8.3) and this binary complex could further 
associate with PPM1A to form a ternary complex pSmad:PTEN:PPM1A 
(Reaction 67, Table 8.3). The ternary complex could dissociate in the 
manner it was formed, or could alternatively release the phospho-R-Smad 
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alone and the PTEN-PPM1A as a binary complex (Reaction 68, Table 8.3). 
The PTEN-PPM1A complex was assumed to evade degradation while the 
unbound PPM1A would degrade (Reaction 53-54, Table 8.3). PPM1A was 
synthesized in the cytoplasm (Reaction 53, Table 8.3) and was imported 
into the nucleus at a high rate (Reaction 55, Table 8.3) so that PPM1A 
was predominantly in the nucleus. When PTEN bound to PPM1A, 
PPM1A phosphatase activity was assumed to be unchanged (Reaction 62-
65, Table 8.3). We allowed the rate of PTEN-PPM1A imported into the 
nucleus to differ from the rate of import for unbound PPM1A, and the 
actual rates were estimated numerically (Reaction 71, Table 8.3). PTEN in 
the nucleus could be exported back into the cytoplasm (Reaction 72, Table 
8.3). 
 
3.2.1.2 Model Parameters 
3.2.1.2.1 Rate Constants 
The list of rate constants is shown in Table 8.2. We have retained the values of 
the experimentally derived parameters cited by (Klipp and Zi, 2007). We have also 
retained previous rates for the type I and the type II receptors and the recycling 
rate of the ligand-receptor complex in the caveolae, which had been strongly 
constrained by qualitative information. For the other rate constants that were 
estimated by (Klipp and Zi, 2007), we have re-estimated these parameters again in 
the context of our model. In particular, the rate constants for Smad 
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nucleocytoplasmic shuttling were modified to fit our model calibration and the new 
findings in (Schmierer et al., 2008). First of all, the concentrations of species in the 
nucleus are represented as their relative concentrations in the cytoplasm. For 
example, if the absolute concentration of Smad2 in the nucleus is [Smad2nuc ]
abs
, we 
use the relative concentration [Smad2nuc ]
rel = [Smad2nuc ]abs ⋅ (Vnuc /Vcyt )  instead of 
[Smad2nuc ]abs  in our model to simulate the concentrations in two compartments. For 
example, the ODEs of Smad2 using absolute concentrations are: 
d[Smad2cyt ]
dt
= −kimpSmad 2 [Smad2cyt ]+ kexpSmad 2 [Smad2nuc ]abs ⋅
Vnuc
Vcyt




= kimpSmad 2 [Smad2cyt ] ⋅
Vcyt
Vnuc
− kexpSmad 2 [Smad2nuc ]abs + kdephpSmad 2 [ pSmad2nuc ]abs
 
After substituting [Smad2nuc ]
abs
 with [Smad2nuc ]
rel ⋅ (Vcyt /Vnuc ) : 
d[Smad2cyt ]
dt




= kimpSmad 2 [Smad2cyt ]− kexpSmad 2 [Smad2nuc ]rel + kdephrelpSmad 2 [ pSmad2nuc ]rel
 
where 
kdephrelpSmad 2 = kdephpSmad 2 ⋅
Vcyt
Vnuc
= 3 ⋅ kdephpSmad 2
 
The export rates computed in (Schmierer and Hill, 2005) are identical to our 
kexpSmad 2 and kexpSmad 4 . However, the import in (Schmierer and Hill, 2005) are 
actually kim ′pSmad 2 = kimpSmad 2 ⋅ (Vcyt /Vnuc )  and kim ′pSmad 4 = kimpSmad 4 ⋅ (Vcyt /Vnuc ) . So our 
import rates are kimpSmad 2 = kim ′pSmad 2 ⋅ (Vnuc /Vcyt ) = 0.0027 / 3 = 0.0009s
−1 = 0.054min−1  and 
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kimpSmad 4 = kim ′pSmad 4 ⋅ (Vnuc /Vcyt ) = 0.0027 / 3 = 0.0009s−1 = 0.054min−1 . Note that the rates 
of the reactions in the nucleus (e.g. kdephpSmad 2 ) are substituted because the 
concentrations of the reactants are relative. But all these rates are estimated so we 
do not need to substitute any values of them. 
Secondly, it was found that the import rate of Smads complex is higher than 
the monomeric Smad2 (Schmierer et al., 2008). Therefore, we set the import and 
export rate of Smads complex according to (Schmierer et al., 2008). 
3.2.1.2.2 Initial Concentrations 
The initial concentrations of all species were set to their equilibrium points in 
unstimulated cells. The initial concentrations of the receptors followed those in 
(Klipp and Zi, 2007), as the rate constants for receptor trafficking were kept the 
same as those in (Klipp and Zi, 2007). For Smad2 and Smad4, we can derive their 


































The relative concentrations of total Smad2 and total Smad4 in HaCaT cells are 
571.43nM and 1333.33nM (Zi et al., 2011, Klipp and Zi, 2007). We then calculated 
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the steady state concentrations in unstimulated cells as the initial concentrations 
showing in Table 8.1. 
3.2.1.3 Model Simulation and Parameter Estimation 
The model simulation and parameter estimation were performed using 
KroneckerBio toolbox in Matlab. The KroneckerBio toolbox basically calls the 
ode15s function in Matlab to solve the system of ODE equations and the fmincon 
function in Matlab to estimate parameters. Multiple initial guesses were generated 
randomly in order to achieve a more global optimum in parameter estimations. 
Sum of squared errors were used as the objective function to optimize the model to 
experimental data. 
The parameters from literature were validated by simulating the exact 
published models. Our parameter estimation method was also applied to published 
models and the modeling fitting results were highly similar to that in the literature. 
The parameters related to each mechanism are listed in Table 8.4. The 
parameters of the best-fit of each model are listed Table 8.5. 
3.2.2 Biological Essays 
3.2.2.1 HaCaT cell culture and TGF-β treatment 
HaCaT cells (from Cell Lines Service) were cultured following the protocol 
provided by the manufacturer. DMEM culture medium with 10% FBS was used to 
culture the cells. DMEM culture medium without FBS was used during treatment 
of TGF-β as the serum contains TGF-β. 
3.2.2.2 ELISA for phosphorylated Smad2 and total Smad2 
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ELISA kits (from Cell Signaling) were used to quantify phosphorylated Smad2 
and total Smad2. Whole cell lysates were collected using attached cell lysis buffer 
and following the cell lysis protocol in the kits. Sample dilutions for phosphorylated 
Smad2 and total Smad2 are 1 time and 100 times respectively. Serial dilutions of 
one sample were measured to check the linear range of the readouts.  
3.2.2.3 Western blot for total type I receptor and PPM1A  
Whole cell lysates were collected using RIPA buffer from HaCaT cells for 
western blots. Antibodies against the type I receptor (Santa Cruz) and PPM1A 
(Abcam) were used following manufacturers’ instructions. Primary antibody 
dilutions of 1:7500 and 1:250 were used for the type I receptor and PPM1A 
respectively. The quantification of the band intensities was preformed using ImageJ. 
3.3 Results 
We constructed a series of computational models (Table 3.1) examining 
negative regulatory mechanisms in TGF-β/Smad signaling.  All models share a 
common skeleton (Figure 3.1B) of Smad signaling, including TGF-β receptor 
trafficking and Smad nucleo-cytoplasmic shuttling, based on previous models (Vilar 
et al., 2006, Klipp and Zi, 2007, Schmierer et al., 2008).  Molecular interactions 
were modeled using ordinary differential equations (ODEs) for mass action kinetics, 
and the system of ODEs was simulated using KroneckerBio (Toettcher et al., 2011) 
in Matlab (Mathworks, Natick, MA). Model specifications, parameter estimation, 
and other computational methods are specified in Section 3.2 Materials and 
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Methods. The HaCaT cell line was used in the biological assays. Experimental 
methods are also specified in Section 3.2 Materials and Methods. 
3.3.1 Modeling the Negative Regulatory Mechanisms 
Negative regulatory mechanisms were simulated to obtain the dynamics of their 
effects and to estimate their potential contributions to the down-regulation of 
phospho-R-Smad (0.5-24hr). The negative regulatory mechanisms, illustrated in 
Figure 3.1B, include three previously published mechanisms and a fourth 
hypothesized mechanism that we developed during the analysis of the models. The 
focus of our initial modeling was the three previously reported mechanisms of 
negative regulation: 
(1) Receptor Inhibition. Smad complexes can induce the production of I-
Smad (Smad7) (Afrakhte et al., 1998, Itoh et al., 1998). There are three ways I-
Smad can inhibit the ligand-receptor complex: (1a) It can block the activation site 
of the receptor kinase; (1b) I-Smad can recruit E3-ligases to target the ligand-
receptor complex for degradation (Receptor Degradation) (Kavsak et al., 2000); 
and (1c) I-Smad can recruit PP1c to dephosphorylate the type I receptor kinase 
(Shi et al., 2004). We modeled the expression of I-Smad as a black box in which the 
rate of I-Smad production was proportional to the concentration of the Smad 
complex in the nucleus. Mechanism (1b) of I-Smad action (Receptor Degradation) 
was simulated in models 2, 3, and 5.  All types of “receptor inhibition,” (1a), (1b), 
and (1c), were simulated in model 8.  
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(2) P-R-Smad Degradation. R-Smad can be phosphorylated at its tail region 
or its linker region. We use the term phospho-R-Smad to refer to tail region 
phosphorylation, which is more important for gene regulatory function (Alarcon et 
al., 2009).  Phosphorylation of nuclear R-Smad at its linker region  causes Smurf2 
to target R-Smad for proteasome-dependent degradation (Alarcon et al., 2009).  
Assuming Smurf2 concentration to be constant, and assuming linker-region 
phosphorylation to be proportional to tail-region phosphorylation (Alarcon et al., 
2009), we simulate the rate of R-Smad degradation to be proportional to the 
concentration of nuclear R-Smad. 
(3) R-Smad Dephosphorylation. Phospho-R-Smad in the nucleus is 
dephosphorylated specifically by PPM1A, a member of the PP2c family (Lin et al., 
2006).  The rate of dephosphorylation is modeled to be proportional to the 
concentration of phospho-R-Smad in the nucleus. 
  
  38 
Table 3.1 Models with different negative regulatory mechanisms and the name of each mechanism. 
Each row represents one model. The + sign indicates that a mechanism is included in a model, 
and - indicates a mechanism NOT included. 
Model  1 2 3 4 5 6 7 8 9 10 11 
R-Smad Dephosphorylation + + - - + + + + + + + 
Receptor Degradation - + + - + - - - - - - 
P-R-Smad Degradation - - - + + + + - - - + 
Endogenous Synthesis and 
Degrdation of R-Smad - - - - - - + - - - + 
Receptor Inhibition - - - - - - - + - - - 
PPM1A Upregulation by 
Expression - - - - - - - - + - - 
PPM1A Stablization - - - - - - - - - + + 
 
3.3.2 Negative Regulation Occurs at Multiple Time Scales 
R-Smad dynamics depend on the duration of TGF-β stimulation. When TGF-β 
is administered in excess (2ng/ml) (Bakin et al., 2000, Goumans et al., 2002) for 
24hrs, phospho-R-Smad peaks at about 1hr and then decays for 24hrs (Lin et al., 
2006). When TGF-β is administered for 30min and then removed (by washing 
following by receptor inhibition with the compound SB-431542), phospho-R-Smad 
is eliminated within 4hrs (Lin et al., 2006, Schmierer et al., 2008). Both short-
exposure and long-exposure TGF-β treatment datasets (Figure 3.2) were utilized 
when building the models of negative regulation (Table 3.1, Table 8.4).  
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Figure 3.2 Model fitting results with different combinations of known negative regulatory 
mechanisms. (A-E) Phospho-R-Smad simulations were fitted to long-exposure and short-exposure 
P-Smad2 experimental data from Lin et al. (Lin et al., 2006). In the long-exposure experiment, 
HaCaT cells were treated with TGF-β for 24hr (blue dots). In the short-exposure experiment, 
HaCaT cells were treated with TGF-β for 30min, then TGF-β was washed out and SB-431542 
was added to inhibit the receptors (red dots). All P-Smad2 measurements used total cell lysate. 
The model simulations (solid red and blue curves) were fitted to the two sets of data 
simultaneously. Negative regulatory mechanisms in each model are as follows: (A) Model 1: R-
SMAD DEPHOSPHORYLATION; (B) Model 2: R-SMAD DEPHOSPHORYLATION and RECEPTOR 
DEGRADATION; (C) Model 3: RECEPTOR DEGRADATION; (D) Model 4: P-R-SMAD DEGRADATION; 
(E) Model 5: R-SMAD DEPHOSPHORYLATION, RECEPTOR DEGRADATION and P-R-SMAD 
DEGRADATION. The reactions of each model are listed in the Supporting Information. (F-H) 
Predictions of the best-fit model (Model 5) in MG132 pre-treated cells. Simulation of MG132 
treatment was performed by turning off the Smurf2-induced P-R-SMAD DEGRADATION (setting 
kdegpSmad2=0) in Model 5. (F) Comparison of the model prediction and experimental data from 
Lin et al. (Lin et al., 2006) in the short-exposure experiment. (G) Model prediction in the long-
exposure experiment. The green shaded area shows the cumulative difference between +MG132 
and -MG132. (H) A variety of models were fitted to the short-exposure and long-exposure 
experiments, and the cumulative difference in phospho-R-Smad2 between +MG132 and -MG132 
was computed for each case. A histogram plots the cumulative differences seen in the short-
exposure experiment (red) and the long-exposure experiment (blue). 
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Our first simulations studied the kinetics of three previously modeled 
mechanisms. The three mechanisms have conceptual similarities, but we were 
curious whether they would have different kinetic implications for the system. 
Multiple models, with different combinations of these mechanisms, were fitted to 
the long-exposure and short-exposure datasets described above.  
Model 1, with R-Smad Dephosphorylation, was able to recapitulate the short-
exposure TGF-β treatment experiment, as dephosphorylation is a fast process. This 
dephosphorylation model could turn off the signal once the stimulus was cut off 
(Figure 3.2A red curve), but it reached a steady state at about 1hr and was not 
able to recapitulate the extended 24hr decline of phospho-R-Smad in long-exposure 
TGF-β treatment (Figure 3.2A blue curve). Thus we describe R-Smad 
Dephosphorylation as a “fast-mode” mechanism. To explain the decline during long-
exposure experiments, a complementary “slow-mode” might be provided by 
cumulative processes such as degradation effects. Model 2 combines Receptor 
Degradation and R-Smad Dephosphorylation. It succeeded in recapitulating the 
short-exposure TGF-β treatment very well, and it had moderately good agreement 
with the long-exposure dataset (Figure 3.2B). As a control, we modeled Receptor 
Degradation alone (Model 3), but it could not provide an early decline in the short-
exposure experiment (Figure 3.2C). Thus, Receptor Degradation serves as a slow-
mode mechanism as it was able to explain the gradual decline of phospho-R-Smad 
in the long-exposure experiment but not the steep deline of phospho-R-Smad in the 
short-exposure experiment. A model with P-R-Smad Degradation alone (Model 4) 
achieved significant negative regulation for the long-exposure case (Figure 3.2D), 
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because P-R-Smad Degradation would persist for many hours. However, fitted 
Model 4 had difficulty explaining both the short-exposure and long-exposure 
datasets simultaneously, in keeping with previous experimental evidence, showing 
that P-R-Smad Degradation is not responsible for fast-mode effects in short-
exposure conditions (Lin et al., 2006). No single mechanism of negative regulation 
was able to explain pSmad2 behavior. We infer that the experimentally observed 
levels of phospho-R-Smad arise from a combination of fast-mode and slow-mode 
mechanisms (or from higher-order combinations of effects).  
Many models have omitted P-R-Smad Degradation from simulations (Vilar et 
al., 2006, Klipp and Zi, 2007, Schmierer et al., 2008, Zi et al., 2011), perhaps 
because this mechanism was found to be insignificant in the experiments of Lin et 
al. (Lin et al., 2006). Noting that the Lin experiments used short-exposure 
conditions, we ask whether P-R-Smad Degradation, a slow-mode mechanism, might 
have greater significance during the negative regulation induced by long-exposure 
treatments. Model 5 incorporated R-Smad Dephosphorylation, Receptor 
Degradation, and P-R-Smad Degradation (Figure 3.2E). P-R-Smad Degradation 
was significant in this model (Figure 3.2F-H) when its effects were measured after 
more than 1hr of TGF-β treatment. As yet, we have no basis for knowing which 
type of slow-mode degradation would be most important in R-Smad signaling. 
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3.3.3 New Experimental Data Supports P-R-Smad Degradation Rather 
Than Receptor Degradation 
We next tried to assess the relative impact of two slow-mode mechanisms, 
Receptor Degradation and P-R-Smad Degradation, on the dynamics of phospho-R-
Smad in long-exposure TGF-β treatment. The rate constant for Receptor 
Degradation and the rate constant for P-R-Smad Degradation were varied in silico 
(Figure 3.3A), showing that many ratios were equally good at fitting the observed 
dynamics. Several of the successful models exhibited a strong decline in T1R, the 
type I receptor (Figure 3.3B). Moreover, the degree of T1R decline is correlated 
with the rate of Receptor Degradation and the rate of P-R-Smad Degradation 
(Figure 3.3C). Thus, to quantify the relative contribution of Receptor Degradation 
and P-R-Smad Degradation in HaCaT cells, we measured T1R experimentally at 9 
time points (from 15min to 24hr) after TGF-β stimulation (with n=3 replications 
and significance determined by student t-test). Surprisingly, there was no 
significant loss of T1R in experiments (Figure 3.3D-E), even at late time points, 
indicating that Receptor Degradation is very weak in HaCaT cells (phospho-R-
Smad time series concentrations were measured as positive control, Figure 3.3C). A 
weak role for Receptor Degradation has also been suggested by the experimental 
work of Clarke et al. (Clarke et al., 2009). Note that the set of models (Figure 3.3A) 
capable of explaining the dynamics of phospho-R-Smad decline all exhibited a 
negative correlation between the degree of Receptor Degradation and the degree of 
P-R-Smad Degradation (Figure 3.3F), suggesting that these two mechanisms would 
be balanced alternatives. In light of our experimental finding that Receptor 
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Degradation is a very weak effect, we next turned to P-R-Smad Degradation as the 
alternative slow-mode mechanism to explain the long-term decline of phospho-R-
Smad. 
 
Figure 3.3 Predictions and validations of receptor degradation. (A) Different rates of I-Smad-
induced receptor degradation (klid = 10-6 ~10-2) were applied to Model 5, and the rate of Smurf-
induced P-R-Smad Degradation (kdegpSmad2) was fitted to the short-exposure experimental 
data (red dots) and the long-exposure experimental data (blue dots). All the other parameters 
were kept the same as those in Model 5 (B) Different Receptor Degradation rates led to different 
levels of the type I receptor (T1R). Green curves were generated from all models in panel (A) 
with klid = 10-6 ~10-2 and kdegpSmad2 estimated. (C) In the fitted models in panel (A), the 
T1R level has negative correlation with the Receptor Degradation rate (klid) but positive 
correlation with the P-R-Smad Degradation rate (kdegpSmad2). (D) Quantified data from 3 
replicates of the western blot in (E). There is no significant loss of the T1R comparing the first 
and last data points (P>0.05). (E) Western blot of the T1R from whole cell lysates of HaCaT 
cells treated with TGF-β for 24hrs (representative of 3 replicates). (F) In the fitted models in 
panel (A), the rates of Receptor Degradation (klid) and P-R-Smad Degradation (kdegpSmad2) 
have negative correlation.  
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3.3.4 P-R-Smad Degradation Is Not Sufficient to Cause the Peak and 
Decay of Phosphorylated R-Smad 
A model with R-Smad Dephosphorylation and P-R-Smad Degradation (Model 6, 
without Receptor Degradation) provided an excellent fit to both the long-exposure 
and short-exposure treatment data (Figure 3.4A). However, an unavoidable 
consequence of this model was dramatic decline of total R-Smad (Figure 3.4B). 
Previous experiments in HaCaT cells failed to observe a large fold-change of total 
R-Smad (Lin et al., 2006) but the amount of decline was not quantified. To clarify 
this potential conflict, we repeated the experimental measurement of total R-Smad 
levels after TGF-β treatment, using ELISA assays, a more quantitative method. 
Measurements of total R-Smad at 7 time points during 24hrs of TGF-β treatment 
showed no significant decrease of total R-Smad (Figure 3.4B-C). There is an 
apparent conflict between the constant level of total R-Smad (observed 
experimentally) and the significant degradation of R-Smad induced by TGF-β 
(according to Model 6). Note also that we see a plateau of phospho-R-Smad levels 
after 8 hrs (Figure 3.4C), but this is a minor discrepancy from the continuing 
decline seen by Lin et al. (Lin et al., 2006). The question of degradation becomes 
still more complex if degradation occurs in the presence of Endogenous 
Synthesis and Degradation of R-Smad, meaning the basal process of R-Smad 
turnover without TGF-β stimulation. We therefore expanded the model to include 
Endogenous Synthesis and Degradation of R-Smad (Model 7). If endogenous R-
Smad is synthesized in an unphosphorylated form, and targeted by Smurf2 for 
degradation only in its phosphorylated form, then can P-R-Smad Degradation 
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explain the decline of phospho-R-Smad despite the constant levels of total R-Smad? 
However, Model 7 diverged strongly from the observed dynamics of phospho-R-
Smad, when constrained to maintain a constant level of total R-Smad (Figure 
3.4D). 
Hence, our modeling analysis and experimental validation shows that current 
understanding of slow-mode negative regulation is not sufficient to explain 
phsopho-R-Smad dynamics. There might be some other mechanism that causes the 
peak and decline of phospho-R-Smad after the long-exposure of TGF-β. 
 
Figure 3.4 Simulations and experiments for P-R-Smad Degradation. (A) Model 6 with P-R-Smad 
Degradation and R-Smad Dephosphorylation (but no Receptor Degradation) was fitted to both 
the short-exposure (red) and long-exposure (blue) experimental data. (B) Model 6 predicted 
significant loss of total R-Smad (green curve), while ELISA measurements showed insignificant 
change (P>0.05, comparing the first and last data points) in total R-Smad concentration (green 
dots). (C) ELISA measurements of phospho-R-Smad are consistent with previous measurements 
performed by Western blot (Lin et al., 2006). Cell lysates were from the same samples as panel B. 
(D) Model 7 was fitted to the phospho-R-Smad data while constraining the total R-Smad level to 
be constant. Fitting used parameters vSmad2 = 5.7143 nMs-1 for R-Smad production, and 
kdegSmad2 = 0.01 s-1 for R-Smad degradation. 
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3.3.5 Sensitivity Analysis of All Species to Two Degradation 
Mechanisms 
Sensitivity analysis of Model 5 to perturbations in degradation rates revealed 
that T1R and total R-Smad are highly sensitive to changes in Receptor 
Degradation and P-R-Smad Degradation, respectively. Thus, our choices of T1R 
and total R-Smad measurements are sensitive to the mechanisms that we tested. 
We performed sensitivity analysis on the parameters of Model 7 to determine 
which proteins levels would most sensitively reflect the behavior of degradation 
mechanisms in the model. We computed the local sensitivities of all species to the 
Receptor Degradation and P-R-Smad Degradation mechanisms. This was done by 
perturbing the parameters related to these mechanisms individually, and computing 
the effect of the perturbations on the protein levels. The parameters were perturbed 
by a spectrum of relative changes (from 10-4 to 102) with the expectation that 
changes within 10-fold would be most relevant. The sensitivities (Figure 3.5) 
indicate that the total type I receptor and total R-Smad levels have higher 
sensitivity than other proteins did, to the Receptor Degradation and P-R-Smad 
Degradation mechanisms, respectively. This confirms our choice of total T1R levels 
and total R-Smad levels for testing our hypotheses about receptor degradation and 
P-R-Smad degradation. 
Different species are sensitive to different reactions or parameters in the model. 
This sensitivity analysis can also be applied to other species at other part of the 
signaling pathway. When we want to study certain mechanism or certain reaction 
in the pathway, it is often important to understand its sensitivity.  
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Figure 3.5 Sensitivity analysis heat map (Model 7). (A) The sensitivity of the P-R-Smad 
Degradation rate to each species with relative perturbations of the rate from 10-4 to 102. (B) The 
sensitivity of the receptor degradation rate to each species with relative perturbations of the rate 
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Figure S3: Sensitivity analysis heat map (Model 7). (A) The sensitivity of the P-R-SMAD DEGRADATION rate to each species with 
relative perturbations of the rate from 10-4 to 102. (B) The sensitivity of the receptor degradation rate to each species with relative 
perturbations of the rate from 10-4 to 102. 
!
S1.4 Transient and Sustained Signaling in the TGF-β Signaling Pathway 
Our model with PPM1A upregulation (Model 11) is also capable of producing the same dose-response 
behavior in short-term and long-term signals as shown by Klipp et al. {Zi, 2011 #78}. The phospho-R-
Smad concentration at 45 min increased when the dose of TGF- did (Fig. S4A). But if the dose of 
TGF- were high enough, the phospho-R-Smad concentration would be saturated at 45 min. The 
concentration of phospho-R-Smad did not remain elevated at 24 hr after TGF-β treatment unless the TGF-
β dose exceeds a certain threshold (Fig. S4B). This shows an ultrasensitive signaling response to TGF-β 
dose. We speculate that the saturation of the signal is mainly due to saturated TGF-β receptor, since R-
Smad was not saturated (only 30% of the R-Smads were phosphorylated). If the receptors were saturated, 
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3.3.6 Extended I-Smad-Mediated Receptor Inhibitions 
Our models (Model 1-7) were not capable of explaining experimental 
observations including the peak and decay of phospho-R-Smad, using only the three 
known negative regulatory mechanisms (Receptor Degradation, R-Smad 
Dephosphorylation and P-R-Smad Degradation). The loss of type I receptor caused 
by Receptor Degradation led us to degradation-independent I-Smad-mediated 
Receptor Inhibition mechanisms. One possible mechanism we considered for 
negative regulation of phospho-R-Smad is dephosphorylation of the receptor-ligand 
complex induced by I-Smad, which can recruit phosphatases in addition to E3-
ligases (Shi et al., 2004). Dephosphorylation would inhibit the kinase activity of the 
type I receptor without affecting its concentration. The other mechanism is that I-
Smad could bind to and block the active site of the type I receptor. Our model of 
Smad activation, adopted from previously published models, includes localization 
effects with caveolae and endosomes, which have distinct roles in receptor 
endocytosis. Because I-Smad co-localizes with caveolae (Di Guglielmo et al., 2003), 
we wanted to find a model fitting to the phospho-R-Smad data, in which I-Smad 
mainly associates with the ligand-receptor complex in caveolae, and in which the 
type I receptor is minimally lost. Figure 3.6 summarizes the results we got by 
extending the Receptor Inhibition mechanisms to include not only Receptor 
Degradation, but also Receptor Dephosphorylation and I-Smad Antagonism. As 
indicated by the red box, models were not capable of maintaining the observed 
concentrations of total T1R, while the I-Smad was co-localize with caveolae. We 
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were unable to construct an I-Smad-induced receptor inhibition mechanism that 
could explain the dynamics of phospho-R-Smad. 
 
 
Figure 3.6 Fitted models with extended receptor inhibition mechanism (Model 8). Each blue 
point represents a single model. The x-axis is the type I receptor (T1R) level simulated at 24hr. 
The y-axis is the ratio of I-Smad-bound ligand-receptor complex in the early endosome and 
caveolae. We rescaled the axes to better visualize the majorities of the data points (upper left 
sub-figure). Models in the red box region should be able to explain both the type I receptor level 
and localization of I-Smad. However, no fitted model falls in the red box. 
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3.3.7 The Rate of Receptor Internalization Does Not Affect the Peak 
and Decline of phospho-R-Smad When TGF-β is Saturating 
Receptor internalization has multiple effects on TGF-β/Smad signaling. 
Internalization is a part of signal transduction because internalization promotes 
association of the receptor kinase with its substrate R-Smad in the cytoplasm. At 
the same time, receptor internalization is also a negative regulatory mechanism as 
it reduces the availability of receptors on the cell surface. In other systems such as 
EGFR pathway, receptor internalization has been shown to cause down-regulation 
of downstream signals (Schoeberl et al., 2002). Thus we studied how receptor 
internalization could have a negative regulatory effect in our system. We first 
tested if varying the internalization rates in Model 1 could cause a peak and decline 
of phospho-R-Smad. The Adaptation Index was calculated as in Equation (3.1) to 
indicate the existence of a peak and decline. When a model has Adaptation 
Index=0, that means it has failed to show any decline of phospho-R-Smad. 
 Adaptation Index = [pSmad2]max − [pSmad2]t=24h[pSmad2]t=24h
 (3.1) 
As shown in Figure 3.7A (blue curve), the Adaptation Index remained zero, 
even when the rate of internalization for the ligand-receptor complex (LRC) was 
changed by a factor of 10-3 to 103. This is mainly due to early reached steady state 
of LRC when TGF-β dose is saturating (data not shown). Although the 
internalization rate could not induce Model 1 to exhibit a peak and decline of 
phospho-R-Smad, there may be other conditions in which internalization rates 
would play an important role. To find such conditions, we did perturbation analysis 
of all rate constants in Model 1 to see if any other parameters combined with the 
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internalization rates could affect the Adaptation Index. We found that the 
Adaptation Index was most significantly increased when we decreased the 
production rate of T1R and increased the production rate of T2R (Figure 3.7C-D). 
It seems that decreasing the production rate of T1R and increasing the production 
rate of T2R by 10 fold in Model 1 would enhance the role of receptor 
internalization in the regulation of phospho-R-Smad. Indeed, inhibiting the 
internalization rates of LRC significantly blunted the peak of phospho-R-Smad 
(Figure 3.7B) and the internalization rates of LRC were positively correlated with 
the Adaptation Index (red curve, Figure 3.7A). However, in this scenario (low 
production of T1R and high production of T2R), the saturating dose of TGF-β was 
shifted significantly higher (Figure 3.7E-F). As shown in Figure 3.7F, 2ng/ml of 
TGF-β was no longer a saturating dose in this scenario. In contrast, we already 
know that 2ng/ml of TGF-β does saturate Smad signaling (Klipp and Zi, 2007, Zi 
et al., 2011). The scenario with low production of T1R and high production of T2R 
is not realistic for our system where 2ng/ml of TGF-β is a saturating dose, but at 
lower doses, receptor internalization could affect the peak and decline of phospho-
R-Smad.   
In summary, we have failed to identify any internalization parameters that 
could affect the Adaptation Index for phospho-R-Smad negative regulation, when 
TGF-β is saturating. In our system, we find receptor internalization does not 
contribute to explaining the peak and decline of phospho-R-Smad. As a result, we 
do not vary the parameters for receptor internalization in our analysis of negative 
regulatory mechanisms. 
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Figure 3.7 Analysis of receptor internalization in Model 1. (A) Perturbation analysis of the rate 
of ligand-receptor complex (LRC) internalization. Log Parameter Perturbation is the log ratio of 
perturbed LRC internalization rate (the rate for internalizing early endosome and caveolae were 
changed with the same ratio) to its original value. Blue curve shows the result of perturbation 
analysis in Model 1, while red curve shows the result of perturbation analysis after changing the 
production rates of T1R (10-fold decrease) and T2R (10-fold increase) in Model 1. (B) Inhibition 
of LRC internalization in Model 1 after changing the production rates of T1R (10-fold decrease) 
and T2R (10-fold increase). Curves change from blue to red as LRC internalization rate decreases 
from 1 to 10-3 in log scale. (C) Adaptation Index change (x-axis) with 10-fold increase of each 
parameter. (D) Adaptation Index change (x-axis) with 10-fold decrease of each parameter. (E) 
Dose response at 45min. (F) Dose response at 45min. In panel E and F, blue curve shows dose 
response in Model 1, while red curve shows dose response in Model 1 after changing the 
production rates of T1R (10-fold decrease) and T2R (10-fold increase) in Model 1. 
  
3.3.8 PPM1A Is Upregulated After Treatment with TGF-β 
After exhausting the most widely-accepted mechanisms of Smad negative 
regulation, we proceeded to examine less obvious alternatives. We then 
systematically examined possible influences at each step along the Smad pathway, 
seeking quantitative consistency with the observed peak and decline of phospho-R-
Smad. One scenario that could not be rejected on kinetic grounds was upregulation 
of PPM1A, the phosphatase targeting phospho-R-Smad. If PPM1A were to be 
upregulated by TGF-β signaling, this could affect the temporal decay of phospho-R-
Smad. Model 9 permits the nuclear Smad complex to induce upregulation of 
PPM1A which in turn improved the fit of the model to the phospho-R-Smad data 
(Figure 3.8A), without changing the levels of T1R or total R-Smad (Figure 3.8B-C).  
To test this model, we performed Western blots of the PPM1A protein after 
TGF-β treatment. HaCaT cells were treated with 2ng/ml of TGF-β and measured 
after 0.25, 0.5, 1, 2, 4, or 8hr. We found that the intensity of the PPM1A western 
blot band increased 2.4-fold after 1 hour of TGF-β treatment (p<0.05, Figure 3.8D-
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E). To the best of our knowledge, this is the first study to report that TGF-β 
causes upregulation of the PPM1A phosphatase. 
 
 
Figure 3.8 Predictions and validation of PPM1A UPREGULATION: (A) Model 9, in which PPM1A 
is upregulated by Smad complex in the nucleus, was fitted to the long-exposure and the short-
exposure phospho-R-Smad experimental data. (B) Model 9 predicted unchanged T1R levels 
(green curve), in agreement with our experimental results (green dots). (C) Model 9 predicted 
unchanged total R-Smad levels (green curve), in agreement with our experimental results (green 
dots). (D) Model 9 predicted PPM1A upregulation under long-exposure of TGF-β (green curve). 
Our experimental validation showed significant upregulation of PPM1A (green dots, 
quantification from 3 Western blots, P<0.05 comparing the untreated data point and the 1hr 
data point). (E) Western blot of PPM1A in HaCaT cells with 2ng/ml TGF-β treatment, 
representative of 3 replicates. 
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3.3.9 Model-based Prediction of The Mechanism of PPM1A 
Upregulation 
The time series measurements in Figure 3.8D showed a rapid increase of 
PPM1A protein levels, with steady state achieved by about 1hr. In contrast, the 
behavioral effect we were hoping to explain, the gradual down-regulation of 
phospho-R-Smad, lasts for at least 4hrs. The idealized Model 9 predicted PPM1A 
upregulation at 4hr and not 1hr (Figure 3.8E). Does the early upregulation of 
PPM1A fail to explain the extended down-regulation of phospho-R-Smad? We next 
built a hypothetical model, inspired by known PPM1A interactions, attempting to 
harmonize the observed effects. 
Previous work does not indicate how PPM1A might be upregulated by TGF-β, 
but the speed of the effect suggests post-translational regulation (such as enhanced 
stability) or post-transcriptional regulation. PTEN has been shown in fibroblasts to 
associate with PPM1A and to protect PPM1A from proteasomal degradation (Bu 
et al., 2008). In the fibroblast context, TGF-β caused decreased levels of PPM1A, 
and caused dissociation of PTEN from phospho-R-Smad. It is possible that in our 
HaCaT system (keratinocytes), TGF-β could cause the opposite effect, upregulation 
of PPM1A, but also by regulating the association with PTEN. In HaCaT cells, 
TGF-β was reported to cause increased association between PTEN and phospho-
R-Smad (Hjelmeland et al., 2005), not the dissociation observed in fibroblasts. We 
therefore propose model 10 (specific to HaCaT cells), in which TGF-β would induce 
stabilization of PPM1A by PTEN. In this model, we halted degradation of PPM1A 
whenever it was associated with PTEN, but PTEN was not allowed to form a 
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complex directly with PPM1A, (i.e., in the absence of TGF-β stimulation). Rather, 
a ternary complex of pSmad2:PTEN:PPM1A could form, and a PTEN:PPM1A 
complex could be released from the ternary complex. This recapitulates the 
observation that PTEN-Smad2 association is dependent on TGF-β stimulation 
(Hjelmeland et al., 2005). In this model, we required the upregulation of PPM1A 
protein to match the fast kinetics observed, but we also wanted the increased 
phosphatase activity against phospho-R-Smad to match the observed phospho-R-
Smad dynamics. We do not know whether PPM1A activity, conformation, or 
localization would be changed by binding to PTEN. It is possible that PTEN-
PPM1A association could cause some transient sequestration of PPM1A activity, 
which might delay the functional impact of PPM1A upregulation. In Model 10, we 
assumed that unbound PPM1A is rapidly imported into the nucleus, but PPM1A 
bound to PTEN has slow import into the nucleus. Because phospho-R-Smad 
accumulates in the nucleus, delayed nuclear import of PPM1A during PTEN-
mediated stabilization would delay the functional impact of PPM1A activity, 
relative to the total PPM1A levels. Complete reaction equations and parameters 
appear in the Supporting Information. Model 10 successfully recapitulated the 
experimentally observed dynamics of phospho-R-Smad (Figure 3.9A); the fast 
kinetics of PPM1A upregulation (Figure 3.9B); and the unchanged levels of T1R 
and total R-Smad (Figure 3.9C-D). 
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Figure 3.9 Model-based predictions of the mechanism of PPM1A UPREGULATION: (A) Model 10, 
in which PPM1A is stabilized by PTEN, was fitted to the long-exposure and the short-exposure 
phospho-R-Smad experimental data. (B) Model 10 predicted early PPM1A upregulation (within 
1hr) under long-exposure treatments with TGF-β (green curve). This is in agreement with our 
experimental measurements of PPM1A (greed dots). (C) Model 10 predicted unchanged T1R 
levels (green curve), in agreement with our experimental results (green dots). (D) Model 10 
predicted unchanged total R-Smad levels (green curve), in agreement with our experimental 
results (green dots).  
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3.3.10 The Role of P-R-Smad Degradation in the Context of PPM1A 
Stabilization 
Model 10 is the first model in our series that is consistent with all the 
experimental data (including our own) for the impact of TGF-β on HaCaT cells. As 
shown in Figure 3.4, P-R-Smad Degradation could not by itself explain the long-
term decline of phospho-R-Smad. We now examine the role of P-R-Smad 
Degradation in the context of Model 10 where PPM1A Stabilization is partially 
responsible for the Smad negative regulation. Previous studies assessed P-R-Smad 
Degradation using MG132 to inhibit proteasomal degradation, but with conflicting 
conclusions: Massague et al. saw a strong effect implying an important role for 
degradation (Lo and Massague, 1999, Alarcon et al., 2009), while Lin et al. found 
negligible effects of MG132 (Lin et al., 2006). Both protocols measured long-term 
behavior of pSmad2, but the Lin protocol triggered pSmad2 using a 30min exposure 
to TGF-β, while the Massague protocol used a 6h exposure. To examine this 
apparent conflict, we extended Model 10, adding Endogenous Synthesis and 
Degradation of R-Smad, and adding P-R-Smad Degradation, to obtain Model 11. 
Like Model 10, Model 11 shows a good fit to phospho-R-Smad dynamics (Figure 
3.10A) and unchanged levels of total R-Smad (Figure 3.10B). Simulations of Model 
11 with MG132 inhibition of proteasomal degradation show that MG132 would 
have minimal impact on Smad signaling, when triggered by brief exposure to TGF-
β (Figure 3.10C). In surprising contrast, MG132 would have a strong impact on 
Smad signaling, when pSmad2 is triggered by longer exposures to TGF-β (Figure 
3.10D). Figure 3.10E compares the P-Smad2 Change calculated from Figure 3.10C 
  60 
(red curve) and Figure 3.10D (blue curve) with experimental data from Lin et al. 
(Lin et al., 2006) (red dots) and Alarcon et al. (Alarcon et al., 2009) (blue dots). 
The P-Smad2 Change was calculated as Equation (3.2). Model 11 thus provides 
mathematical support that the Lin observations and the Massague observations can 
occur in the same system. Finally, Model 11 demonstrates that PPM1A 
Stabilization, and P-R-Smad Degradation are consistent with, and sufficient to 
explain, the negative regulation and degradation nuances of the Smad signaling 
system. 
 P-Smad2 Changet=ti =
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Figure 3.10 Combination of PP1MA Stabilization, P-R-Smad Degradation, R-Smad Endogenous 
Synthesis and Degradation: (A) Model 11, combining PP1MA Stabilization, P-R-Smad 
Degradation, R-Smad Endogenous Synthesis and Degradation, was fitted to the long-exposure 
and the short-exposure phospho-R-Smad experimental data. (B) Model 11 predicted unchanged 
total R-Smad levels (green curve), in agreement with our experimental results (green dots). (C) 
Red solid curve shows simulation of Model 11 with short-exposure (30min) of TGF-β, while the 
yellow dotted curve shows the same simulation except with MG132 pre-treatment. MG132 was 
simulated as turning off P-R-Smad Degardation (kdegpSmad2=0). (D) The blue solid curve shows 
simulation of Model 11 with long-exposure (8hr) of TGF-β, and the green dotted curve shows the 
same simulated except with MG132 pre-treatment. (E) The relative change in P-Smad2 levels 
after MG132 treatment, calculated from Eq. 1 and simulations of Model 11. The P-Smad2 change 
simulated using Model 11 in both short-exposure (30min, red curve) and long-exposure (8hr, blue 
curve) simulations was compared with the P-Smad2 change in the experimental results of Lin et 
al. (Lin et al., 2006) (30min-exposure, red dots) and Alarcon et al. (Alarcon et al., 2009) (6hr-
exposure, blue dots). Data points from Alarcon et al. (Alarcon et al., 2009) were quantified from 
one published image. The discrepancy between our simulations and Alarcon et al for the 7hr 
measurement may be partially explained by MG132-independent differences. Their -MG132 
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3.3.11 Transient and Sustained Signaling in the TGF-β Signaling 
Pathway 
Our model with final model (Model 11) is also capable of producing the same 
dose-response behavior in short-term and long-term signals as shown by Klipp et al. 
(Zi et al., 2011). The phospho-R-Smad concentration at 45 min increased when the 
dose of TGF-β did (Figure 3.11A). But if the dose of TGF-β were high enough, the 
phospho-R-Smad concentration would be saturated at 45 min. The concentration of 
phospho-R-Smad did not remain elevated at 24 hr after TGF-β treatment unless 
the TGF-β dose exceeds a certain threshold (Figure 3.11B). This shows an 
ultrasensitive signaling response to TGF-β dose. We speculate that the saturation 
of the signal is mainly due to saturated TGF-β receptor, since R-Smad was not 
saturated (only 30% of the R-Smads were phosphorylated). If the receptors were 
saturated, then the dose of TGF- β only affects the duration, but not the intensity 
of the signal in the long-term (Figure 3.11C). This suggests that the reason for the 
decay of phosphorylated R-Smad with saturating TGF-β dose is down-stream 
regulatory mechanisms, but not the consumption of TGF-β. 
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Figure 3.11 TGF-β dose response. (A) Simulated P-Smad2 levels at 45min under different doses 
of TGF-β treatment. (B) Simulated P-Smad2 levels at 24hr under different doses of TGF-β 
treatment. (C) Simulations of the P-Smad2 dynamics with different doses of TGF-β. The color of 




Several negative regulatory mechanisms in the Smad signaling pathway have 
been identified and individually studied (Afrakhte et al., 1998, Itoh et al., 1998, 
Kavsak et al., 2000, Lin et al., 2006, Lo and Massague, 1999, Alarcon et al., 2009, 
Shi et al., 2004, Nakao et al., 1997). We focused our modeling and experiments on 
these specific mechanisms with published evidence. R-Smad Dephosphorylation by 
PPM1A is widely recognized to be a strong form of negative regulation, having 
significant fast-mode impact, but the relative importance of other mechanisms, 
compared with R-Smad Dephosphorylation, was not clear. We found that multiple 
combinations of fast-mode and slow-mode mechanisms could match the phospho-R-
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Smad data moderately well, but these combinations (e.g., Models 2,5, and 6) could 
only recapitulate phospho-R-Smad dynamics at the expense of very strong, 
cumulative degradation; as much as 90% decrease of T1R at 24hr (Figure 3.3B), or 
90% decrease in total R-Smad at 24hr (Figure 3.4B). Our experimental 
measurements in HaCaT found that total T1R protein levels did not decline 
significantly (Figure 3.3D) nor did total R-Smad (Figure 3.4B). This contrasts with 
previous work in 293T and COS-1 cells (Kavsak et al., 2000, Eichhorn et al., 2012). 
In (Kavsak et al., 2000), 293T cells were transfected with I-Smad which was able to 
induce significant receptor degradation. The significant degradation seen in 
(Kavsak et al., 2000) may be due to the effects of transfection (Clarke et al., 2009) 
or may be due to cell line differences. Although most dynamic models of signal 
transduction represent an amalgam of findings from multiple cell lines, our model 
(and the previous models we rely on) are specific to the HaCaT cell line. Thus a 
discrepancy with (Kavsak et al., 2000) is not necessarily a flaw of our model. 
In light of our experimental measurement that TGF-β treatment does not cause 
any significant drop in R-Smad levels or T1R levels, we conclude that degradation 
effects, if they occur in HaCaT, must be counterbalanced by endogenous synthesis. 
Model 7 simulated a balance of synthesis and degradation (Endogenous Synthesis 
and Degradation of R-Smad) such that phospho-R-Smad was degraded while 
unphosphorylated Smad was synthesized; this model was not able to induce the 
observed long-term decay of phospho-R-Smad. We conclude that degradation of R-
Smad or T1R, with or without endogenous synthesis, is not sufficient to explain the 
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slow-mode of Smad negative regulation in HaCaT cells. Degradation with synthesis 
remains a plausible effect but it must occur alongside other mechanisms.  
After simulating all the previously published mechanisms of negative regulation, 
including Receptor Inhibition (See Model 8, Section 3.3.6)(Afrakhte et al., 1998, 
Itoh et al., 1998, Ebisawa et al., 2001, Hayashi et al., 1997, Kavsak et al., 2000), R-
Smad Dephosphorylation (Lin et al., 2006), and P-R-Smad Degradation (Lo and 
Massague, 1999, Alarcon et al., 2009, Lin et al., 2000), no model could explain the 
“slow-mode” of phospho-R-Smad decline after long exposures to TGF-β, unless they 
violated the observations of other experiments. In silico exploration of hypothetical 
mechanisms led us to question whether PPM1A levels could change during Smad 
pathway activation (Model 9).  
We then tested the model-inspired question, whether PPM1A is upregulated by 
TGF-β. PPM1A western blots showed 2.4-fold increase in PPM1A protein levels 
(Fig. 5D-E), suggesting a negative feedback effect, in which TGF-β upregulates 
PPM1A to control the levels of phospho-R-Smad. In Model 10 we studied how this 
novel finding might relate to the negative regulation of phospho-R-Smad. Not 
knowing the exact mechanism for TGF-β to cause upregulation of PPM1A, we 
simulated combinations of individual effects, many taken from reports in other 
contexts, to provide a theoretical model of PPM1A stabilization. PPM1A is known 
to be stabilized by PTEN (Bu et al., 2008). If TGF-β can promote PTEN-PPM1A 
interaction in HaCaT, that might explain the observed increase in PPM1A as a 
stabilization effect. Another consideration is that TGF-β can induce association 
between PTEN and R-Smad (Hjelmeland et al., 2005). The detailed interactions or 
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competitions among PTEN, R-Smad and PPM1A are not known, but we assumed 
that TGF-β would induce PTEN-PPM1A interaction and PPM1A stabilization 
through phosphorylation of R-Smad. A model simulating this assumption alone was 
not consistent with observations, so in Model 10 we further hypothesized that 
PTEN-mediated stabilization would temporarily sequester PPM1A, for example 
through decreased nuclear import of the PTEN-PPM1A complex. There are many 
plausible ways that PTEN-induced stabilization of PPM1A could sequester or delay 
PPM1A enzymatic activity, such as conformational change or post-translational 
modification. Our model shows one simplistic mechanism namely PPM1A 
Stabilization, with delayed nuclear import, was sufficient to reconcile the early 
upregulation of PPM1A total protein with later PPM1A effects on phospho-R-
Smad. Our theoretical model could be useful for the design of experiments to 
determine how the upregulation actually occurs. Future work should test whether 
PPM1A is stabilized and/or sequestered by PTEN after TGF-β treatment in 
HaCaT, as illustrated in Models 10-11. Pull-down experiments could be applied to 
study the association among phospho-R-Smad, PPM1A and PTEN. The order of 
binding reaction might be complex and ternary complex may exist. Our model 
would recommend testing for PPM1A-PTEN binding at 30min-1hr to catch their 
peak interaction, but testing for increased PPM1A activity at 4hr, significantly 
later than the upregulation. 
Our model and experimental validation suggested that PPM1A upregulation 
could be important to explain the peak and decline of phospho-R-Smad in long 
exposure to TGF-β. However, negative regulation of TGF-β pathway could be a 
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complex process and other mechanism may also be involved. Further study may 
also consider other effects such as scaffold proteins. Scaffold proteins can facilitate 
the association between receptor kinase and R-Smads. If scaffold proteins are down 
regulated or their activities are blocked under TGF-β treatment, phospho-R-Smad 
level might reduce. 
Careful examination of a broader set of previous work reveals some effects that 
appear to be discrepancies. The steepness of phospho-R-Smad decline in HaCaT 
appears to differ between the experiments of Massague and colleagues in (Lo and 
Massague, 1999, Alarcon et al., 2009) (green curve in Figure 3.1A) versus the 
experiments of Lin et al. (Lin et al., 2006) (blue curve), which are similar to our 
results (Figure 3.4C) and similar to the results of (Zi et al., 2011). One possible 
explanation is a difference in the effective concentrations of TGF-β. TGF-β has a 
very short half-life, and the dissolving conditions, such as carrier protein 
concentration, can alter the effective concentration of TGF-β. Previous authors did 
not report how their TGF-β was dissolved, but we found that dissolving TGF-β 
without carrier protein led to a steeper decline of phospho-R-Smad, similar to 
Massague et al. (Lo and Massague, 1999, Alarcon et al., 2009) (data not shown). 
We believe this discrepancy in slope is a technicality of the experiments and not 
fundamental to the pathway analysis.  
Recent work has shown the importance of TGF-β depletion as a determinant of 
Smad signaling kinetics, for cells treated with low doses of TGF-β (10pM and 25pM) 
(Clarke et al., 2009). Our work did not emphasize low-dose contexts, but our 
models are consistent with observed TGF-β depletion behaviors. Figure 3.11 shows 
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simulations of Model 11 with low-dose TGF-β treatments. Smad signaling was 
indeed dominated by TGF-β scarcity. When the Smad system was externally 
limited by TGF-β availability, self-limiting mechanisms and negative regulatory 
effects were not apparent. Negative self-regulation of the Smad system was strongly 
apparent in treatments with 2ng/ml (80pM) of TGF-β, which is the dose studied in 
most previous experimental and computational studies of Smad dynamics.  
After successfully predicting PPM1A upregulation and achieving recapitulation 
of all available datasets, our final contribution was to address an existing 
controversy about the role of proteasomal degradation in Smad signaling. We 
discovered that an apparent conflict about the role of degradation was in fact a 
mutually consistent set of trajectories that can both emerge from a single model. 
Degradation is intuitively understood to be a cumulative effect seen in long-term 
observations, but in this case the duration of observation was irrelevant, and the 
crucial variable for degradation was the duration of the TGF-β stimulus. MG132 
(an inhibitor of proteasomal degradation) had negligible effect on pSmad levels (at 
1,2,4,6 hr), in a system triggered with 30min exposure to TGF-β, but MG132 had a 
significant effect on pSmad levels (at 1,2,4,6 hr), in a system triggered with long 
exposure to TGF-β. In other words, the importance of degradation in Smad 
signaling depended not on the timepoint at which p-Smad2 was measured, but 
rather on the duration with which the Smad system had been induced. The 
consistence between the two experiments can be rationalized in retrospect because 
degradation depends on the “area under the curve,” which is large in systems with 
prolonged stimulus, and very small in systems with short stimulus. However, the 
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consistency between Lin et al. and Massague et al. was not apparent prior to 
modeling, and mathematical inference of kinetic implications is dramatically 
different from the interpretations provided by the previous authors.  
Our modeling provides a consistent, quantitative, and fine-grained integration 
of available information about the negative regulation of phospho-R-Smad, both 
from published literature and from our experiments. Our integration of modeling 
with experiments showed that published mechanisms such as Receptor Degradation 
have a minor effect, and led us to discover upregulation of PPM1A. Modeling can 
make additional predictions (e.g., future experiments should test for peak 
perturbation of PPM1A binding and activity.) Also modeling has provided a new 
and non-obvious interpretation for the effects of MG132 treatment. When 
interpreting the biological meaning of observed kinetics, informal intuition can 
unwittingly lead to flawed conclusions. Our updated model of Smad signaling may 
in the future be useful to other researchers interpreting data, designing experiments, 
or strategizing therapeutic perturbations. The field of biochemistry has a long 
history of using kinetics to gain insight into mechanism. Likewise our work has 
studied kinetic as our concrete contribution, but the larger outcome is to shed light 
on mechanisms. 
Our final model of TGF-β pathway made some improvement to current state-
of-art of TGF-β pathway modeling. Thus, it is better to integrate our model of 
TGF-β pathway Venkatraman’s upstream model of TGF-β activation, as the 
upstream model treated TGF-β signaling pathway as a black box. This integration 
is useful to study the important factors to the bistable behavior in the whole 
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system. For example, integrating the upstream and downstream networks could 
help to discover combination of drug targets in both upstream and downstream 
networks which could cause synergistic effect.  
As we mentioned earlier in the introduction (Chapter 1), the upstream network 
takes the averaged response from Smad pathway in a population of cells. Cell-to-
cell variability may also be an important factor affecting the bistable behavior of 
the system. It is better to integrate an upstream network with a population of 
downstream networks. However, to simulate such a network is time-consuming. 
Therefore, we sought to develop efficient algorithms to simulate or approximate 
network behaviors from a population of cells. Assuming molecules are mixed fast 
enough in the upstream network, we can integrate the upstream network and the 
output of a population of downstream networks. 
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4  Chapter 4: Approximating Cell-population 
Behavior of Signaling Pathways Based on Single-
cell Models 
4.1 Introduction 
Cell-to-cell variability and heterogeneity has been paid more and more 
attention in study of signaling pathways and other cell behaviors. This trend 
emerged mainly because of advanced single-cell based techniques for biological 
studies developed and applied in the past decade, such as imaging and flow 
cytometry. The earlier studies of signaling pathways assume homogeneity of 
monoclonal cell populations. However, single-cell based methods show significant 
cell-to-cell viability in a variety of signaling pathways including EGFR pathway, 
NFκB pathway (Lee and Covert, 2010), TRAIL-induced apoptosis pathway (Tay et 
al., 2010, Spencer et al., 2009a). 
Although the difference between single-cell and cell-population behaviors has 
been shown, most systems biology studies of signaling pathways are still based on 
bulk experiments because most of the knowledge and data is available in bulk 
experiments. Thus, systems biologists often need to compare single-cell based model 
to cell-population based experiments. In order to do this, Monte Carlo simulation 
could be used in the way that simulation results from multiple models representing 
multiple cells are averaged to get the cell-population simulation. However, Monte 
Carlo simulation usually needs a large number of simulations to converge to the 
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averaged results. This is very time-consuming to just simulate the cell-population 
behaviors and it is not possible to estimate parameters because one parameter 
estimation procedure often takes thousands of simulations. Therefore, it would be 
very useful if we can simulate cell-population behaviors using single-cell models 
faster. If the simulation is fast enough, we may even estimate parameters of both 
single-cell models and cell-to-cell variability by comparing simulated cell-population 
behaviors to bulk experimental data. 
In this study, we developed two approaches to approximate cell-population 
simulation using single-cell models, assuming the initial concentrations of all species 
vary from cell to cell. In the first approach, we derived Population ODE that 
approximates the means of concentrations of all species. This approach needs only 
one simulation. It is significantly faster than Monte Carlo simulation which needs 
thousands of simulations. But in some biological systems, such as bistable systems, 
Population ODE does not approximate the population behavior well enough. We 
then developed our second approach. The second approach, Sample Reduction, is 
by significantly reducing the dimension of sampling space and further reduces the 
number of samples required. This approach is a sampling-based approach, similar 
to Monte Carlo simulation. However, our approach significantly reduces the sample 
size and facilitates the simulation of population behavior. 
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4.2 Materials and Methods 
4.2.1 Construction of Population ODE 
The Population ODE requires the A1  and A2  matrices and the k  vector from 
single-cell models. We used KroneckerBio toolbox (Toettcher et al., 2011) in 
Matlab to build the models and KroneckerBio toolbox generated the A1  and A2  
matrices and the k  vector we need. These matrices and vector were then built into 
the Matlab ode files and the function ode15s in Matlab was used to simulate the 
Population ODE.  
4.2.2 Initial Distribution of Species Concentrations and Monte Carlo 
Simulation 
In all the cases we studied, we assumed the initial distribution of species 
concentration as a Gaussian distribution with expected value of its original initial 
concentration and with standard deviation of 20% of its original initial 
concentration. The variation of species with non-zero initial concentration was 
considered. The initial concentrations of the other species were kept 0. In Monte 
Carlo simulation, we randomly sampled the species with non-zero initial 
concentration individually as we assumed that they were independent at time 0. 
In Monte Carlo simulation, it is possible that random sampling from a Gaussian 
distribution will generate negative values for initial concentrations. As this chance 
is low based on our assumption, we simply ignored those samples with negative 
initial concentrations. 
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4.2.3 Sample Reduction in the Case of Apoptosis Pathway 
The sensitivity matrix was calculated at 20 different time points in this case. 
The time points were chosen according to 
dy
dt , in which y  was the output species 
(activated caspase 3). The time steps were set to satisfy the condition below so that 
the larger 
dy
























, (n = 20)  (4.1) 
4.2.4 Integration of Upstream Network of TGF-β Activation and 
Downstream Smad Signaling 
To integrate these two networks, we need to break up two black-box reactions 
in Venkatraman’s model, in which TSP1 production rate and PAI1 production rate 
are respectively kp1[TGFβ ] and kp2[TGFβ ] . Then we modeled these two black 
boxes explicitly with Smad signaling pathway. Thus, the production rates of TSP1 
and PAI1 should be proportional to Smad complexes in the nucleus as these 
complexes are the species regulating gene expressions. We therefore set the 
production rates of TSP1 and PAI1 to be kp1([Smad24nuc ]+ [Smad22nuc ])  and 
kp2([Smad24nuc ]+ [Smad22nuc ]) . Since TGF-β already existed in both networks, 
we simply merged TGF-β in both networks to a single species. Hence, we have 
integrated the upstream network of TGF-β activation and downstream Smad 
signaling. Note that the parameters kp1 and kp2 should not have the sample value 
as in Venkatraman’s model because the concentrations of TGF-β and Smad 
complexes are different. 
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4.3 Results 
Cell-to-cell variability may be caused by variations of different factors, such as 
different concentrations of molecules, mutations of molecules, and different 
responses to environmental change. Correspondingly, there are different ways we 
can introduce different types of variations to the ODE system which models cellular 
behaviors. In the ODE system, variations can come from initial concentrations, 
reaction rate constants, and time varying input functions. Variation in initial 
concentrations can represent different concentrations of molecules in different cells. 
Variation in rate constants can reflect mutations of molecules, for example. 
Stochastic time varying input function is a more general way to model cell-to-cell 
variability than the previous two. This can be used to model variation sources 
which are not modeled by the ODE system. Different ways of modeling variations 
need different simulation strategies. Here, we develop simulation strategies for one 
type of variations which is the variation in initial concentration of molecules. In 
this case, we assume that the different cells have only different initial 
concentrations in the ODE system. Any other part of the ODE system, including 
rate constants, network structure, is assumed to be the same among different cells. 
4.3.1 Propagating Population ODE System Based on Single-Cell ODE 
Model 
In Chapter 2 (Section 2.1.4), we have introduced ODE model for Mass Action 
Kinetics. Mass Action Kinetics can be applied to describe the rate of most 
biochemical reactions. We have also showed how the ODEs of any type of Mass 
Action Kinetics can be written in a form of Kronecker product (Section 2.1.4.1, 
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repeated as in Equation (4.2)). This Kronecker product form of ODEs below is the 




1x + A2x⊗ x + k  (4.2) 
4.3.1.1 Derived ODEs for the population mean requires the value of the 
covariance matrix 
Simulation of cell-population result can be easily achieved by Monte-Carlo 
simulation. But it is time consuming because it needs to simulate multiple samples 
of single-cell ODE systems. To facilitate the population, we want to derive a 
Population ODE model based on the single-cell ODE system, and this population 
ODE system determines the time-evolution of the population mean of each species 
concentration. With this population ODE system, we are able to simulate the 
population mean of each species concentration without sampling. To achieve that, 
we denote each species concentration as xi = µi +δ i , where µi  denotes the 
expected value (population mean) of all xi , and δ i  is a variable representing the 
variation of species concentration among different cells. To write concentrations of 
all species together, we have the vector form x = µ + δ . Here, both x(t)  and δ (t)  
are functions of t  and random variables varying among different cells. In other 
words, we want to derive 
dµ
dt  based on 
dx
dt  using the substitution x = µ + δ . 
Taking expected value of both sides of Equation (4.2), we have, 
  







1E(x)+ A2E(x⊗ x)+ k
= A1µ + A2E[(µ + δ )⊗ (µ + δ )]+ k





E(δ ⊗δ ) = vec
δ1δ1  δ nδ1
  























1µ + A2µ⊗ µ + A2vec(CT )+ k  (4.5) 
Here, vec(CT )  denotes the vec operation of the transpose of the covariance 
matrix C . Note that the time-evolution of µ(t)  depends on not only itself but also 
the covariance matrix. Equation (4.5) is also a proof to the concept that the 
behavior of a population of cells is different from that of a single cell. The 
covariance matrix C  also evolves with time. Therefore, in order to compute C  
which is required for computing 
dµ
dt , we further derive ODEs for vec(C
T ) . 
4.3.1.2 Approximating time-evolution of the covariance matrix by ignoring 
the third moment 
Taking expected value of δ ⊗δ , we have 
 
E[vec(CT )]= E(δ ⊗δ )
= E[(x − µ )⊗ (x − µ )]
= E[x⊗ x]− µ⊗ µ
 (4.6) 












dt  (4.7) 
Then we derive the two terms on the right hands side of Equation (4.7) 








= x⊗ (A1x + A2x⊗ x + k)+ (A1x + A2x⊗ x + k)⊗ x
 (4.8) 
Applying the rule (A⊗ B)(C⊗ D) = (AC)⊗ (BD)  and taking expected value 




1⊗ I + I⊗ A1)E(x⊗ x)
+(A2⊗ I + I⊗ A2)E(x⊗ x⊗ x)
+µ⊗ k + k⊗ µ
 (4.9) 
The term E(x⊗ x)  can be expressed by µ  and vec(CT )  as in Equation (4.6). 
Then we need to express E(x⊗ x⊗ x)  by µ  and vec(CT )  as well. To simplify 
the derivation, we derive E(δ ⊗δ ⊗δ )  instead. 
 
E(δ ⊗δ ⊗δ ) = E[(x − µ )⊗ (x − µ )⊗ (x − µ )]
= E(x⊗ x⊗ x)+ 2µ⊗ µ⊗ µ
−E(x⊗ x⊗ µ )− E(x⊗ µ⊗ x)− E(µ⊗ x⊗ x)
= E(x⊗ x⊗ x)− µ⊗ µ⊗ µ
−vec(CT )⊗ µ − E(δ ⊗ µ⊗δ )− µ⊗ vec(CT )
 (4.10) 
Note that 
  79 
 
 

























































δ1µ1δ  δ nµ1δ
  





















= E vec µ⊗ δ1δ  δ nδ( )⎡⎣⎢ ⎤⎦⎥{ }
= vec(µ⊗CT )
 (4.11) 
Thus, from Equation (4.6) and Equation (4.10), we have  
 
E(x⊗ x) = µ⊗ µ + vec(CT )
E(x⊗ x⊗ x) = µ⊗ µ⊗ µ
+µ⊗ vec(CT )+ vec(CT )⊗ µ + vec(µ⊗CT )













1⊗ I + I⊗ A1)[µ⊗ µ + vec(CT )]
+(A2⊗ I + I⊗ A2)[µ⊗ µ⊗ µ
+µ⊗ vec(CT )+ vec(CT )⊗ µ + vec(µ⊗CT )
+E(δ ⊗δ ⊗δ )]
+µ⊗ k + k⊗ µ
 (4.13) 
Hence, we have derived the first term on the right hand side of Equation (4.7). 







dt ⊗ µ  (4.14) 
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Substituting 
dµ
dt  using Equation (4.5) and applying the rule 




1⊗ I + I⊗ A1)(µ⊗ µ )
+(A2⊗ I + I⊗ A2)(µ⊗ µ⊗ µ )
+(A2⊗ I )[vec(CT )⊗ µ ]+ (I⊗ A2)[µ⊗ vec(CT )]
+µ⊗ k + k⊗ µ
 (4.15) 
With the first term derived in Equation (4.13) and second term derived in 
Equation (4.15), we have fully derived Equation (4.7) for the time-evolution of the 












= (A1⊗ I + I⊗ A1)vec(CT )
+(A2⊗ I )[µ⊗ vec(CT )+ vec(µ⊗CT )]
+(I⊗ A2)[vec(C)⊗ µ + vec(µ⊗CT )]
+(A2⊗ I + I⊗ A2)E(δ ⊗δ ⊗δ )
 (4.16) 
Note that the variables in ODE for vec(CT )  include only µ  and vec(CT )  
except E(δ ⊗δ ⊗δ ) . The term E(δ ⊗δ ⊗δ )  has the same coefficent matrix as 
µ⊗ vec(CT ) , vec(CT )⊗ µ  and vec(µ⊗CT ) . As E(δ ⊗δ ⊗δ )  is significantly 
smaller than µ⊗ vec(CT ) , vec(C)⊗ µ  and vec(µ⊗C
T )  in most cases, we 
ignore the third moment term E(δ ⊗δ ⊗δ )  to approximate dvec(C
T )
dt . By 
ignoring the third moment, 
dµ
dt  and 
dvec(CT )
dt  as a combined ODE system can be 
sloved. Thus, the time-evolution of the population mean of each species can be 
approximated by the new population ODE system as in Equation (4.17).  




1µ + A2µ⊗ µ + A2vec(CT )
dvec(CT )
dt = (A
1⊗ I + I⊗ A1)vec(CT )
+(A2⊗ I )[µ⊗ vec(CT )+ vec(µ⊗CT )]











This population ODE system provides us a faster way to estimate the 
population mean than the Monte-Carlo method. With the population ODE, we 
only need to simulate a larger system (n2+n number of species, n is the number of 
species in the original system) once to estimate the population mean µ(t) . This 
population ODE system also estimates the covariance matrix as a function of time 
CT (t) . It not only makes the simulation more efficient, but also allows us to apply 
methods for ODEs such as parameter estimation and sensitivity analysis for the 
population behavior.  
4.3.1.3 Derivation of the Jacobian matrix of the population ODEs 
The Jacobian matrix of the population ODEs has an analytic solution. So we 
can derive the Jacobian matrix explicitly to allow faster ODE simulation. 






































Therefore, the Jacobian matrix can also be writtien in 4 blocks as in Equation 
(4.19), and each block can be derived individually. 



























Each block in the Jacobian matrix is derived as below. For detailed derivation, 




= A1 + A2(µ⊗ I + I⊗ µ )  (4.20) 
 
∂Fµ
∂vec(CT ) = A




= (A2⊗ I )[I⊗ vec(CT )+ E(δ ⊗ I⊗δ )]




∂vec(CT ) = (A
1⊗ I + I⊗ A1)
+(A2⊗ I )(µ⊗ I⊗ I + I⊗ µ⊗ I )
+(I⊗ A2)(I⊗ µ⊗ I + I⊗ I⊗ µ )
 (4.23) 
Please note that some matrices in the four equations above are even larger than 
the Jacobian matrix itself. For example, the size of A2⊗ I  is n2 × n3 . This would 
take a lot of memory if we compute the Jacobian matrix based on the above four 
equations. Since we only need the result of the Jacobian matrix but not the 
intermeidate terms such as A2⊗ I , we tried to faciliate calculation of each block 
of the Jacobian matrix. Actually, after we looked into the details of the Kronecker 
product and matrix product opertations in Equation (4.22) and (4.23), we found 
that these equations can be simplified in terms of matrix operations. Simplifications 
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of Equation (4.22) and (4.23) are shown below. Please refer to the detailed 
derivation in the Appendix. 
For Equation (4.22), we need to write A2  as a block matrix 
 
 
















and to write C* = C +CT as a block matrix as well 
 
 




















= T1 + [A2vec(C)]⊗ I +T 3  (4.26) 
where the k-th column of T1  is  
 
 
 T1:,k = vec(CTBTk )  (4.27) 
 
and the k-th row of T3  is 
 T3k ,: = A2(ck ⊗ I )  (4.28) 




, which we have evaluated in Equation (4.20).  





⊗ I + I⊗ ∂Fµ
∂µ
 (4.29) 
Hence, we have simplified the calculation of the Jacobian matrix. The largest 
matrix required for the calculation of the Jacobian matrix has size n × n2 , smaller 
than n2 × n3  before simplification. Some unnecessary calculations are also avoided 
such as that in Equation (4.23). We can use the result of (4.20) to make the 
calculation of Equation (4.23) almost trivial as derived in Equation (4.29). 
4.3.2 Case Study Using Population ODE System 
After derivation of the population ODE system, we wanted to test the performance 
of this approximation approach in both speed and accuracy. Since we did not know 
the truth of cell-population dynamics, we compared our simulation results using 
population ODEs to the results from Monte-Carlo simulation with large sample size. 
The convergence plot for Monte-Carlo simulation was plotted to show the sample 
size we selected  
4.3.2.1 Applying Population ODE to EGFR Pathway 
EGFR (Epidermal Growth Factor Receptor) pathway is one of the most 
studied signaling pathways both biologically and computationally as its important 
function in regulating cell division, motility and apoptosis (Citri and Yarden, 2006). 
Because of the importance and extensive investigation, the studies of EGFR 
pathway have also been most widely transferred to biomedical research (Citri and 
Yarden, 2006). Besides its classical role in the history of signaling pathway studies, 
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cell-to-cell variability has also been found in EGFR pathway. Thus, we chose 
EGFR pathway to be our first attempt of the Population ODE. 
There are dozens of models about EGFR pathway published. The earliest 
models studied ligand-receptor binding and receptor trafficking (Wiley and 
Cunningham, 1981). Then, Kholodenko et al. built the first model including the 
early target proteins in the signaling cascade, such as Grb2, Shc and SOS 
(Kholodenko et al., 1999). Schoeberl et al. added more downstream events such as 
Ras-dependent MAPK cascade based on Kholodenko’s model (Schoeberl et al., 
2002). These two models then served as platforms for more complex EGFR 
pathway models. Recent models include a model expanding the EGF receptor to 
ErbB receptor family (Chen et al., 2009), a model focusing on the ligand-specific 
control of the dynamics of ErbB network (Nakakuki et al., 2010), and models which 
have crosstalk with other pathways (Sivakumar et al., 2011). As the recent models 
become very large and sometimes case-specific, we chose to apply the Population 
ODE to Schoeberl’s model (Schoeberl et al., 2002), which serves as a backbone for 
most of the later models. 
Schoeberl’s model has 29 species and 10 species out of 29 have non-zero initial 
concentrations. We assume that the EGF ligand outside the cell has no cell-to-cell 
variability. As we do not know the distribution of the concentration of the other 9 
species in a population of cells, we assume the concentration of the other 9 species 
are normally distributed with the variance of 20% of its initial concentration. This 
assumption allows significant variations among different cells and also keeps only 
about 0.000003% concentration to be negative, which we can simply ignore. With 
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such assumption, we can first do a Monte-Carlo simulation to approximate the 
population mean over time and also check the rate of convergence using this 
method. 
Sampled single cell simulations are plotted (Figure 4.1A). The variation among 
different cells could be very large. There are many different criteria to check the 
convergence of Monte Carlo simulation and the choice of the criterion is often 
context dependent. In our case, we plotted the standard error of mean (SEM) of 
the area under the Monte Carlo simulation trajectory (Figure 4.1B). The standard 
error of mean was calculated using bootstrap with 1000 sampling. As shown in 
Figure 4.1B, the SEM decreases with increasing sample size in Monte Carlo 
simulation. This means that when the sample size becomes larger, the population 
mean computed using Monte Carlo simulation is less variable. However, we cannot 
increase the sample size to infinity. To check if the Monte Carlo simulation is 
converged in our case, we used the criterion that the slope of the SEM curve was 
less than 10-6. Because the SEM curve is fluctuating, we compute the slope at a 
specific sample size with smoothing as in Equation (4.30). In Equation (4.30), N is 
the sample size of a Monte Carlo simulation, k is the step size when we increase the 
sample size, and x is the index of the point where the slope is calculated. We 
highlighted the first converged point in Figure 4.1B with a red circle. Later on, we 
use this converged Monte Carlo simulation as a reference of the population 






k  (4.30) 
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Then, we compare the converged Monte Carlo simulation with the single cell 
simulation in Figure 4.1C. The single cell simulation was simulated using the initial 
concentrations as the expected value of the initial concentrations from a population 
of cells. Figure 4.1C shows a significant difference between the single cell and cell 
population dynamics. Can our Population ODE approximate the cell population 
behavior better? We then plotted the converged Monte Carlo simulation together 
with the Population ODE simulation in Figure 4.1D. Although the Population 
ODE did not match the Monte Carlo simulation perfectly, it did improve 
significantly from the single cell simulation. 
 
Figure 4.1 Applying Population ODE to EGFR Pathway. (A) 10 random samples of single cell 
simulation (blue curves) versus converged Monte Carlo simulation (red curve). (B) Convergence 
of Monte Carlo simulation. (C) Single cell simulation with initial concentrations equal to their 
expected values (green curve) versus converged Monte Carlo simulation (red curve). (D) 
Simulation of Population ODE (blue curve) versus Monte Carlo simulation (red curve). 
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4.3.2.2 Applying Population ODE to NFκB Pathway 
NFκB (Nuclear Factor κ -light-chain-enhancer of activated B cells) is a family of 
transcription factors which regulate a variety of genes involved in cell division, 
apoptosis and inflammation (Hoffmann, 2002). Because of its importance in innate 
immune response, it is considered a potential drug target for chronic inflammatory 
diseases (Hoffmann, 2002). Dynamic response is important for drug development 
and systems biology tools such as computational modeling have been used to study 
NFκB pathway (Nelson, 2004). This pathway was found to have an identical 
behavior, which is dampened oscillation. It was also found that the oscillation is 
greatly affected by the cell-to-cell variability (Lee and Covert, 2010). Single-cell 
measurements and modeling of the variations among different cells were used to fill 
in the gap of cell-to-cell variability in NFκB pathway (Ashall et al., 2009, Lee et al., 
2009). Thus, we find this is a good case for us to apply the Population ODE to see 
if it can approximate the population behavior of an oscillating system. 
The first computational model for studying NFκB pathway was built to study 
the response of this pathway to TNF-α ligand (Hoffmann, 2002). The following 
work has added new components (Nelson, 2004) based on Hoffmann’s Model and 
has also modeled the response to other ligand (Lee et al., 2009). Furthermore, 
computational modeling studies have also investigated single-cell dynamics in 
NFκB pathway. Nelson et al. first attempted to use single-cell time-lapse imaging 
combined with single-cell model to analyze the parameters that affect the 
oscillation of NFκB localization (Nelson, 2004). Later models were not only 
compared with single-cell experimental data but also utilized stochastic methods to 
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simulate population behaviors (Lee et al., 2009). These models showed significant 
heterogeneity among a population of cells. A more recent model of NFκB pathway 
emphasized the difference between single-cell and cell-population dynamics based 
on both experimental and computational results (Ashall et al., 2009). 
Models of NFκB pathway exhibit many successful examples of computational 
methods in studying the dynamics of signaling pathways. There are also extensive 
experimental results confirming that the difference between single-cell and cell-
population behaviors is significant. The importance of both computational modeling 
and cell-to-cell variability leads us to apply our Population ODE to this pathway. 
Unfortunately, many recent models of NFκB pathway did not use Mass Action 
Kinetics to model all reactions. Thus, we apply our Population ODE to the basis of 
NFκB pathway models (Hoffmann, 2002), in which all reactions are ruled by the 
Mass Action Kinetics. 
Sampled single cell simulations are plotted (Figure 4.2A). Although individual 
cells are still oscillating at later time points, their phase becomes different. 
Therefore, averaged molecule oscillation is much more dampened than the molecule 
oscillation in a single cell. As shown by (Hoffmann, 2002), some parameter could 
affect the duration of oscillation. Thus, comparing single cell dynamics to cell 
population measurements could lead to incorrect estimation of certain parameter. 
In the case of NFκB pathway, we use the same criterion as that used in EGFR 
pathway to identify the converged Monte Carlo simulation (Figure 4.2B). 
Comparison between the single cell simulation and converged Monte Carlo 
simulation shows a significant difference of behavior (Figure 4.2C), especially the 
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magnitude of oscillations at later time points. This can be considered as a 
qualitative difference and it is important to have a population model which can be 
compared to population behavior. Our Population ODE also approximates the 
population dynamics better than single cell simulation (Figure 4.2D). 
 
Figure 4.2 Applying Population ODE to NFκB Pathway. (A) 10 random samples of single cell 
simulation (blue curves) versus converged Monte Carlo simulation (red curve). (B) Convergence 
of Monte Carlo simulation. (C) Single cell simulation with initial concentrations equal to their 
expected values (green curve) versus converged Monte Carlo simulation (red curve). (D) 
Simulation of Population ODE (blue curve) versus Monte Carlo simulation (red curve). 
 
4.3.2.3 Applying Population ODE to Intrinsic Apoptosis Pathway 
Apoptosis is an important process in developmental biology. Researchers also 
try to take advantage of triggering the apoptosis signal to kill disease related cells 
such as cancer cells. Therefore, better understanding of the mechanism of apoptosis 
would lead us to better drug for developmental disease or cancer. 
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Apoptosis pathway is one of the earliest pathways that were found to have 
different behaviors between single cell and cell population. One of the reasons is 
that the outcome of this pathway is cell death. It is often found in a population of 
cells that a portion of cells went apoptosis after triggering apoptosis pathway. This 
leads researchers to use single cell data for apoptosis pathway studies and to 
unravel the cell-to-cell variability. Spencer et al. have studied non-genetic origins of 
cell-to-cell variability in TRAIL-induced apoptosis (Spencer et al., 2009b). They 
claim "naturally occurring differences in the levels of states of proteins regulating 
receptor-mediated apoptosis are the primary causes of cell-to-cell variability in the 
timing and probability of death in human cell lines". This supports our assumption 
of different initial concentrations in the way that different initial concentrations 
could be one of the most important factors of cell-to-cell variability.  
Mathematical models have also been built to understand how analog extrinsic 
signals (concentration of stimulus) could lead to digital cell decisions (live or die) 
(Albeck et al., 2008). Here we chose to apply our Population ODE to Eissing's 
model (Eissing, 2004). This model has the main backbone of the caspase cascade in 
apoptosis pathway and it exhibits a typical bistable behavior, which is often seen in 
biological network. Thus, it could be a representative of a class of pathways that 
are bistable. These bistable systems are also often much more non-linear than other 
types of systems. We also want to test our Population ODE method in more 
extreme cases such as the bistable apoptosis pathway. 
Sampled single-cell simulations are shown in Figure 4.3A. In bistable system, 
we usually observe a “switch-like” behavior, which means the species concentration 
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switch from one steady state to the other within a very short time. As in Figure 
4.3A, different initial concentrations led to different time of switching but not the 
final steady state of activated caspase 3. Figure 4.3A also shows the population 
mean of activated caspase 3 from Monte Carlo simulation. This population 
behavior is dramatically different from any of the single-cell behaviors. We also did 
convergence study of Monte Carlo simulation (Figure 4.3B). Figure 4.3C shows the 
difference between single-cell and Monte Carlo simulations. This shows bistable 
systems are extreme cases in which bulk experiments can hardly be used to build 
single-cell models. 
However, our Population ODE does not predict the population behavior 
accurately enough in this particular case Figure 4.3D. This leads us to develop 
another method (Sample Reduction) to simulate the population behavior more 
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Figure 4.3 Applying Population ODE to Intrinsic Apoptosis Pathway. (A) 10 random samples of 
single cell simulation (blue curves) versus converged Monte Carlo simulation (red curve). (B) 
Convergence of Monte Carlo simulation. (C) Single cell simulation with initial concentrations 
equal to their expected values (green curve) versus converged Monte Carlo simulation (red curve). 
(D) Simulation of Population ODE (blue curve) versus Monte Carlo simulation (red curve). 
 
4.3.3 Sample Reduction Based on Singular Value Decomposition of the 
Special Sensitivity Matrix 
4.3.3.1 Singular Value Decomposition (SVD) of the Special Sensitivity Matrix 
to Reduce Sampling Space 
As shown in the previous section, Population ODE does not work well in some 
cases, such as bistable systems. Other types of complex systems besides mono-
stable, oscillatory, and bistable systems could also exist even if we have not 
discovered any. We therefore seek to develop more general methods to facilitate the 
simulation of population behavior. 
The dimension of biological systems is often large. This makes the sampling 
space of the initial concentrations large and the sample density decreases 
exponentially as the dimension of the sampling space increases. Moreover, in 
biological systems we often have very few outputs to focus. If we consider the 
initial concentrations as the input, the system then has a very large input space 
and a very small output space (one dimension in most cases as we can simulate one 
output at a time). Although Monte-Carlo method implicitly projects the input 
space to the output space without the knowledge of their relationship, we might be 
able to improve the simulation efficiency by analyzing the relationship between the 
input space and output space. To analyze this relationship is a possible task 
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because the relationship between the input space and output space in embedded in 
the ODE system. 
In our study, we utilized the sensitivity of all initial concentrations to the 
output species concentration at different time points. The sensitivity matrix S  was 
calculated as in Equation (4.31). This sensitivity matrix provides us the 
information of how the change in the initial concentrations would affect the output 
dynamics. Then, by taking the Singular Value Decomposition (SVD) of this 
particular sensitivity matrix, we could get the most important directions in the 
sampling space of initial concentrations that affects the output. 
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The SVD of the sensitivity matrix S  is shown in Equation (4.32). One of the 
most important applications of SVD is matrix approximation. We approximate the 
sensitivity matrix S  by ignoring small singular value and their associated singular 
vectors. We chose to keep the large singular values of which the summation is 
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larger than 90% of the summation of all singular values. In such a case, the 
approximated sensitivity matrix  S  is written as that in Equation (4.33), in which 
l  is the number of large singular values we keep. 
 
 
S = σ iuiviT
i=1
l
∑  (4.33) 
Then, we approximate the difference of the output  Δy  to be 
 
 
Δy = SΔx0 = σ i
i=1
l
∑ uiviTΔx0 = σ i
i=1
l
∑ uiΔx0′ (Δx0′ = viTΔx0 )  (4.34) 
We can infer from Equation (4.34) that the difference of output value is 
approximately due to the difference of Δx0′ . Note that the dimension of Δx0  is 
n ×1  and the dimension of Δx0′  is l ×1. We then can interpret Δx0′  as variations 
of initial concentrations in a reduced space (l-dimension), which spanned by 
orthogonal vectors  v1,v2,,vl . When we observe a single output, l  is usually 
much smaller than n . Thus, we can reduce the sampling space of initial 
concentrations from n-dimension to l-dimension and approximate the variations of 
the output. However, random sampling in the reduced sampling space does not 
reduce the sample size significantly. As the reduced space often has extremely small 
dimension (less than 3), we try to use orthogonal sampling in the reduced sampling 
space. 
4.3.3.2 Orthogonal Sampling in the Reduced Space of Initial Concentrations 
In typical orthogonal sampling, the sampling space is divided into equally 
probable subspaces. Then all subspaces are sampled once and the population mean 
is estimated by the sample average. In our case, we used a slightly different 
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orthogonal sampling strategy. We divided the sampling space into subspaces with 
equal sizes (not equal probabilities) and then the population mean equals a 
weighted sum of the samples in all subspaces. The weight for each sample is equal 
to the cumulative probability of the subspace it is sampled from. This modified 
orthogonal sampling covers the sampling space evenly. In bistable systems, the 
larger the variations of initial concentrations are, the larger the difference between 
single cell and cell population is. Therefore, it is better to make all subspaces have 
similar variations of initial concentrations when we use only one sample to 
represent a subspace in orthogonal sampling. This is done by making the sizes of 
subspaces identical. 
As the reduced sampling space is spanned by orthogonal vectors ( v1,v2,,vl ), 
the cumulative probability in a hypercube subspace can be calculated as below in 
Equation (4.35). We previously assumed the initial concentrations of all species 
follow a multivariate Gaussian distribution with expected value µ0  and covariance 
matrix C0 . We also assumed that each species is independent of others. Thus, the 
initial covariance matrix C0  has only non-zero values on its diagonal. Assuming the 
starting and end points of a hypercube in direction vi  are pi  and pi′ , the 
cumulative probability in such a hypercube is 

































  97 
and ′µ0  and ′C0  are projected expected values and covariance matrix in the 




























































C0 v1  vl⎡⎣ ⎤⎦
 (4.37) 
Note that the projected covariance matrix ′C0  has non-zero off-diagonal 
elements. Therefore, projected/linear combinations of initial concentrations are not 
independent any more. 
With the cumulative probability of each subspace, we are able to estimate the 
population mean of the output by a weighted sum of all samples as 
 y(t) = Phypercube(i )yhypercube(i )(t)
i=1
Nsub
∑  (4.38) 
The weights are the cumulative probabilities Phypercube(i )  of subspaces and the 
number of subspace Nsub  is pre-defined. One sample is taken from the center of a 
subspace as the representative of the subspace (Figure 4.4). 
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Figure 4.4 Orthogonal Sampling. The whole sampling space is divided into subspaces with 
uniform size (blue cuboid). The number of grid spaces in all directions are N1=2, N2=3, and 
N3=4. One sample (center of the subspace, red sphere) is taken from one subspace. 
 
Hypercubes of subspaces are sliced by grid lines in the reduced space (Figure 
4.4). Since different directions in the reduced space have different significance 
according to their corresponding singular values, the number of grid spaces on each 
direction is determined by the corresponding singular value. We set the relationship 










Obviously, the total number of subspaces Nsub = Ni
i=1
l
∏ . Therefore, when Nsub  
is defined,  N1,…,Nl  can be solved. Sometimes the ratio between two singular 
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than 1 and we simply ignore those directions and further reduce the dimension of 
the sampling space. 
4.3.4 Case Study Using Sample Reduction 
4.3.4.1 Applying Sample Reduction to Intrinsic Apoptosis Pathway 
As shown in Section 4.3.2.3 (Figure 4.3D), Population ODEs failed to 
approximate the mean of activated caspase 3. We then apply our Sample Reduction 
method to this case. Firstly, we need to compute the special sensitivity matrix and 
its singular value decompostion (SVD) described above. We used 20 time points for 
the special sensitivity matrix and the singular values of this matrix is shown in 
Figure 4.5A. There were 5 species with non-zero initial concentrations in this 
pathway. All the 5 orthogonal vectors ( v1,…,v5 ) computed from SVD spanned the 
whole sampling spaces of initial concentrations. According to their corresponding 
singular values, the first orthogonal vector pointed the most important direction in 
the sampling space. Since the first singular value was already more than 90% of the 
sum of all singular values, we reduce the sampling space to a 1-dimentional reduced 
space, spanned by v1 . Orthogonal sampling described in Section 4.3.3.2 was used 
and the averaged concentration of activated caspase 3 ( y(t) ). To compare Sample 
Reduction and Monte Carlo simulation, we computed the normalized integrated 
squared error (ISE) using both methods to our reference (converged Monte Carlo 
simulation, yref (t) ). The ISE is defined as in Equation (4.40) and solved 
numerically. As orthorgonal sampling is not random, the ISE using Sample 
Reduction is deterministic. However, Monte Carlo simulation uses random sampling. 
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To have a better approximation of the ISE, we again used bootstrap sampling 
(bootstrap sample size Ns=1000) to calculate the convergence of averge ISE in 
Monte Carlo simulation. 
 ISEnorm =









As shown in Figure 4.5B, when we increaed the sample size, the ISE decreased 
much faster using our Sample Reduction method than using Monte Carlo 
simulation. Therefore, much smaller sample size was required in Sample Reduction 
to achieve the same accuracy. Note that the ISE is larger in Sample Reduction than 
that in Monte Carlo simulation when the sample size is larger than a threshold. 
This is because we lost information of the sampling space when we reduce its 
dimension and there is a limit of reducing ISE in Sample Reduction by increasing 
the sample size (the limit can be greater than 0). However, smaller limit can be 
achieved by increasing the dimension of the reduced space. 
As biological measurements often have large variations, 10% normalized ISE 
should be acceptable as a good approximation to the population mean. We 
therefore compared the results with 10% normalized ISE from Sample Reduction 
and Monte Carlo simulation to the reference. As shown in Figure 4.5C, Sample 
Reduction approximated the population mean as good as Monte Carlo simulation 
(both 10% normalized ISE), but Sample Reduction required much less sample size 
(N=18) than Monte Carlo simulation (N=82). Another advantage of Sample 
Reduction method is that it converges much faster than Monte Carlo simulation 
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and there is no fluctuation of the approximation because orthogonal sampling is not 
random. Figure 4.5D shows a smooth curve from Sample Reduction and a fluctuant 
curve from Monte Carlo simulation with the same sample size (N=200). The 
deterministic nature of our Sample Reduction method can also faciliate all types of 
model analysis by avoiding further sampling and averaging. 
 
Figure 4.5 Applying sample reduction to intrinsic apoptosis pathway. (A) The singular values 
from largest to smallest. The red text indicates that the first singular value is 99.98% of the sum 
of all singular values. (B) Normalized ISE calculated as in Equation (4.40) using Monte Carlo 
simulation (red curve) and Sample Reduction (blue curve). (C) Monte Carlo simulation (green 
curve) and Sample Reduction (blue curve) with 10% normalized ISE were compared to the 
reference (red curve). (D) Monte Carlo simulation (green curve) and Sample Reduction (blue 
curve) using the same sample size (N=200) were compared to the reference (red curve). 
 
4.3.5 Case Study of TGF-β Network 
As mentioned in Chapter 2 (Section 2.2.4), previous work has studied an 
upstream network of TGF-β (Venkatraman et al., 2012). This network mainly 
consists of two TGF-β activators: plasmin and TSP1, and the urokinase system for 
  


































































































  102 
plasmin activation. Note that TGF-β regulates PAI1 and TSP1 by inducing their 
gene expression through Smad signaling pathway (Figure 2.3). In Venkatraman’s 
model, the Smad signaling pathway was built as a black box of a single reaction. 
All species in this network present in the ECM and all reactions take place in the 
ECM except the Smad signaling. Thus, all species are secreted by a number of cells 
and their concentrations are averaged from a population of cells. Similar to what 
we have seen in previous examples of other signaling pathways, TGF-β may also 
induce different responses of Smad signaling in different cells. The averaged 
dynamics of PAI1 and TSP1 may be different from the dynamics of these proteins 
secreted by a single cell. Previous work used a black box for the Smad pathway and 
assumed all cells are identical. Since the Smad pathway exists in both feedback 
loops in this network, it is critical for the bistable behavior of the whole system. 
Therefore, we wanted to study whether the cell-to-cell variability will affect the 
bistable behavior of this network.  
To achieve our goal, we need to integrate our Smad pathway model (Model 11, 
Section 3.3.10) into the upstream network of TGF-β activation as a replacement of 
the original black box. We also considered cell-to-cell variability of the outcome of 
Smad signaling pathway. This actually makes the integration of two systems very 
difficult as the species in the upstream network are already averaged from a 
population of cells. Thus, it is an integration of a population level network in the 
ECM and a population of single cell models inside cells. More importantly, PAI1 
and TSP1 are mixed quickly (roughly at each time step of simulation) from 
secretion of different cells. Although this task may cause a lot of problems for the 
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sampling based methods such as Monte Carlo simulation, it is ideal to use our 
Population ODE since the outcome of the Population ODE is averaged dynamics of 
a population of cells. Thus, the upstream network of TGF-β activation and the 
Population ODE of Smad signaling pathway can be integrated as a whole ODE 
system and we analyze this system as the same as other ODE systems. As we have 
seen in Chapter 3, Smad signaling did not show a bistable behavior. We believe the 
Population ODE can well approximate its population dynamics. 
As same as the previous examples, we assumed that the cell-to-cell variability 
was only due to different initial concentrations of species. The detailed settings of 
the integration are described in the Materials and Methods (Section 4.2). In the 
integrated model, there were two parameters kp1 and kp2 of which the meaning 
had been changed. They previously represented the production rates of TSP1 and 
PAI1 induced directly by TGF-β in (Venkatraman et al., 2012). In the integrated 
system, TSP1 and PAI1 expression was not induced by TGF-β but Smad complex 
in the nucleus, which is the output species of Smad signaling pathway. Therefore, 
the values of kp1 and kp2 were different in the integrated model. Then, we did the 
“going-up and coming-down” simulation as in (Venkatraman et al., 2012) regarding 
the kp1 and kp2 parameters. The “going-up and coming-down” simulation was done 
by initiating the system at a mono-stable steady state (i.e. low value of a certain 
parameter) and then increasing the parameter and simulate the steady state of 
TGF-β to get the going-up curve (blue curves, Figure 4.6A-B) until the system 
becomes mono-stable again. After that, the parameter was decreased and steady 
state of TGF-β was simulated. As shown in Figure 4.6, there was a range of kp1 
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and a range of kp2 at which the going-up and coming-down curves did not overlap. 
Within these ranges, the system had two steady states even if the parameters (kp1 
and kp2) were fixed. This means that the integrated system could also be bistable 
within certain ranges of kp1 and kp2.  
 
Figure 4.6 Going-up and coming-down simulation of integrated pathway of TGF-β activation and 
Smad signaling. (A) Simulations with increasing kp1 from 0 to 0.05 (blue dots) and decreasing 
kp1 from 0.05 to 0 (red dots). (B) Simulations with increasing kp2 from 0 to 0.1 (blue dots) and 
decreasing kp2 from 0.1 to 0 (red dots). 
4.4 Discussion 
In this study, we developed two methods to facilitate model simulation of the 
dynamical behavior of a population of cells. The first method was a new ODE 
system, Population ODE, derived from ODE models of single cell. The Population 
ODE could well approximate the expected value of species concentration in a 
population of cell in most cases. We have tested Population ODE in some well-
known signaling pathways including EGFR pathway and NFκB pathway and 
Population ODE can well approximate the population behavior with a single 
simulation. Because Population ODE failed to approximate the cell-population 
behavior in bistable system, we developed our second method, Sample Reduction. 
Sample Reduction is a sampling-based method, similar to Monte Carlo simulation. 
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However, through significantly reduction of the sampling space, we were able to 
significantly reduce the sample size required, which makes the simulation much 
faster.  
Cell-to-cell variability is a common phenomenon in many types of cells. Since 
typical computational modeling of signaling pathway simulates single-cell behavior 
while most biological experiments measures species from a population of cells, there 
is often a discrepancy between computational models and bulk experiments. Monte 
Carlo simulation can simulate cell-population behavior but it is often time 
consuming. Therefore, developing algorithms for fast simulation of population 
behavior can be beneficial for most computational modeling studies, not only our 
study of TGF-β networks. Our methods are not only faster than Monte Carlo 
simulation. Population ODE also has capability of using all kinds of analysis which 
can be applied to typical ODE models. The case of integrating TGF-β upstream 
network and downstream signaling shows the advantage of using Population ODE. 
Because we wanted to integrate a network outside the cell and a population of 
pathways inside cells, it is ideal to have a system as a whole to represent a 
population of cells. Population ODE can serve the purpose because it is still an 
ODE system. It may also be useful in other cases because the methods we use for 
ODE system can be directly applied to Population ODE as an analysis of the 
population behavior. In an integrated TGF-β networks, perturbation analysis or 
sensitivity analysis could be applied to both the upstream species and downstream 
species in the same system. The integrated model of TGF-β networks is a better 
tool to predict combination of drug targets. Synergistic effect is often seen in a 
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bistable system. A combination of upstream target and downstream target may 
exist and the integrated model has the capability of finding this kind of 
combination.  
  In the case of integrating TGF-β networks, we have seen that the bistable 
behavior still maintained even if we considered cell-to-cell variability. This bistable 
behavior was compared to a co-culture experiments in which hepatocytes and 
hepatic stellate cells (HSCs) were uniformly seeded in the culture dish 
(Venkatraman et al., 2012). In this case, although cells express TSP1 (in HSCs) 
and PAI1 (in both hepatocytes and HSCs) differently, the secretion was transient 
and the molecules were mixed in the culture medium quickly before they reach any 
steady state. However, in in vivo situation of liver fibrosis, the fibrotic regions do 
not distribute evenly. Therefore, two steady states of TGF-β may exist at different 
regions of liver tissue. The concentrations of molecules may not be affected mainly 
by the mixing effect but mainly by the stability of steady states. This spatial 
property of liver fibrosis led us to move one step further to a tissue-level model to 
study the spatial dynamics of a bistable system. 
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5  Chapter 5: Diffusion Model of TGF-β Activation 
Network 
5.1 Introduction 
Liver fibrosis is a wound-healing response caused by injury of liver parenchyma. 
Different types of liver injury could lead to different patterns of pathogenesis in 
liver fibrosis (Hernandez-Gea and Friedman, 2011). For example, chronic hepatitis 
C causes fibrotic septa connecting portal tracts and central vein; and biliary fibrosis 
has the pattern of portal-portal fibrotic septa. Among these different patterns, 
there is a common phenomenon that fibrotic region does not distribute uniformly in 
liver tissue. It is often seen that part of the tissue becomes fibrotic with 
accumulation of ECM and large number of hepatic stellate cells (HSCs) (Cassiman 
et al., 2002, Knittel et al., 1999). The fibrotic region is surrounded by normal tissue 
with hepatocytes as the dominant cell type and less ECM. 
Previously we have briefly introduced Venkatraman’s bistable model of TGF-β 
activation (Venkatraman et al., 2012). The two steady states of this model are 
related to normal and fibrotic states in liver tissue. Here we introduce the two 
states in more detail. Figure 5.1 shows the TGF-β activation network in 
Venkatraman’s model. The two major players: plasmin and TSP1 are expressed 
mainly in hepatocytes (red cells) and activated HSCs (blue cell) respectively. In 
normal liver tissue, hepatocytes are dominant and also the negative feedback in this 
network (left part of the diagram in Figure 5.1). On the other hand, in fibrotic 
tissue, hepatocytes are damaged and activated HSCs are much more than that in 
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normal tissue. Therefore the positive feedback (right part of the diagram in Figure 
5.1) is dominant in fibrotic tissue. It was shown in Venkatraman’s model that one 
steady state of the system had high levels of TGF-β and TSP1 and low level of 
plasmin. This is consistent with the fibrotic state in liver when the positive 
feedback is dominant. The other steady state shown in Venkatraman’s model has 
low levels of TGF-β and TSP1 and high level of plasmin. This can be explained by 
the dominance of the negative feedback in normal state in liver because plasmin 
can inhibit TSP1 irreversibly to break the positive feedback loop. The reason why 
TGF-β is relatively low when the negative feedback is dominant is that plasmin is a 
relatively weak activator of TGF-β comparing to TSP1. In summary, TGF-β-low 
and TGF-β-high steady state in this network can be respectively related to normal 
state and fibrotic state of liver tissue. 
 
Figure 5.1 The schematic diagram of TGF-β activation network in liver fibrosis. The red cells 
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High level of TGF-β in the fibrotic state may induce more activation of HSCs 
and then more ECM secretion. It has been predicted and experimentally validated 
that plasmin, a representative species of the normal state, has potential to switch 
fibrotic state to normal state (Venkatraman et al., 2012). Based on Venkatraman’s 
model, we believe that the regression of liver fibrosis might be led by switching of 
fibrotic state to normal state. As we mentioned, fibrotic tissue is often surrounded 
by normal tissue. We thought that computational modeling could help us initiate 
studies of the spatial effect between normal tissue and fibrotic tissue. The molecule 
exchange between normal and fibrotic tissue could affect the steady state of 
molecules and further affect the state of the cells and even tissue. On the other 
hand, the accumulation of ECM in liver fibrosis could block the molecule exchange. 
We therefore asked how the two steady states in TGF-β activation network would 
affect each other and whether the accumulation of ECM could affect the 
reversibility of liver fibrosis. 
In this study, we built our so-called diffusion model on top of Venkatraman’s 
model of TGF-β activation network to allow species in this network to diffuse in 
space. The diffusion process in this model was simulated by a finite-element 
approximation. Instead of using partial differential equations (PDE), we discretized 
the space into small blocks/regions (Figure 5.2) and the diffusion of species between 
adjacent blocks was modeled by mass action reactions and ODEs. ODE modeling of 
the diffusion process allowed us to easily integrate the model of TGF-β activation 
network with diffusion, and to easily simulate the diffusion model. 
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Our diffusion model predicted a solution of a traveling wave in space. The wave 
propagated because one steady state affected the other steady state nearby and 
made it to switch. The model also predicted that the wave direction was always 
from TGF-β-low (normal) state to TGF-β-high (fibrotic) state. This prediction is 
similar to liver fibrosis regression and was also shown to be highly robust. We also 
experimentally confirmed that the central species of the normal state, plasmin 
could be blocked from reducing TGF-β activation by the low diffusion rate. Finally, 
we showed that our model not only predicted the direction of the wave, but also 
could serve as a platform to compute the wave speed. 
 
Figure 5.2 Graphical representation of the diffusion model. The whole space was discretized into 
small blocks and the model of TGF-β activation network (Venkatraman et al., 2012) was 
included in every block. Different color represents different concentration of species. 
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5.2 Materials and Methods 
5.2.1 Simulation of the Diffusion Model 
The diffusion process in our diffusion model was approximated by discretization 
of space and mass action reactions. As shown in Figure 5.3, a species P could have 
different concentrations in different regions of the space. We modeled the diffusion 
of species P as a set of reactions in Equation (5.1). 
 







   P1
kdiff
kdiff
   
kdiff
kdiff
   Pn  (5.1) 
Here the diffusion rate (kdiff) depends on the size of the discretized space and 
its relationship to the diffusion coefficient (D) in physics can be expressed as in 
Equation (5.2). In this equation, D is defined to have the unit of cm2/s. Thus, we 
defined the length of a region as l  (assuming discretization is the same and uniform 
in all dimensions) to have the unit of cm. Then kdiff has the unit of s-1.  
 kdiff = Dl2  (5.2) 
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Then, we were able to build the diffusion model as a whole ODE model. 
Assuming the species concentrations in a region i is a vector xi , we express the 


















Because the local reactions are the same in all regions and the diffusion 
reactions are all first order, the whole diffusion model could be written as in 
Equation (5.4). The function F(t,xi )  is the same for all regions. The term Dx  
represents the diffusion reactions and note the matrix D  is different from the 
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The diffusion model could be large depending on the number of regions. 
Fortunately, the diffusion system has an explicit form of the Jacobian matrix so we 
can simulate the system efficiently. The Jacobian matrix of the whole system is as 
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5.2.2 Stochastic Simulation of ECM Accumulation 
In this simulation, we assumed two stochastic events of ECM production and 
degradation. The rates of these two events were determined by TGF-β level as in 
Equation (5.6) below. The parameter kECM determined how fast ECM was regulated 
by TGF-β. We also set an upper bound ([ECM]max) and a lower bound ([ECM]min) 
for ECM to avoid negative or extremely high amount of ECM. [TGFβ]low was the 
low steady state of TGF-β. This made the production rate and degradation rate 
balanced when TGF-β was at its low steady state (normal state). 
 
Rprod = kECM [TGFβ ]([ECM ]max − [ECM ])






We simulated these two stochastic reactions using binomial τ -leap algorithm 
(Chatterjee et al., 2005). The amount of ECM was initated from 1 at all regions in 
space. After the amount of ECM was changed, we divided the diffusion rates (kdiff) 
for two adjacent regions by the averaged ECM in these two regions. The diffusion 
model was continuously simulated and only kidff in the diffusion model needs to be 
updated after each time step of stochastic simulation. As we set the kECM to be 
much smaller than the reaction rates, the change of ECM was much slower than 
changes of all other species and the time step of stochastic simulation is large 
enough for the effect of diffusion to be stablized.  
5.2.3 Cell Culture Experiments 
T6 cell line was cultured for 3 days in 1ml of DMEM culture medium with 10% 
FBS to make sure the cells were activated (T6 cells undergo self-activation on hard 
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surface such as plastic). In the groups without collagen, cell culture insert was not 
used and plasmin was added directly into the well. In those groups with collagen, 
collagen solution was coated on the PET membrane of culture inserts and was 
incubated overnight at 37°C. After that, plasmin was diluted in 500ul of DMEM 
medium and the solution was added into the culture insert. In such cases, the 
concentration of plasmin was calculated as the total amount of plasmin added 
divided by the total volume of medium in the well and the insert (1.5ml). 
 
5.3 Results 
5.3.1 Diffusion Effect of Bistable System Shows a Traveling Wave in 
Space 
It has been proven mathematically that diffusion effect of simple bistable 
system exhibits a wave propagation behavior in space (Bates et al., 2006). It is also 
known from the theoretical study that the wave speed is related to the diffusion 
coefficient D. However, the direction of the traveling wave is often non-obvious in 
complex systems like TGF-β activation network, as it depends on the parameters of 
the system. We simulated our diffusion model to first confirm the traveling wave 
behavior and secondly to see the direction of the wave if it exists. 
We did multiple simulations of the diffusion model in one-dimensional space 
with different diffusion rates (kdiff, please see the relationship between kdiff and the 
diffusion coefficient D in Material and Methods, Section 5.2.1). In each simulation, 
diffusion rate was the same for all species for simplification. Representative 
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simulation results are shown in Figure 5.4. In these simulations, we initiated the 
system with 1 region at TGF-β-low (normal) steady state and other 99 regions at 
TGF-β-high (fibrotic) steady state. As shown in Figure 5.4A, there was an obvious 
traveling wave from normal state to fibrotic state. After we decreased the diffusion 
rate, the traveling wave still existed but the wave speed was slower (Figure 5.4B). 
We also decreased the diffusion rate to extremely low values. For better 
visualization, we initiated the system with half normal and half fibrotic states in 
this case. The traveling wave completely disappeared when the diffusion rate was 
too low (actually lower than a threshold, data not shown) even though we simulate 
the system for very long time (i.e. 1010s, Figure 5.4C). This disappearance of the 
traveling wave was an artifact of the discretization. We will show the relationship 
between the wave speed and the diffusion rate (kdiff) as well as the diffusion 
coefficient (D), and theoretical existence of traveling wave at low diffusion rate. 
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Figure 5.4 Traveling waves in the diffusion model of TGF-β activation network. Simulation of 
TGF-β concentration in space was plotted at 10 different time points. The color in the curves 
indicates the concentration of TGF-β (red: high concentration; blue: low concentration). (A) 
Simulation of 1D diffusion with the diffusion rate kdiff=10. The model was simulated from 0 to 
100s. (B) Simulation of 1D diffusion with the diffusion rate kdiff=0.1. The model was simulated 
from 0 to 100s. (C) Simulation of 1D diffusion with the diffusion rate kdiff=10-7. The model was 
simulated from 0 to 1010s. 
 
Note that the traveling wave was always directed from TGF-β-low (normal) 
steady state to TGF-β-high (fibrotic) steady state. Superisingly, this directional 
effect between normal and fibrotic regions is similar to liver fibrosis regression in 
vivo because fibrosis regresses spontaneously if there is no outside perturbations (i.e. 
liver injury) to the system. However, this direction was only a prediction of the 
model and it could be affected by the parameters in the local TGF-β activation 
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prove the direction from normal to fibrotic tissue experimentally, we can at least 
analyze how robust this prediction is. 
5.3.2 Robustness Analysis of the Traveling Wave Direction 
In the robustness analysis, we initiated the diffusion model with half normal 
state and half fibrotic state in space. After perturbing parameters such as diffusion 
rates and rate constants, we simulated the system to see the direction of the 
traveling wave. It was possible that some combinations of parameters could result 
in no traveling wave (artifact of discretization) or even making the system mono-
stable. We therefore categorized the simulation results with different parameters to 
four categories: 1) traveling wave from normal state to fibrotic state; 2) traveling 
wave from fibrotic state to normal state; 3) no traveling wave; 4) mono-stable 
system (Figure 5.5). It is possible that different species could have different 
diffusion rates in the ECM because of their molecular weights, charge and different 
affinities to ECM proteins. Therefore, we randomly varied diffusion rates in the 
range of 10-2 to 102 for different species. Each polygon in the polar plot in Figure 
5.5A shows a combination of different diffusion rates for all species and the color of 
the polygon indicates the category of simulation results (listed on the top of the 
figure). All polygons are blue in this case suggested that the wave direction from 
normal state to fibrotic state is highly robust to diffusion rate as well as the 
differences of diffusion rates among species. The rate constants in local systems 
could also affect the wave direction. We then varied all rate constants randomly 
with less than 20% perturbation for each rate constants. We chose the range 20% 
based on previous robustness analysis that about 80% of the models were still 
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bistable with 20% perturbation of each rate constants (Venkatraman et al., 2012). 
As shown in Figure 5.5B, most of the models showed traveling wave from normal 
to fibrotic state. This suggested that the wave direction from normal to fibrotic 
state was also highly robust to the change of reaction rates in local systems. We 
can also infer that this traveling wave direction depends more on the structure of 
TGF-β activation network (biologically validated) but less on the kinetic rates. 
 
Figure 5.5 Robustness analysis of traveling wave direction. Top of the figure shows 4 categories of 
the simulation results with color labels. (A) The log of 18 diffusion rates (kdiff) for 18 species was 
plotted on the polar plot along 18 different angles. The radius represents the log of each kdiff. A 
combination of 18 diffusion rates was connected to a ploygon and the color labels the category of 
simulation results. (B) The normalized values of 28 rate constants was plotted on the polar plot 
along 28 different angles. The radius represents the normalized value of each rate constant. A 
combination of 28 rate constants was connected to a ploygon and the color labels the category of 
simulation results. 
5.3.3 Wave Speed, Diffusion Rate and Diffusion Coefficient 
Our diffusion model could predict the direction of traveling wave and our 
analysis showed that the wave from normal state to fibrotic state was robust. This 
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highly depends on the diffusion rates of different species, and also the reaction rates. 
Although these rates were not validated and our prediction of wave speed could be 
inaccurate, our model can still be used to compare relative change of speed at 
different conditions. We also show that our model simulation could be a platform 
for computing the wave speed when measurements of certain rates are available. 
 We again simulated the diffusion model in one-dimensional space for 
computing of the wave speed. As we have shown that the direction of the wave was 
only from normal state to fibrotic state, we initiated the system with 5 region at 
normal state (TGF-β low) and 95 other regions at fibrotic state (TGF-β high). We 
have also shown that too small kdiff could cause no wave propagation in simulation 
(artifact of discretization). Thus, we set kdiff to be large enough to have traveling 
wave in simulation. To compute the speed of the wave, we snapshot the wave front 
position at a frame rate of 100s (Figure 5.6A). The wave front position and time 
showed a clear linear relationship (Figure 5.6B). This means that the wave speed 
was a constant when it propagated through the space and we could easily compute 
the wave speed as the slope of the straight line in Figure 5.6B. Note that the wave 
speed we calculated has the unit of region/s. 
  120 
 
Figure 5.6 Computing the speed of the traveling wave based on simulations. (A) Wave front at 
three time frames (ti-1, ti and ti+1). The exact position of the wave front was computed as the 
position having TGF-β concentration closest to the mean of two steady-state concentrations of 
TGF-β. (B) The wave front position at 11 time frames (red circles) and the linear curve-fit to the 
red circles (blue line). (C) The wave speed calculated with different kdiff (10-3 to 10-1) versus the 
reciprocal of the length of the subspace (red circle). The blue line is the linear curve-fit to the red 
circles. (D) The relationship between the wave speed and diffusion coefficient. 
 
Then we wanted to examine the relationship between kdiff and the wave speed. 
We varied kdiff (from 10-3 to 10-1) and computed the wave speed for each kdiff 
using the method we described above. What does the relationship between kdiff and 
the wave speed (region/s) mean? According to the relationship between the 
diffusion rate (kdiff) and diffusion coefficient (D) in the Materials and Methods 
(Section 5.2.1), the change of the diffusion rate (kdiff) in the diffusion model could 
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mean either the change of the diffusion coefficient (D) or the change of the length (l) 
of the subspace, or even both. Then, is the wave speed dependent on kdiff or D? To 
answer this question, we set the diffusion coefficient D=10-5cm2/s, which is 
approximately the coefficient of proteins diffusing in water. With the kdiff values 
we set for model simulation (10-3 to 10-1), we can calculate the length of the 
subspace l = 10
−5
kdiff (cm)  according to Equation (5.2). Then we plotted the wave 
speed (region/s) versus 
1
l . Figure 5.6C shows a linear relationship between wave 
speed (region/s) and 
1
l . This means that the real wave speed (cm
2/s), which equals 
the wave speed (region/s) times the length of subspace/region l, is a constant. 
Therefore, we confirmed that the wave speed was only affected by the diffusion 
coefficient D when the rate constants were fixed. The slope of the straight line in 
Figure 5.6C is actually the real wave speed (cm2/s). We then plotted the 
relationship between the real wave speed and the diffusion coefficient D Figure 
5.6D. The wave speed increases when the diffusion coefficient increases. 
5.3.4 Plasmin Could be Blocked From Inhibiting TGF-β Activation by 
Low Diffusion Coefficient 
Our model predicted that low diffusion coefficient could cause slow wave 
propagation, meaning that normal state switched its adjacent fibrotic state more 
slowly. When normal state switched its adjacent fibrotic state, plasmin played a 
central role because it could break the positive feedback loop of TSP1 and then 
inhibit TGF-β activation. We therefore wanted to experimentally test whether the 
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inhibition of TGF-β activation could be blocked by low diffusion coefficient. We 
used a cell culture system with cell culture inserts to do the test. As shown in 
Figure 5.7A, we cultured T6 cell line (rat HSCs) at the bottom of the well. Then 
we added plasmin into the system either directly in the well or in the culture insert 
with a layer of collagen gel slowing the diffusion of plasmin from top chamber to 
the bottom chamber. Plasmin has a short half life in culture medium so its 
inhibition effect decreases significantly after certain time. We measured active 
TGF-β after 2hr treatment of plasmin because the inhibition effect was maximized 
at 2hr (data not shown). Figure 5.7B shows the ELISA measurement of active 
TGF-β in our culture system. In the control group without plasmin treatment, T6 
cells express high level of active TGF-β. Active TGF-β level was significantly 
reduced with high level of plasmin (500ng/ml). However, this reduction of TGF-β 
was significantly blocked by a thick layer of collagen (500ul in 6-well plate). This 
experiment confirmed that low diffusion coefficient (or excessive ECM) could block 
the effect of plasmin inhibiting TGF-β activation. 
 
Figure 5.7 Plasmin could inhibit TGF-β activation but the inhibition could be blocked by low 
diffusion coefficient (thick collagen). (A) The experimental design using cell culture insert. T6 
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at its bottom. Collagen gel was coated on the PET membrane. Plasmin was added either into the 
culture insert or directly into the culture medium. (B) ELISA measurement of active TGF-β in 
the culture medium (mean of 3 biological replicates). Different concentration of plasmin were 
added (low: 200ng/ml; high: 500ng/ml). Different amount of collagen was coated in the culture 
insert for 6-well plate (low: 200ul; high: 500ul). The asterisk indicates significant changes between 
groups (p<0.05, t-test was used). 
 
5.3.5 Stochastic Simulation of ECM Accumulation Under Chronic 
Injury 
Based on the fact that plasmin could be blocked by excessive ECM, it is 
possible that the excessive ECM localized in the fibrotic tissue could block plasmin 
from its adjacent normal tissue and then slow down the switch of fibrotic state to 
normal state (a sign of fibrosis regression). It is known that high level of TGF-β 
could induce activation of HSCs and secretion of ECM proteins . We then wanted 
to simulate the effect of TGF-β-high steady state on slow accumulation of ECM. 
We did not know how exactly ECM proteins were regulated by TGF-β steady 
states and we simply simulated this as two stochastic events: ECM production and 
degradation. The firing rates of these events depended on TGF-β levels. After firing 
a event of ECM production or degradation, the amount of ECM in a certain region 
in space was changed, we then changed the diffusion rates according to the amount 
of ECM. The detailed setup and simulation method of this stochastic model are 
described in the Materials and Methods (Section 5.2.2).  
After setting up the model, we initiated the model with all normal steady states 
in the whole space. Then, we introduced repeated injury, represented by sudden 
increase of TGF-β, to simulate liver fibrosis caused by chronic injury. The 
simulation result is shown in an attached movie file (Movie_5.1.mov). We can see 
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from the movie that at early stage, fibrotic state could be recovered back to normal. 
However, when ECM slowly accumulated, the wave speed (speed of regression) 
becomes slower and it was more and more difficult for the normal regions to switch 
the state of the fibrotic regions. Interestingly, this simulation result is similar to 
liver fibrosis progression in vivo. In most cases, with mild acute injury, fiborsis 




In this study, we built a diffusion model of TGF-β activation network. This 
model simulated how two steady states of a bistable system would affect each other 
in space. The simulation results first showed a traveling wave from normal state to 
fibrotic state. We further confirmed by computational analysis that this direction of 
wave was robust. Our model could also predict the speed of the traveling wave and 
it showed a positive correlation between diffusion coefficient D and wave speed. 
Our experiment of plasmin treated HSCs suggested that plasmin could be blocked 
from inhibiting TGF-β activation by low diffusion. Since plasmin was a major 
player in the wave from normal state to fibrotic state, our experimental result was 
consistent with the prediction that low diffusion coefficient was correlated to low 
wave speed. Based on the experimental test and model prediction, we further added 
stochastic change of ECM into our diffusion model. With this model, we were able 
to simulate the effect of repeated injury causing accumulation of ECM and slowing 
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down the speed of regression. This predicted behavior is consistent with the 
observations in liver fibrosis. 
This work is an initiation of studying spatial effect in liver fibrosis and other 
biological processes. Observation of dynamic changes of molecules or cells in vivo is 
still a challenging task in biological studies. However, computational modeling can 
handle the spatial dynamics quite well. In our study, we predicted a traveling wave 
of a bistable system in space. We also predicted that the wave speed could be 
significantly affected by the amount of extracellular matrix. It would be good if 
future studies validated our model predictions. Validating the traveling wave is a 
challenging task. First of all, bistable behavior in the extracellular matrix is 
difficult to measure. This is mostly because the molecules are not as concentrated 
as those in cells. Reporter genes or reporter cells may be used in the system as an 
indicator of the TGF-β level in the extracellular matrix, for example. Secondly, 
observing dynamical change in the extracellular matrix is also difficult. To validate 
the traveling wave, future work might still need to measure steady state changes in 
two chamber of culture systems. Perturbation can also be applied to the system to 
see if certain perturbation can change the direction of the traveling wave. This 
could further support the existence of traveling wave. Tissue imaging can also be 
used to study the effect of diffusion in liver fibrosis. Fluorescence-labeled proteins 
can be observed in tissue slice and its location can be easily determined from the 
images. The disadvantage of tissue imaging is that we cannot observe dynamic 
changes of the concentration of localization of molecules from tissue slice, but 
studies using tissue imaging is more relevant to liver fibrosis than cell culture 
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studies. Our modeling could also be used to generate interesting predictions which 
can be tested by more static measurements such as imaging of fixed tissue samples. 
Taking our study as an example, our final perdition of the repeated injury suggests 
that ECM accumulation in the fibrotic region could block the anti-fibrotic effect in 
its neighbor. Not only the effect from the normal tissue, but also the treatments 
outside the fibrotic region could be blocked. Therefore, treatments targeting the 
fibrotic region should be more efficient and might be even necessary.   
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6  Chapter 6: Conclusion 
In this thesis, we used computational and systematic analysis to study TGF-β 
related regulations in liver fibrosis at three levels: cellular level, cell population level 
and tissue level. 
We first studied TGF-β signaling pathway within cells. In this part of study, 
tightly coupled computational analysis and experiments suggested that current 
knowledge of negative regulations in this pathway could not explain the dynamics 
of phospho-R-Smad. We then sought alternative mechanisms extensively using 
computational analysis. We ruled out many possible mechanisms and we found that 
PPM1A upregulation could not be ruled out by our modeling studies. With the 
support of biological experiments, we finally concluded with a model which could 
explain all measured data from both literature and our experiments. This final 
model was also capable of explaining a contradiction in the literature. This level of 
understanding of the negative regulations in TGF-β signaling pathway could not be 
achieved from only a biological point of view. Computational modeling and systems 
biology approach gained us further insights into observed phenomenon and led us 
to discover novel mechanism. 
Motivated by previous study of TGF-β activation network in the ECM and the 
fact that cell-to-cell variability is common in many types of cells, we wanted to 
integrate our TGF-β signaling pathway within cells with the TGF-β activation 
network outside the cell. The integration would obviously affected by the cell-to-
cell variability and we wanted to simulate a population of 
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then focused on developing two algorithms to efficiently approximate the species 
concentrations in a population of cells based on single-cell models. We tested the 
performance of our algorithms in some well-known pathway models and applied one 
of our algorithm, Population ODE to the problem of integrating TGF-β activation 
network and intracellular signaling pathway. Population ODE was used to 
approximate a population of intracellular pathways and the Population ODE (not 
the model for intracellular pathway) was integrated with the TGF-β activation 
network outside the cells. Population ODE is ideal for this integration because it is 
not sampling based. Our algorithms also have potentials to be applied to other 
systems when cell-to-cell variability needs to be considered. 
Inspired by the simulation of a population of cells in liver fibrosis and the fact 
that fibrotic tissue is often distributed unevenly in liver fibrosis, we moved one step 
further from a population of uniformly distributed cells to spatially localized 
different states of tissue. The bistability of the TGF-β activation network is a good 
representation of two states of tissue in liver fibrosis, normal state and fibrotic state. 
It is difficult to observe in vivo how fibrotic tissue and normal tissue could affect 
each other in space. However, our in silico simulations could generate meaningful 
predictions. Our model simulations predicted a robust behavior that normal state 
could switch its adjacent fibrotic state and formed a traveling wave of regression. 
The speed of the wave could be reduced by excessive ECM. The effect of plasmin 
on inhibiting TGF-β activation was confirmed experimentally to be blocked by low 
diffusion. Our model was also capable to predicting the effect of repeated injury in 
liver fibrosis. This prediction is consistent with the fact that only repeated injury 
  129 
could cause continuous accumulation of ECM. This prediction also suggested that 
treatments targeting fibrotic region might be more efficient. 
6.1 Future Work 
With the understanding of TGF-β regulations in liver fibrosis at multiple levels 
and multiple scales, we have improved the models and systematic studies of TGF-β 
and its regulations in liver fibrosis. 
One of the future perspectives could be experimental validation of detaild 
mechanism of PPM1A upregulation. Our model analysis suggested how PPM1A 
could be upregulated by stabilization, but how each step of interaction happens 
need to be validated by more biological studies. This could be a new biological 
project and it could be guided by our current model. 
Another future work could be improvement of our algorithms of approximating 
cell-population behavior. There is still some room for improvement such as reducing 
time steps in Population ODE simulation and better choice of the sensitivity 
matrix in Sample Reduction. It would be also great if these algorithms could be 
integrated into parameter estimation methods. Then single-cell models could be 
fitted to bulk experiment without the assumption that cells are identical. Applying 
our algorithms to other kinds of analysis such as bifurcation analysis could also be 
interesting. 
A simple assumption of diffusion could possibly explain the progression of 
chronic liver disease. The diffusion model may open a new door to the field of liver 
fibrosis or even other biological systems. Both computational and biological studies 
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could consider more about the spatial behaviors. For example, late stage of liver 
fibrosis, cirrhosis is characterized by destruction of blood vessels in liver tissue. It is 
generally considered that cirrhosis is hard to be reversed. How the spatial change of 
liver tissue could result in irreversibility remains a question. Studies focusing on the 
spatial properties may help us answer this kind of questions. 
  
  131 
7  Bibliography 
AFRAKHTE, M., MOREN, A., JOSSAN, S., ITOH, S., SAMPATH, K., 
WESTERMARK, B., HELDIN, C. H., HELDIN, N. E. & TEN DIJKE, P. 
1998. Induction of inhibitory Smad6 and Smad7 mRNA by TGF-beta family 
members. Biochem Biophys Res Commun, 249, 505-11. 
AGGARWAL, K. & MASSAGUE, J. 2012. Ubiquitin removal in the TGF-beta 
pathway. Nat Cell Biol, 14, 656-7. 
ALARCON, C., ZAROMYTIDOU, A. I., XI, Q., GAO, S., YU, J., FUJISAWA, S., 
BARLAS, A., MILLER, A. N., MANOVA-TODOROVA, K., MACIAS, M. J., 
SAPKOTA, G., PAN, D. & MASSAGUE, J. 2009. Nuclear CDKs drive Smad 
transcriptional activation and turnover in BMP and TGF-beta pathways. Cell, 
139, 757-69. 
ALBECK, J. G., BURKE, J. M., SPENCER, S. L., LAUFFENBURGER, D. A. & 
SORGER, P. K. 2008. Modeling a Snap-Action, Variable-Delay Switch 
Controlling Extrinsic Cell Death. PLoS Biol. 2008/12/05 ed. 
ALBERGHINA, L. & WESTERHOFF, H. V. 2005. Systems biology: definitions and 
perspectives. 
ANNES, J. P., MUNGER, J. S. & RIFKIN, D. B. 2003. Making sense of latent 
TGFbeta activation. J Cell Sci, 116, 217-24. 
ANONICK, P. K., YOO, J. K., WEBB, D. J. & GONIAS, S. L. 1993. 
Characterization of the antiplasmin activity of human thrombospondin-1 in 
solution. Biochem J, 289 ( Pt 3), 903-9. 
ARTHUR, M. J. 1997. Matrix degradation in liver: a role in injury and repair. 
Hepatology, 26, 1069-71. 
ASHALL, L., HORTON, C. A., NELSON, D. E., PASZEK, P., HARPER, C. V., 
SILLITOE, K., RYAN, S., SPILLER, D. G., UNITT, J. F., BROOMHEAD, 
D. S., KELL, D. B., RAND, D. A., SÉE, V. & WHITE, M. R. H. 2009. 
Pulsatile stimulation determines timing and specificity of NF-kappaB-dependent 
transcription. Science. 
ATTISANO, L. & WRANA, J. L. 2002. Signal transduction by the TGF-beta 
superfamily. Science, 296, 1646-7. 
BAKIN, A. V., TOMLINSON, A. K., BHOWMICK, N. A., MOSES, H. L. & 
ARTEAGA, C. L. 2000. Phosphatidylinositol 3-kinase function is required for 
transforming growth factor beta-mediated epithelial to mesenchymal transition 
and cell migration. J Biol Chem, 275, 36803-10. 
  132 
BARABASI, A. L. & OLTVAI, Z. N. 2004. Network biology: understanding the cell's 
functional organization. Nat Rev Genet, 5, 101-13. 
BASSING, C. H., YINGLING, J. M., HOWE, D. J., WANG, T., HE, W. W., 
GUSTAFSON, M. L., SHAH, P., DONAHOE, P. K. & WANG, X. F. 1994. A 
transforming growth factor beta type I receptor that signals to activate gene 
expression. Science, 263, 87-9. 
BATALLER, R. & BRENNER, D. A. 2005. Liver fibrosis. J Clin Invest, 115, 209-18. 
BATES, P. W., CHEN, X. & CHMAJ, A. J. J. 2006. Traveling Waves of Bistable 
Dynamics on a Lattice. SIAM J  Math  Anal, 35, 520-546. 
BENYON, R. C. & IREDALE, J. P. 2000. Is liver fibrosis reversible? Gut, 46, 443-6. 
BU, S., KAPANADZE, B., HSU, T. & TROJANOWSKA, M. 2008. Opposite effects of 
dihydrosphingosine 1-phosphate and sphingosine 1-phosphate on transforming 
growth factor-beta/Smad signaling are mediated through the PTEN/PPM1A-
dependent pathway. J Biol Chem, 283, 19593-602. 
CASSIMAN, D., LIBBRECHT, L., DESMET, V., DENEF, C. & ROSKAMS, T. 2002. 
Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat 
livers. Journal of hepatology, 36, 200-9. 
CHATTERJEE, A., VLACHOS, D. G. & KATSOULAKIS, M. A. 2005. Binomial 
distribution based tau-leap accelerated stochastic simulation. J Chem Phys, 122, 
024112. 
CHEN, W. W., SCHOEBERL, B., JASPER, P. J., NIEPEL, M., NIELSEN, U. B., 
LAUFFENBURGER, D. A. & SORGER, P. K. 2009. Input–output behavior of 
ErbB signaling pathways as revealed by a mass action model trained against 
dynamic data. Mol Syst Biol. 
CHUNG, S. W., MILES, F. L., SIKES, R. A., COOPER, C. R., FARACH-CARSON, 
M. C. & OGUNNAIKE, B. A. 2009. Quantitative modeling and analysis of the 
transforming growth factor beta signaling pathway. Biophys J, 96, 1733-50. 
CITRI, A. & YARDEN, Y. 2006. EGF–ERBB signalling: towards the systems level. 
Nat Rev Mol Cell Biol. 
CLARKE, D. C., BROWN, M. L., ERICKSON, R. A., SHI, Y. & LIU, X. 2009. 
Transforming growth factor beta depletion is the primary determinant of Smad 
signaling kinetics. Molecular and cellular biology, 29, 2443-55. 
CURRIER, A. R., SABLA, G., LOCAPUTO, S., MELIN-ALDANA, H., DEGEN, J. L. 
& BEZERRA, J. A. 2003. Plasminogen directs the pleiotropic effects of uPA in 
liver injury and repair. Am J Physiol Gastrointest Liver Physiol, 284, G508-15. 
  133 
DALLAS, S. L., ROSSER, J. L., MUNDY, G. R. & BONEWALD, L. F. 2002. 
Proteolysis of latent transforming growth factor-beta (TGF-beta )-binding 
protein-1 by osteoclasts. A cellular mechanism for release of TGF-beta from 
bone matrix. J Biol Chem, 277, 21352-60. 
DANIEL, C., WIEDE, J., KRUTZSCH, H. C., RIBEIRO, S. M., ROBERTS, D. D., 
MURPHY-ULLRICH, J. E. & HUGO, C. 2004. Thrombospondin-1 is a major 
activator of TGF-beta in fibrotic renal disease in the rat in vivo. Kidney Int, 
65, 459-68. 
DESMET, V. J. & ROSKAMS, T. 2004. Cirrhosis reversal: a duel between dogma and 
myth. Journal of hepatology, 40, 860-7. 
DI GUGLIELMO, G. M., LE ROY, C., GOODFELLOW, A. F. & WRANA, J. L. 
2003. Distinct endocytic pathways regulate TGF-beta receptor signalling and 
turnover. Nat Cell Biol, 5, 410-21. 
EBISAWA, T., FUKUCHI, M., MURAKAMI, G., CHIBA, T., TANAKA, K., 
IMAMURA, T. & MIYAZONO, K. 2001. Smurf1 interacts with transforming 
growth factor-beta type I receptor through Smad7 and induces receptor 
degradation. J Biol Chem, 276, 12477-80. 
EICHHORN, P. J., RODON, L., GONZALEZ-JUNCA, A., DIRAC, A., GILI, M., 
MARTINEZ-SAEZ, E., AURA, C., BARBA, I., PEG, V., PRAT, A., 
CUARTAS, I., JIMENEZ, J., GARCIA-DORADO, D., SAHUQUILLO, J., 
BERNARDS, R., BASELGA, J. & SEOANE, J. 2012. USP15 stabilizes TGF-
beta receptor I and promotes oncogenesis through the activation of TGF-beta 
signaling in glioblastoma. Nat Med, 18, 429-35. 
EISSING, T. 2004. Bistability Analyses of a Caspase Activation Model for Receptor-
induced Apoptosis. Journal of Biological Chemistry. 
ENG, F. J. & FRIEDMAN, S. L. 2000. Fibrogenesis I. New insights into hepatic 
stellate cell activation: the simple becomes complex. Am J Physiol Gastrointest 
Liver Physiol, 279, G7-G11. 
FRIEDMAN, S. L. 2000. Molecular regulation of hepatic fibrosis, an integrated cellular 
response to tissue injury. J Biol Chem, 275, 2247-50. 
FRIEDMAN, S. L. 2003. Liver fibrosis -- from bench to bedside. J Hepatol, 38 Suppl 1, 
S38-53. 
GOUMANS, M. J., VALDIMARSDOTTIR, G., ITOH, S., ROSENDAHL, A., 
SIDERAS, P. & TEN DIJKE, P. 2002. Balancing the activation state of the 
endothelium via two distinct TGF-beta type I receptors. EMBO J, 21, 1743-53. 
GRESSNER, A. M. & WEISKIRCHEN, R. 2006. Modern pathogenetic concepts of 
liver fibrosis suggest stellate cells and TGF-beta as major players and 
therapeutic targets. J Cell Mol Med, 10, 76-99. 
  134 
GRESSNER, A. M., WEISKIRCHEN, R., BREITKOPF, K. & DOOLEY, S. 2002. 
Roles of TGF-beta in hepatic fibrosis. Front Biosci, 7, d793-807. 
HAMMEL, P., COUVELARD, A., O'TOOLE, D., RATOUIS, A., SAUVANET, A., 
FLEJOU, J. F., DEGOTT, C., BELGHITI, J., BERNADES, P., VALLA, D., 
RUSZNIEWSKI, P. & LEVY, P. 2001. Regression of liver fibrosis after biliary 
drainage in patients with chronic pancreatitis and stenosis of the common bile 
duct. N Engl J Med, 344, 418-23. 
HAYASHI, H., ABDOLLAH, S., QIU, Y., CAI, J., XU, Y. Y., GRINNELL, B. W., 
RICHARDSON, M. A., TOPPER, J. N., GIMBRONE, M. A., JR., WRANA, 
J. L. & FALB, D. 1997. The MAD-related protein Smad7 associates with the 
TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell, 
89, 1165-73. 
HERNANDEZ-GEA, V. & FRIEDMAN, S. L. 2011. Pathogenesis of liver fibrosis. 
Annual review of pathology, 6, 425-56. 
HJELMELAND, A. B., HJELMELAND, M. D., SHI, Q., HART, J. L., BIGNER, D. 
D., WANG, X. F., KONTOS, C. D. & RICH, J. N. 2005. Loss of phosphatase 
and tensin homologue increases transforming growth factor beta-mediated 
invasion with enhanced SMAD3 transcriptional activity. Cancer research, 65, 
11276-81. 
HOFFMANN, A. 2002. The Ikappa B-NF-kappa B Signaling Module: Temporal Control 
and Selective Gene Activation. Science. 
HOGG, P. J., STENFLO, J. & MOSHER, D. F. 1992. Thrombospondin is a slow 
tight-binding inhibitor of plasmin. Biochemistry, 31, 265-9. 
INUI, M., MANFRIN, A., MAMIDI, A., MARTELLO, G., MORSUT, L., SOLIGO, S., 
ENZO, E., MORO, S., POLO, S., DUPONT, S., CORDENONSI, M. & 
PICCOLO, S. 2011. USP15 is a deubiquitylating enzyme for receptor-activated 
SMADs. Nat Cell Biol, 13, 1368-75. 
IREDALE, J. P. 2007. Models of liver fibrosis: exploring the dynamic nature of 
inflammation and repair in a solid organ. J Clin Invest, 117, 539-48. 
IREDALE, J. P., BENYON, R. C., PICKERING, J., MCCULLEN, M., NORTHROP, 
M., PAWLEY, S., HOVELL, C. & ARTHUR, M. J. 1998. Mechanisms of 
spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and 
reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest, 102, 
538-49. 
ITOH, S., LANDSTROM, M., HERMANSSON, A., ITOH, F., HELDIN, C. H., 
HELDIN, N. E. & TEN DIJKE, P. 1998. Transforming growth factor beta1 
induces nuclear export of inhibitory Smad7. J Biol Chem, 273, 29195-201. 
  135 
KAVSAK, P., RASMUSSEN, R. K., CAUSING, C. G., BONNI, S., ZHU, H., 
THOMSEN, G. H. & WRANA, J. L. 2000. Smad7 binds to Smurf2 to form an 
E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol Cell, 
6, 1365-75. 
KELLEY, L. A. & STERNBERG, M. J. 2009. Protein structure prediction on the Web: 
a case study using the Phyre server. Nat Protoc, 4, 363-71. 
KHOLODENKO, B. N., DEMIN, O. V., MOEHREN, G. & HOEK, J. B. 1999. 
Quantification of short term signaling by the epidermal growth factor receptor. 
J Biol Chem, 274, 30169-81. 
KINNMAN, N., GORIA, O., WENDUM, D., GENDRON, M. C., REY, C., POUPON, 
R. & HOUSSET, C. 2001. Hepatic stellate cell proliferation is an early platelet-
derived growth factor-mediated cellular event in rat cholestatic liver injury. Lab 
Invest, 81, 1709-16. 
KLIPP, E. & ZI, Z. 2007. Constraint-based modeling and kinetic analysis of the smad 
dependent tgf-Beta signaling pathway. PLoS ONE, 2, e936. 
KNITTEL, T., KOBOLD, D., PISCAGLIA, F., SAILE, B., NEUBAUER, K., 
MEHDE, M., TIMPL, R. & RAMADORI, G. 1999. Localization of liver 
myofibroblasts and hepatic stellate cells in normal and diseased rat livers: 
distinct roles of (myo-)fibroblast subpopulations in hepatic tissue repair. 
Histochemistry and cell biology, 112, 387-401. 
KONDOU, H., MUSHIAKE, S., ETANI, Y., MIYOSHI, Y., MICHIGAMI, T. & 
OZONO, K. 2003. A blocking peptide for transforming growth factor-beta1 
activation prevents hepatic fibrosis in vivo. J Hepatol, 39, 742-8. 
KUTZ, S. M., HIGGINS, C. E., SAMARAKOON, R., HIGGINS, S. P., ALLEN, R. 
R., QI, L. & HIGGINS, P. J. 2006. TGF-beta 1-induced PAI-1 expression is E 
box/USF-dependent and requires EGFR signaling. Exp Cell Res, 312, 1093-105. 
LEE, T. K. & COVERT, M. W. 2010. High-throughput, single-cell NF-ÎºB dynamics. 
Current Opinion in Genetics &amp; Development. Elsevier Ltd. 
LEE, T. K., DENNY, E. M., SANGHVI, J. C., GASTON, J. E., MAYNARD, N. D., 
HUGHEY, J. J. & COVERT, M. W. 2009. A Noisy Paracrine Signal 
Determines the Cellular NF- B Response to Lipopolysaccharide. Science 
Signaling. 
LIN, X., DUAN, X., LIANG, Y. Y., SU, Y., WRIGHTON, K. H., LONG, J., HU, M., 
DAVIS, C. M., WANG, J., BRUNICARDI, F. C., SHI, Y., CHEN, Y. G., 
MENG, A. & FENG, X. H. 2006. PPM1A functions as a Smad phosphatase to 
terminate TGFbeta signaling. Cell, 125, 915-28. 
  136 
LIN, X., LIANG, M. & FENG, X. H. 2000. Smurf2 is a ubiquitin E3 ligase mediating 
proteasome-dependent degradation of Smad2 in transforming growth factor-beta 
signaling. J Biol Chem, 275, 36818-22. 
LO, R. S. & MASSAGUE, J. 1999. Ubiquitin-dependent degradation of TGF-beta-
activated smad2. Nat Cell Biol, 1, 472-8. 
LYONS, R. M., GENTRY, L. E., PURCHIO, A. F. & MOSES, H. L. 1990. 
Mechanism of activation of latent recombinant transforming growth factor beta 
1 by plasmin. J Cell Biol, 110, 1361-7. 
MASSAGUE, J. 1998. TGF-beta signal transduction. Annu Rev Biochem, 67, 753-91. 
MASSAGUE, J., BLAIN, S. W. & LO, R. S. 2000. TGFbeta signaling in growth 
control, cancer, and heritable disorders. Cell, 103, 295-309. 
MASSAGUE, J. & WOTTON, D. 2000. Transcriptional control by the TGF-
beta/Smad signaling system. EMBO J, 19, 1745-54. 
MELKE, P., JONSSON, H., PARDALI, E., TEN DIJKE, P. & PETERSON, C. 2006. 
A rate equation approach to elucidate the kinetics and robustness of the TGF-
beta pathway. Biophys J, 91, 4368-80. 
MURPHY-ULLRICH, J. E. & POCZATEK, M. 2000. Activation of latent TGF-beta 
by thrombospondin-1: mechanisms and physiology. Cytokine Growth Factor Rev, 
11, 59-69. 
NAKAKUKI, T., BIRTWISTLE, M. R., SAEKI, Y., YUMOTO, N., IDE, K., 
NAGASHIMA, T., BRUSCH, L., OGUNNAIKE, B. A., OKADA-
HATAKEYAMA, M. & KHOLODENKO, B. N. 2010. Ligand-Specific c-Fos 
Expression Emerges from the Spatiotemporal Control of ErbB Network 
Dynamics. Cell. Elsevier Ltd. 
NAKAO, A., AFRAKHTE, M., MOREN, A., NAKAYAMA, T., CHRISTIAN, J. L., 
HEUCHEL, R., ITOH, S., KAWABATA, M., HELDIN, N. E., HELDIN, C. H. 
& TEN DIJKE, P. 1997. Identification of Smad7, a TGFbeta-inducible 
antagonist of TGF-beta signalling. Nature, 389, 631-5. 
NELSON, D. E. 2004. Oscillations in NF- B Signaling Control the Dynamics of Gene 
Expression. Science. 
NUMMINEN, K., SIPILA, O. & MAKISALO, H. 2005. Preoperative hepatic 3D 
models: virtual liver resection using three-dimensional imaging technique. Eur J 
Radiol, 56, 179-84. 
SALGADO, S., GARCIA, J., VERA, J., SILLER, F., BUENO, M., MIRANDA, A., 
SEGURA, A., GRIJALVA, G., SEGURA, J., OROZCO, H., HERNANDEZ-
PANDO, R., FAFUTIS, M., AGUILAR, L. K., AGUILAR-CORDOVA, E. & 
  137 
ARMENDARIZ-BORUNDA, J. 2000. Liver cirrhosis is reverted by urokinase-
type plasminogen activator gene therapy. Mol Ther, 2, 545-51. 
SCHMIERER, B. & HILL, C. S. 2005. Kinetic analysis of Smad nucleocytoplasmic 
shuttling reveals a mechanism for transforming growth factor beta-dependent 
nuclear accumulation of Smads. Mol Cell Biol, 25, 9845-58. 
SCHMIERER, B., TOURNIER, A. L., BATES, P. A. & HILL, C. S. 2008. 
Mathematical modeling identifies Smad nucleocytoplasmic shuttling as a 
dynamic signal-interpreting system. Proc Natl Acad Sci U S A, 105, 6608-13. 
SCHOEBERL, B., EICHLER-JONSSON, C., GILLES, E. D. & MULLER, G. 2002. 
Computational modeling of the dynamics of the MAP kinase cascade activated 
by surface and internalized EGF receptors. Nat Biotechnol, 20, 370-5. 
SCHULTZ-CHERRY, S., RIBEIRO, S., GENTRY, L. & MURPHY-ULLRICH, J. E. 
1994. Thrombospondin binds and activates the small and large forms of latent 
transforming growth factor-beta in a chemically defined system. J Biol Chem, 
269, 26775-82. 
SHERMAN, I. A., PAPPAS, S. C. & FISHER, M. M. 1990. Hepatic microvascular 
changes associated with development of liver fibrosis and cirrhosis. The 
American journal of physiology, 258, H460-5. 
SHI, W., SUN, C., HE, B., XIONG, W., SHI, X., YAO, D. & CAO, X. 2004. 
GADD34-PP1c recruited by Smad7 dephosphorylates TGFbeta type I receptor. 
J Cell Biol, 164, 291-300. 
SHI, Y. & MASSAGUE, J. 2003. Mechanisms of TGF-beta signaling from cell 
membrane to the nucleus. Cell, 113, 685-700. 
SHMULEVICH, I., DOUGHERTY, E. R., KIM, S. & ZHANG, W. 2002. Probabilistic 
Boolean Networks: a rule-based uncertainty model for gene regulatory networks. 
Bioinformatics, 18, 261-74. 
SIVAKUMAR, K. C., DHANESH, S. B., SHOBANA, S., JAMES, J. & 
MUNDAYOOR, S. 2011. A systems biology approach to model neural stem cell 
regulation by notch, shh, wnt, and EGF signaling pathways. OMICS, 15, 729-
37. 
SPENCER, S. L., GAUDET, S., ALBECK, J. G., BURKE, J. M. & SORGER, P. K. 
2009a. Non-genetic origins of cell-to-cell variability in TRAIL-induced 
apoptosis. Nature, 459, 428-32. 
SPENCER, S. L., GAUDET, S., ALBECK, J. G., BURKE, J. M. & SORGER, P. K. 
2009b. Non-genetic origins of cell-to-cell variability in TRAIL-induced 
apoptosis. Nature. 2009/04/14 ed. 
  138 
TAY, S., HUGHEY, J. J., LEE, T. K., LIPNIACKI, T., QUAKE, S. R. & COVERT, 
M. W. 2010. Single-cell NF-κB dynamics reveal digital activation and analogue 
information processing. Nature. 
TOETTCHER, J. E., APGAR, J. F., CASTILLO, A. R., TIDOR, B. & WHITE, J. 
2011. Recycling Circuit Simulation Techniques for Mass-Action Biochemical 
Kinetics. In: LI, P., SILVEIRA, L. M., FELDMANN, P. & EDS. (eds.) 
chapter in Simulation and Verification of Electronic and Biological Systems. 
Springer. 
VANHEULE, E., GEERTS, A. M., VAN HUYSSE, J., SCHELFHOUT, D., PRAET, 
M., VAN VLIERBERGHE, H., DE VOS, M. & COLLE, I. 2008. An intravital 
microscopic study of the hepatic microcirculation in cirrhotic mice models: 
relationship between fibrosis and angiogenesis. International journal of 
experimental pathology, 89, 419-32. 
VASSALLI, J. D., SAPPINO, A. P. & BELIN, D. 1991. The plasminogen 
activator/plasmin system. J Clin Invest, 88, 1067-72. 
VENKATRAMAN, L., CHIA, S. M., NARMADA, B. C., WHITE, J. K., 
BHOWMICK, S. S., FORBES DEWEY, C., JR., SO, P. T., TUCKER-
KELLOGG, L. & YU, H. 2012. Plasmin triggers a switch-like decrease in 
thrombospondin-dependent activation of TGF-beta1. Biophys J, 103, 1060-8. 
VENKATRAMAN, L., YU, H., BHOWMICK, S. S., DEWEY, F. & TUCKER-
KELLOGG, L. 2010. The steady States and dynamics of urokinase-mediated 
plasmin activation. Pac Symp Biocomput, 190-200. 
VILAR, J. M., JANSEN, R. & SANDER, C. 2006. Signal processing in the TGF-beta 
superfamily ligand-receptor network. PLoS Comput Biol, 2, e3. 
VOLLMAR, B., SIEGMUND, S. & MENGER, M. D. 1998. An intravital fluorescence 
microscopic study of hepatic microvascular and cellular derangements in 
developing cirrhosis in rats. Hepatology, 27, 1544-53. 
WEISS, J. N., QU, Z. & GARFINKEL, A. 2003. Understanding biological complexity: 
lessons from the past. FASEB J, 17, 1-6. 
WILEY, H. S. & CUNNINGHAM, D. D. 1981. A steady state model for analyzing the 
cellular binding, internalization and degradation of polypeptide ligands. Cell, 25, 
433-40. 
WRANA, J. L. & ATTISANO, L. 2000. The Smad pathway. Cytokine Growth Factor 
Rev, 11, 5-13. 
YINGLING, J. M., BLANCHARD, K. L. & SAWYER, J. S. 2004. Development of 
TGF-beta signalling inhibitors for cancer therapy. Nature reviews. Drug 
discovery, 3, 1011-22. 
  139 
ZEISBERG, M., YANG, C., MARTINO, M., DUNCAN, M. B., RIEDER, F., 
TANJORE, H. & KALLURI, R. 2007. Fibroblasts derive from hepatocytes in 
liver fibrosis via epithelial to mesenchymal transition. J Biol Chem, 282, 
23337-47. 
ZHANG, L., ZHOU, F., DRABSCH, Y., GAO, R., SNAAR-JAGALSKA, B. E., 
MICKANIN, C., HUANG, H., SHEPPARD, K. A., PORTER, J. A., LU, C. 
X. & TEN DIJKE, P. 2012. USP4 is regulated by AKT phosphorylation and 
directly deubiquitylates TGF-beta type I receptor. Nat Cell Biol, 14, 717-26. 
ZI, Z., FENG, Z., CHAPNICK, D. A., DAHL, M., DENG, D., KLIPP, E., 
MOUSTAKAS, A. & LIU, X. 2011. Quantitative analysis of transient and 
sustained transforming growth factor-beta signaling dynamics. Molecular 




  140 
8  Appendix 
8.1 Appendix for Chapter 3 
8.1.1 Appendix Tables of Smad Pathway Models 
  
  141 
Table 8.1 Initial Concentrations (I.C.) in nM. Nuclear species have been expressed relative to the 
concentrations in cytoplasm. 
 
  
Species Name Species Description I.C. Reference 
TGF-β The TGF-β ligand 80 (Klipp 2007) 
T1RSurf The type I receptor on the cell surface 0.237 (Klipp 2007) 
T1RCave The type I receptor in the caveolae 2.092 (Klipp 2007) 
T1REE The type I receptor in the early endosome 2.06 (Klipp 2007) 
T2RSurf The type II receptor on the cell surface 0.202 (Klipp 2007) 
T2RCave The type II receptor in the caveolae 1.778 (Klipp 2007) 
T2REE The type II receptor in the early endosome 1.148 (Klipp 2007) 
pT2RSurf Ligand-bound type II receptor on the cell surface 0  
pT2RCave Ligand-bound type II receptor in the caveolae 0  
pT2REE Ligand-bound type II receptor in the early endosome 0  
LRCSurf The ligand-receptor complex on the cell surface 0  
LRCCave The ligand-receptor complex in the caveolae 0  
LRCEE The ligand-receptor complex in the early endosome 0  
T1R:T2R The T1R-T2R complex released from LRC 0  
RI The receptor inhibitor SB-431542 600 (Schmierer 2008) 
LRCEE:RI The complex of the receptor inhibitor and LRC 0  
LRC:Smad2 The complex of Smad2 and LRC 0  
Smad2Cyt Smad2 in the cytoplasm 494.67 (Klipp 2007) 
Smad2Nuc Smad2 in the nucleus 76.76 (Klipp 2007) 
pSmad2Cyt Phosphorylated Smad2 in the cytoplasm 0  
pSmad2Nuc Phosphorylated Smad2 in the nucleus 0  
Smad4Cyt Smad4 in the cytoplasm 666.65 (Klipp 2007) 
Smad4Nuc Smad4 in the nucleus 666.65 (Klipp 2007) 
Smad2:Smad4Cyt The complex of Smad2 and Smad4 in the cytoplasm 0  
Smad2:Smad4Nuc The complex of Smad2 and Smad4 in the nucleus 0  
Smad2:Smad2Cyt The homo-dimer of Smad2 in the cytoplasm 0  
Smad2:Smad2Nuc The homo-dimer of Smad2 in the nucleus 0  
Smad7 Smad7 0  
dephLRCCave Dephosphorylated LRC in the caveolae 0  
dephLRCEE Dephosphorylated LRC in the early endosome 0  
LRCCave:Smad7 The complex of Smad7 and LRC in the caveolae 0  
LRCEE:Smad7 The complex of Smad7 and LRC in the early endosome 0  
PPM1ACyt PPM1A in the cytoplasm 1  
PPM1ANuc PPM1A in the nucleus 100  




PTENNuc PTEN in the nucleus 0  
pSmad2:PPM1ACyt The complex of pSmad2 and PPM1A in the cytoplasm 0  
pSmad2:PPM1A:PTENCyt The complex of pSmad2 and PPM1A:PTEN in the cytoplasm  0  
pSmad2:PTENCyt The complex of pSmad2 and PTEN in the cytoplasm 0  
pSmad2:PTEN:PPM1ACyt The complex of pSmad2:PTEN and PPM1A in the cytoplasm 0  
PPM1A:PTENCyt 
The PPM1A-PTEN complex released from 
pSmad2:PTEN:PPM1A in the cytoplasm 0  
pSmad2:PPM1ANuc The complex of pSmad2 and PPM1A in the nucleus 0  
pSmad2:PPM1A:PTENNuc The complex of pSmad2 and PPM1A:PTEN in the nucleus  0  
PPM1A:PTENCyt 
The PPM1A-PTEN complex released from 
pSmad2:PTEN:PPM1A in the nucleus 0  !
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Rate Constant Name Values Reference 
vT1R 0.0103 (Klipp 2007) 
vT2R 0.02869 (Klipp 2007) 
kiEE 0.33 (Klipp 2007) 
krEE 0.033 (Klipp 2007) 
kiCave 0.33 (Klipp 2007) 
krCave 0.03742 (Klipp 2007) 
kdegT1R 0.005 (Klipp 2007) 
kdegT2R 0.025 (Klipp 2007) 
kcd 0.005 (Klipp 2007) 
kLRC1 estimated  
kLRC2 estimated  
krReceptor 10000  
kfSmad2 estimated 
 
krSmad2 estimated  
kfSmadsComplex estimated  
krSmadsComplex estimated  
kimpSmad2 0.054 (Schmierer 2008) 
kexpSmad2 0.348 (Schmierer 2008) 
kimpSmad4 0.054 (Schmierer 2008) 
kexpSmad4 0.054 (Schmierer 2008) 
kimpSmadsComplex 0.27 (Schmierer 2008) 
klid estimated  
kdephpSmad2 estimated  
kdegpSmad2 estimated  
vSmad2 estimated  
kdegSmad2 estimated  
kSmad7 estimated  
kfSmad7Cave estimated  
kbSmad7Cave estimated  
kfSmad7EE estimated  
kbSmad7EE estimated  
kdephLRC:Smad7 estimated  
kdegLRC:Smad7 estimated  
vPPM1A estimated  
kdegPPM1A estimated  
kfPPM1A estimated  
kbPPM1A estimated 
 
krPPM1A estimated  
kdephPPM1A estimated  
kfPP estimated  
kbPP estimated 
 
krPP estimated  
kfPTEN estimated  
kbPTEN estimated  
kimpPPM1A estimated  
kimpPP estimated  
kexpPP estimated  
kexpPTEN estimated  
kfRI 100 (Schmierer 2008) 
kbRI 684 (Schmierer 2008) 
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Table 8.3 Reactions Table: All reactions in Model 1-11 with rate constants labeled. (Continued 
on the next page) 
 
  
 Reaction Models 
1 vT 1R⎯ →⎯⎯ T1RSurf ! All 
2 vT 2R⎯ →⎯⎯ T 2RSurf ! All 
3 
 
T1RSurf kiEEkrEE   T1REE ! All 
4 
 
T1RSurf kiCavekrCave   T1RCave ! All 
5 
 
T 2RSurf kiEEkrEE   T 2REE ! All 
6 
 
T 2RSurf kiCavekrCave   T 2RCave ! All 
7 
 
pT 2RSurf kiEEkrEE   pT 2REE ! All 
8 
 
pT 2RSurf kiCavekrCave   pT 2RCave ! All 
9 T1REE kdegT 1R⎯ →⎯⎯ ! All 
10 T 2REE kdegT 2R⎯ →⎯⎯ ! All 
11 pT 2REE kdegT 2R⎯ →⎯⎯ ! All 
12 TGFβ +T 2RSurf kLRC1⎯ →⎯⎯ pT 2RSurf ! All 
13 pT 2RSurf +T1RSurf kLRC2⎯ →⎯⎯ LRCSurf ! All 
14 LRCSurf kiEE⎯ →⎯ LRCEE ! All 
15 LRCEE krEE⎯ →⎯⎯ T1R :T 2R +TGFβ ! All 
16 LRCSurf kiCave⎯ →⎯⎯ LRCCave ! All 
17 LRCCave krCave⎯ →⎯⎯ T1R :T 2R +TGFβ ! All 
18 T1R :T 2R krR⎯ →⎯ T1RSurf +T 2RSurf ! All 
19 LRCEE kcd⎯ →⎯ ! All 
20 LRCEE + Smad2Cyt kfSmad2⎯ →⎯⎯ LRC :Smad2 ! All 
21 LRC :Smad2 krSmad2⎯ →⎯⎯⎯ LRCEE + pSmad2Cyt ! All 
22 pSmad2Cyt + Smad4Cyt kfSmadsComplex⎯ →⎯⎯⎯⎯ Smad2 :Smad4Cyt ! All 
23 pSmad2Cyt + pSmad2Cyt kfSmadsComplex⎯ →⎯⎯⎯⎯ Smad2 :Smad2Cyt ! All 
24 
 
pSmad2Nuc + Smad4Nuc kfSmadsComplexkrSmadsComplex   Smad2 :Smad4Nuc ! All 
25 
 
pSmad2Nuc + pSmad2Nuc kfSmadsComplexkrSmadsComplex   Smad2 :Smad2Nuc ! All 
26 
 
Smad2Cyt kimpSmad 2kexpSmad 2   Smad2Nuc ! All 
27 
 
pSmad2Cyt kimpSmad 2kexpSmad 2   pSmad2Nuc ! All 
28 
 
Smad4Cyt kimpSmad 4kexpSmad 4   Smad4Nuc ! All 
29 Smad2 :Smad4Cyt kimpSmadsComplex⎯ →⎯⎯⎯⎯ Smad2 :Smad4Nuc ! All 
30 Smad2 :Smad2Cyt kimpSmadsComplex⎯ →⎯⎯⎯⎯ Smad2 :Smad2Nuc ! All !
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31 LRCCave + Smad2 :Smad4Nuc klid⎯ →⎯ ! Model(2,3,5) 
32 LRCCave + Smad2 :Smad2Nuc klid⎯ →⎯ ! Model(2,3,5) 
33 pSmad2Nuc kdephpSmad 2⎯ →⎯⎯⎯ Smad2Nuc ! Model(1,2,5,6,7,8) 





   Smad2Cyt ! Model(7,11) 
36 Smad2Cyt kdegSmad 2⎯ →⎯⎯⎯ ! Model(7,11) 
37 Smad2Nuc kdegSmad 2⎯ →⎯⎯⎯ ! Model(7,11) 
38 pSmad2Cyt kdegSmad 2⎯ →⎯⎯⎯ ! Model(7,11) 
39 pSmad2Nuc kdegSmad 2⎯ →⎯⎯⎯ ! Model(7,11) 
40 Smad2 :Smad4Nuc kSmad 7⎯ →⎯⎯ Smad2 :Smad4Nuc + Smad7 ! Model(8) 
41 Smad2 :Smad2Nuc kSmad 7⎯ →⎯⎯ Smad2 :Smad2Nuc + Smad7 ! Model(8) 
42 Smad7 kcd⎯ →⎯ ! Model(8) 
43 LRCEE :Smad7 kcd⎯ →⎯ ! Model(8) 
44 
 
LRCCave + Smad7 kfSmad 7CavekrSmad 7Cave   LRCCave :Smad7 ! Model(8) 
45 
 
LRCEE + Smad7 kfSmad 7EEkrSmad 7EE   LRCEE :Smad7 ! Model(8) 
46 LRCCave :Smad7 kdephLRC:Smad 7⎯ →⎯⎯⎯⎯ dephLRCCave + Smad7 ! Model(8) 
47 LRCEE :Smad7 kdephLRC:Smad 7⎯ →⎯⎯⎯⎯ dephLRCEE + Smad7 ! Model(8) 
48 LRCCave :Smad7 kdegLRC:Smad 7⎯ →⎯⎯⎯⎯ ! Model(8) 
49 LRCEE :Smad7 kdegLRC:Smad 7⎯ →⎯⎯⎯⎯ ! Model(8) 
50 dephLRCCave krCave⎯ →⎯⎯ T1R :T 2R +TGFβ ! Model(8) 










   PPM1ACyt ! Model(10,11) 
54 PPM1ANuc kdegPPM 1A⎯ →⎯⎯⎯ ! Model(10,11) 
55 PPM1ACyt kimpPPM 1A⎯ →⎯⎯⎯ PPM1ANuc ! Model(10,11) 
56 Smad2 :Smad4Nuc kPPM1A⎯ →⎯⎯⎯ Smad2 :Smad4Nuc + PPM1ANuc ! Model(9) 
57 Smad2 :Smad2Nuc kPPM1A⎯ →⎯⎯⎯ Smad2 :Smad2Nuc + PPM1ANuc ! Model(9) 
58 
 pSmad2Nuc + PPM1ANuc
kfPPM1A
kbPPM1A
   pSmad2 :PPM1ANuc ! Model(9,10,11) 
59 pSmad2 :PPM1ANuc kdephPPM 1A⎯ →⎯⎯⎯ Smad2Nuc + PPM1ANuc ! Model(9,10,11) 
60 
 pSmad2Cyt + PPM1ACyt
kfPPM1A
kbPPM1A
   pSmad2 :PPM1ACyt ! Model(10,11) 
61 pSmad2 :PPM1ACyt kdephPPM 1A⎯ →⎯⎯⎯ Smad2Cyt + PPM1ACyt ! Model(10,11) 
62 
 pSmad2Nuc + PTEN :PPM1ANuc
kfPPM1A
kbPPM1A
   pSmad2 :PTEN :PPM1ANuc ! Model(10,11) 
63 pSmad2 :PTEN :PPM1ANuc kdephPPM 1A⎯ →⎯⎯⎯ Smad2Nuc + PTEN :PPM1ANuc ! Model(10,11) 
64 
 pSmad2Cyt + PTEN :PPM1ACyt
kfPPM1A
kbPPM1A
   pSmad2 :PTEN :PPM1ACyt ! Model(10,11) 
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65 pSmad2 :PTEN :PPM1ACyt kdephPPM 1A⎯ →⎯⎯⎯ Smad2Cyt + PTEN :PPM1ACyt ! Model(10,11) 
66 
 pSmad2Cyt + PTENCyt
kfPTEN
kbTEN
   pSmad2 :PTENCyt ! Model(10,11) 
67 
 pSmad2 :PTENCyt + PPM1ACyt
kfPP
kbPP
   pSmad2 :PTEN :PPM1ACyt ! Model(10,11) 
68 pSmad2 :PTEN :PPM1ACyt krPP⎯ →⎯⎯ pSmad2Cyt + PTEN :PPM1ACyt ! Model(10,11) 
69 PTEN :PPM1ACyt krPPM1A⎯ →⎯⎯⎯ PTENCyt + PPM1ACyt ! Model(10,11) 
70 PTEN :PPM1ANuc krPPM1A⎯ →⎯⎯⎯ PTENNuc + PPM1ANuc ! Model(10,11) 
71 
 
PTEN :PPM1ACyt kimpPPkexpPP   PTEN :PPM1ANuc ! Model(10,11) 
72 PTENNuc kexpPTEN⎯ →⎯⎯⎯ PTENCyt ! Model(10,11) 
73 
 LRCEE + RI
kfRI
kbRI
   LRCEE :RI ! All !
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ENDOGENOUS SYNTHESIS AND 







kdephpSmad2 estimated 0 0 0 0 0 0 
kdegpSmad2 0 0 estimated estimated 0 0 0 
vSmad2 0 0 0 5.7143 nMmin
-1 0 0 0 
kdegSmad2 0 0 0 0.01 min
-1 0 0 0 
klid 0 estimated 0 0 0 0 0 
kSmad7 0 0 0 0 estimated 0 0 
kfSmad7cave 0 0 0 0 estimated 0 0 
kbSmad7cave 0 0 0 0 estimated 0 0 
kfSmad7ee 0 0 0 0 estimated 0 0 
kbSmad7ee 0 0 0 0 estimated 0 0 
kdephLRC 0 0 0 0 estimated 0 0 
kdegLRC 0 0 0 0 estimated 0 0 
vPPM1A 0 0 0 0 0 estimated estimated 
kdegPPM1A 0 0 0 0 0 estimated estimated 
kdephPPM1A 0 0 0 0 0 estimated estimated 
kPPM1A 0 0 0 0 0 estimated 0 
kfPPM1A 0 0 0 0 0 0 estimated 
kbPPM1A 0 0 0 0 0 0 estimated 
krPPM1A 0 0 0 0 0 0 estimated 
kfPP 0 0 0 0 0 0 estimated 
kbPP 0 0 0 0 0 0 estimated 
kfPTEN 0 0 0 0 0 0 estimated 
kbPTEN 0 0 0 0 0 0 estimated 
kimpPPM1A 0 0 0 0 0 0 estimated 
kimpPP 0 0 0 0 0 0 estimated 
kexpPP 0 0 0 0 0 0 estimated 
kexpPTEN 0 0 0 0 0 0 estimated !
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Table 8.5 Table of Estimated Parameters in Model 1-11. Model 8 is excluded from this table 
because multiple fitted models (with different parameters) were selected from the structure of 
Model 8. The underlined values have been manually tuned. All the others were estimated 
numerically with MATLAB fmincon optimization. The last parameter (for PTEN) is an initial 




 Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 9 Model 10 Model 11 
kLRC1 (nM
-1min-1) 213.3 862.4 125.5 219.9 23.56 2388 34.11 0.9068 10.33 45.07 
kLRC2 (nM
-1min-1) 3459 1218 4706 62.49 10.63 0.1182 1025 0.04956 0.7638 0.02404 
kfSmad2 (nM-1min-1) 0.03958 0.02400 7.395e-4 0.1599 0.03533 0.6500 0.01185 0.9100 0.07978 1.873 
krSmad2 (nM-1min-1) 2.443e5 35.22 2299 1332 7479 2.036e5 99.44 8183 317.8 4.543e3 
kfSmadsComplex (nM-1min-1) 0.4670 5.871e-3 1.001e-3 2.586e-5 2.452e-4 3.122e-4 0.01329 1.074 0.1555 0.2867 
krSmadsComplex (nM-1min-1) 0.2858 0.2927 0.1605 2.297e-3 0.03971 0.05235 0.1560 4.194 3.095 1.720 
kdephpSmad2 (min
-1) 999.6 0.3706 0 0 3.145 11.06 9.676 0 0 0 
kdegpSmad2 (min
-1) 0 0 0 0.6789 0.3058 0.9444 3.163 0 0 0.4516 
vSmad2 (nMmin
-1) 0 0 0 0  0 0 5.714 0 0 5.714 
kdegSmad2 (min
-1) 0 0 0 0 0 0 0.01000 0 0 0.01000 
klid (nM-1min-1) 0 0.01371 8.250e-3 0 5.231e-4 0 0 0 0 0 
vPPM1A (nMmin
-1) 0 0 0 0 0 0 0 0.1000 7.000 7.000 
kdegPPM1A (min
-1) 0 0 0 0 0 0 0 0.01000 0.07000 0.07000 
kdephPPM1A (min
-1) 0 0 0 0 0 0 0 0.3980 16.01 1.502 
kPPM1A (min-1) 0 0 0 0 0 0 0 1.178e-3 0 0 
kfPPM1A (nM-1min-1) 0 0 0 0 0 0 0 45.63 7.153e-3 0.2117 
kbPPM1A (min-1) 0 0 0 0 0 0 0 7.354 1.088 6.500 
krPPM1A (min-1) 0 0 0 0 0 0 0 0 1.137e-8 1.604e-7 
kfPP (nM-1min-1) 0 0 0 0 0 0 0 0 66.60 2.422 
kbPP (min-1) 0 0 0 0 0 0 0 0 5.457e-8 7.366e-8 
krPP (min-1) 0 0 0 0 0 0 0 0 0.08566 0.4037 
kfPTEN (nM-1min-1) 0 0 0 0 0 0 0 0 104.3 20.48 
kbPTEN (min-1) 0 0 0 0 0 0 0 0 5.506e-7 6.788e-7 
kimpPPM1A (min
-1) 0 0 0 0 0 0 0 0 7.000 0.01406 
kimpPP (min
-1) 0 0 0 0 0 0 0 0 2.861e-3 1.978e-3 
kexpPP (min
-1) 0 0 0 0 0 0 0 0 2.180e-7 1.145e-7 
kexpPTEN (min
-1) 0 0 0 0 0 0 0 0 0.5330 0.03268 
PTENCyt (nM) 0 0 0 0 0 0 0 0 180.3 174.9 !
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8.2 Appendix for Chapter 4 
8.2.1 Derivation of the Jacobian Matrix of the Population ODE 
8.2.1.1 Derivation of Each Block in the Jacobian Matrix 
The Jacobian Matrix of the Population ODE can be divided into four blocks as 
shown in Equation (4.19) and the result of the derivation of all blocks are shown in 
Equation (4.20) to (4.23). Here we show how these equations are derived. 
One rule that we applied for our derivation is chain rule for the differentiation 







∂c ⊗ b  (8.1) 





1µ + A2µ⊗ µ + A2vec(CT )]
∂µ





= A1 + A2(µ⊗ I + I⊗ µ )
 (8.2) 








For Equation (4.22), we differentiate FC  with respect to µ  





1⊗ I + I⊗ A1)vec(CT )]
∂µ
+ ∂{(A
2⊗ I )[µ⊗ vec(CT )+ vec(µ⊗CT )]}
∂µ
+ ∂{(I⊗ A
2)[vec(C)⊗ µ + vec(µ⊗CT )]}
∂µ
 (8.4) 




= ∂E(δ ⊗ µ⊗δ )
∂µ
= E δ ⊗ µ⊗ ∂δ
∂µ




























= E(δ ⊗ I⊗δ )
 (8.5) 




= (A2⊗ I ) ∂µ⊗ vec(C
T )
∂µ











































= (A2⊗ I ) I⊗ vec(CT )+ E(δ ⊗ Ι ⊗δ )⎡⎣ ⎤⎦
+(I⊗ A2) vec(CT )⊗ I + E(δ ⊗ Ι ⊗δ )⎡⎣ ⎤⎦
 (8.6) 
For Equation (4.23), we differentiate FC  with respect to vec(CT )  




∂[(A1⊗ I + I⊗ A1)vec(CT )]
∂vec(CT )
+ ∂{(A
2⊗ I )[µ⊗ vec(CT )+ vec(µ⊗CT )]}
∂vec(CT )
+ ∂{(I⊗ A
2)[vec(CT )⊗ µ + vec(µ⊗CT )]}
∂vec(CT )
 (8.7) 
Applying the chain rule in Equation (8.1), we have 
 
∂µ⊗ vec(CT )
∂vec(CT ) = µ⊗ I
2
n2×n2 = µ⊗ I⊗ I
∂vec(CT )⊗ µ
∂vec(CT ) = I
2










∂vec(CT ) , we denote C
T  as in its column vectors 
 
 
CT = c1  cn( )n×n , ci =
E(δ iδ1)

























































µ⊗ I 0 0
0  0











= I⊗ µ⊗ I
 (8.10) 
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Substituting the derivatives in Equation (8.7) using Equation (8.8) and (8.10), 
we have Equation (4.23) derived as 
 
∂FC
∂vec(CT ) = (A
1⊗ I + I⊗ A1)
+(A2⊗ I )(µ⊗ I⊗ I + I⊗ µ⊗ I )
+(I⊗ A2)(I⊗ µ⊗ I + I⊗ I⊗ µ )
 (8.11) 
8.2.1.2 Simplification of Equation (4.22) 





= T1 +T 2 +T3 +T 4
T 1 = (A2⊗ I )[I⊗ vec(CT )]
T 2 = (A2⊗ I )E(δ ⊗ I⊗δ )
T3 = (I⊗ A2)E(δ ⊗ I⊗δ )









For simplification of these four terms, we need to write A2  as a block matrix 
 
 
















and to write CT  as a block matrix (same as that in Equation (8.9)) 
 
 
CT = c1  cn( )n×n , ci =
E(δ iδ1)














Please note that 
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E(δ ⊗ I⊗δ ) =
E[δ1(I⊗δ )]









































Then we can simplify the first term T1  as 
 
 
T1 = (A2⊗ I )[I⊗ vec(CT )]
= B1⊗ I  Bn ⊗ I( )
vec(CT ) 0 0
0  0















Applying the rule vec(AB) = (BT ⊗ I )A , we have 
 
 
T1 = vec(CTB1T )  vec(CTBnT )⎡⎣
⎤
⎦  (8.17) 
We can simplify the second term T 2  as 
 
 
T 2 = (A2⊗ I )E(δ ⊗ I⊗δ )



















Applying the rule (A⊗ B)(C⊗ D) = (AC)⊗ (BD) , we have 
 T 2 = Bk ⊗ ck
k=1
n
∑  (8.19) 
We can simplify the third term T3  as 
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The k-th row in T3  is 
 
 
T3k ,: = A2(I⊗ ck )














= B1ck  Bnck( )
 (8.21) 
We can simplify the fourth term T 4  as  
 
 











































Thus, all four terms of 
∂FC
∂µ
 have been simplified for computation. The largest 
matrix needed for computation has the size of n3 , which is much smaller than that 
without simplification ( n5 ). 
8.2.1.3 Simplification of Equation (4.23) 
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Applying the rule (A⊗ B)(C⊗ D) = (AC)⊗ (BD) , and because kronecker 
product is bilinear, the Equation (4.23) can be written as 
 
∂FC
∂vec(CT ) = (A
1⊗ I + I⊗ A1)
+(A2⊗ I )(µ⊗ I⊗ I + I⊗ µ⊗ I )
+(I⊗ A2)(I⊗ µ⊗ I + I⊗ I⊗ µ )
= (A1⊗ I + I⊗ A1)
+[A2(µ⊗ I + I⊗ µ )]⊗ I
+I⊗[A2(µ⊗ I + I⊗ µ )]
= [A1 + A2(µ⊗ I + I⊗ µ )]⊗ I




⊗ I + I⊗ ∂Fµ
∂µ
 (8.23) 
This simplification allow us to use the previous calculated matrix 
∂Fµ
∂µ
 and it 
has only the size of n2  which is much smaller than that without simplification 
( n5 ). 
 
 
 
